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Introduction
Sophinese Iskander-Rizk, Antonius F.W. van der Steen, and Gijs van Soest.
Based on
"Photoacoustic imaging for guidance of interventions in cardiovascular medicine." 
Physics in Medicine & Biology (2019).
Chapter 1
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Cardiovascular disease (CVD) remains the number one cause of death worldwide, 
killing 17.7 million people in 2015 1. Major risk factors are lifestyle-related: smoking, 
obesity, diet, and lack of exercise are major determinants for the occurrence of all 
cardiac and vascular conditions. While most of these factors are modiﬁable in 
principle, strategies to alter unhealthy behaviour have had limited success so far.
 Incidence of cardiovascular disease is progressive with age. Improved conditions, 
greater access to sanitation, medication and health care, and overall reduction of poverty 
have led to a global increase in life expectancy. This development, which overall is 
excellent news for public health, comes with the widespread adoption of a Western 
diet and lifestyle which are associated with increased cardiovascular risk. Today, 
more than 80% of CVD deaths occur in low- and middle-income countries 2. Increased 
life expectancy is associated to a higher incidence of heart failure. This association 
could be explained by a heightened probability of damage to the heart caused by a 
survived myocardial infarction (MI; a heart attack), for instance, or poorly treated rhythm 
disorders. Providing adequate and affordable care to patients with CVD worldwide is 
a major challenge in the coming decades.
 Treating all these patients with cardiac disease will depend strongly on technology; 
more speciﬁcally on the development of devices for minimally invasive treatment and 
for imaging guidance of these interventions. In minimally invasive interventions, 
functional catheters are advanced to the heart of the patient through a small incision 
in an artery or vein, to locally treat the condition. Catheter-based treatment strategies 
have a huge beneﬁt for patients and the healthcare system as a whole. Our ageing 
population will develop an epidemic of CVD, which requires adequate treatment 
to maintain quality of life and prevent progression of the disease. The alternative to 
minimally invasive treatment in the heart is cardiac surgery. Surgery requires opening 
the sternum, and while this has become a routine operation, the intervention requires 
hospitalization for at least a week and full recovery takes about a year, including 
2-3 months of inability to work.
 In contrast, catheter-based treatments can frequently be done without requiring 
an overnight stay: patients are admitted in the morning and discharged in the evening 
of the same day provided there were no complications. Recovery takes days rather 
than months, and the patient experiences much less physical trauma than in the case 
of an open surgery. The advantages of minimally invasive interventions in cost, demands 
on the healthcare system, and lost productivity are vast, compared to surgery.
 In minimally invasive treatment, interventionists have no direct line-of-sight to 
neither the instruments in use to treat the patient, nor to the pathology being treated. 
In today’s practice, the most common image guidance tool is X-ray ﬂuoroscopy or 
angiography. It provides a two-dimensional projection image of the heart and vessels, 
which are moving organs in three dimensions. Visualization of interventional catheters 
is frequently poor, depending on the presence of radiopaque markers on the devices. 
Soft tissues hardly present any image contrast and vessels are visualized by injection 
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of a contrast dye (angiography), which delineates the lumen but not the artery wall 3. 
Moreover, the cavities of the heart can also not be effectively visualized by means of 
x-ray contrast. Thus, in order to meet the efﬁcacy and safety outcomes of surgical 
treatment, it is crucial for the interventionist to access real-time, accurate imaging that 
provides functional image contrast at an adequate resolution. A real-time imaging 
modality is paramount to (1) support instrument navigation towards the treatment 
site, to (2) inform the therapeutic strategy, to (3) monitor the progress of the intervention 
and to (4) check its result. 
The term “photoacoustic” was introduced in cardiovascular medicine in the context 
of laser tissue ablation, for instance in decalciﬁcation of aortic valve leaﬂets 4 or 
coronary laser angioplasty and clot removal 5-7. It was used to indicate the photo-
mechanical effects of cavitation bubble formation and the subsequent shockwave 
that caused tissue damage 8-10. The acoustic signature of these violent events 
created by high-energy ultraviolet (excimer) or mid-infrared pulse absorption only had an 
intended therapeutic use. The usage of the word “photoacoustic” has evolved to imply 
non-destructive applications such as imaging, sensing or tissue characterization, 
rather than an ablation mechanism. In this thesis, we will discuss photoacoustics as 
an interventional imaging tool, not as a therapeutic intervention on its own. PA imaging 
is a hybrid imaging modality, merging advantages of optical and ultrasonic imaging. 
Optical absorption can provide chemically speciﬁc information, for instance on the 
oxygen saturation of blood. Purely optical imaging methods, however, require a 
coherent wavefront, which is poorly preserved due to tissue scattering, limiting the 
imaging depth. Photoacoustics, on the other hand, relies on both optical power and 
coherence of resulting acoustic waves for imaging, and thus allows one to image 
chemical information relatively deep (up to several centimetres) in biological structures. 
Deeper targets may be reached by miniaturization into endoscopic probes. Photo - 
acoustic (PA) imaging is unique in combining speed, compact instrumentation, and 
innate tissue type contrast (by optical absorption). These features lend it signiﬁcant 
potential for interventional imaging in cardiology. The uniquely tissue-speciﬁc image 
contrast of photoacoustics may, one day, help in unravelling the intricate web of 
causes and effects in CVD.
This chapter discusses the current state of the art in PA imaging for cardiovascular 
applications, speciﬁcally focusing on techniques that aim at guidance of cardiac and 
vascular interventions. CVD comprises interrelated and frequently interacting conditions 
such as vascular disorders, rhythm disorders, structural heart disease, and micro - 
vascular disease. As a result, conditions may be multifactorial from a clinical standpoint, 
with sometimes unclear boundaries. In an actual patient, the location of a previous MI 
may become a nidus for electrical conduction disorders that result in arrhythmias 11. 
Atrial ﬁbrillation, one such arrhythmia, can cause circulating thrombi, which can lodge 
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themselves in the vasculature of the brain, causing an ischemic stroke 12. This chapter 
is organized according to the various single-diagnostic applications for which PA 
imaging technologies have been developed. We summarize the advances in PA 
research for cardiovascular interventions, also outlining today’s practical procedures 
where PA image guidance may fulﬁl an unmet need. We discuss image contrast 
mechanisms, proposed innovative devices, and their envisioned roles in cardio-
vascular interventions guidance, diagnostics and therapy. Treated single diagnostic 
interventions include imaging and guidance of atherosclerosis, rhythm disorders, 
(micro-) vascular structure treatments, and MI characterization.
1.1  Photoacoustic imaging
Prior to introducing the different applications where PA imaging and sensing can 
make an impact, we brieﬂy outline the principles of the imaging modality. The PA 
(or optoacoustic) effect describes the generation of sound waves by light absorption. 
When a chromophore absorbs pulsed, or otherwise time-modulated, light, the 
absorbed optical energy induces a transient thermoelastic expansion, which causes 
a pressure (sound) wave to propagate outward from the absorber 13, 14. This pressure 
wave can be recorded by an ultrasound (US) transducer and electronic data 
acquisition system (Figure 1.1a). Acoustic images of optical absorption can be 
reconstructed from the propagation delays between the light pulse and the arrival of 
the acoustic wave (Figure 1.1b). Tissue optics determine the intensity distribution in 
the image (Figure 1.1c).
Parameters affecting the pressure wave characteristics are described by the following 
PA governing equation:
p0(z,ь) = Э(z)·эa(z,ь)·F(z,ь) (1)
where p0 denotes the source pressure generated at the chromophore location z; эa 
is the absorption coefﬁcient of the medium; F is the local laser ﬂuence and Э = уc2/
CP is the Grüneisen parameter, the conversion factor of thermal to acoustic energy. In 
this deﬁnition, у is the thermal expansion coefﬁcient, c is the speed of sound, and CP 
is the speciﬁc heat at constant pressure. Thus, the pressure generated by photo-
acoustics can provide information on the tissue optical properties (through its 
dependency on ﬂuence and absorption) as well as on tissue thermo-elastic efﬁciency 
properties (through the Grüneisen coefﬁcient). Equation (1) holds under the assumption of 
adiabatic response, which means the pulse duration must be shorter than the acoustic 
transit time across the absorbing volume (stress conﬁnement) and thermal diffusion 
time in that region (thermal conﬁnement). Stress and thermal conﬁnement are 
satisﬁed in most practical scenarios when using lasers emitting nanosecond(s) pulses.
14
Most PA applications aim at identifying and quantifying a chromophore of known 
эa(ь). The dependence of Eq. (1) on the optical wavelength ь indicates the possibility 
to perform spectroscopy to retrieve эa. Since there are generally several different 
types of absorbing tissues in a given image, spectral unmixing techniques are 
needed to identify tissue types and quantify absorber concentrations. In its simplest 
form these are linear ﬁts of the data to a set of reference spectra, but more advanced 
methods use computational analyses to minimize the number of wavelengths swept 
15-17. The unknown optics of the medium under investigation, in which spatially 
varying scattering and absorption parameters modulate the available optical energy 
(ﬂuence) and thus the generated pressure, create the need for more sophisticated 
spectral retrieval techniques which take account of modelled tissue optics and 
acoustics. With carefully designed imaging sequences and analysis algorithms, 
chromophore concentrations 18, 19 in the imaged specimen can be retrieved, but also 
other parameters in (1), such as tissue temperature changes 20, 21, tissue optical 
properties 22, 23, and potentially even thermodynamic properties. For these algorithms 
to work though, stable laser optical outputs or constant optical output power 
measurements are needed.
Figure 1.1  Principle of photoacoustic imaging illustrated. (a). A laser source shines on a 
targeted object and chromophores (e.g. blood vessels) absorb the light, thermoelastically 
expand, and emit acoustic waves which can be detected by an ultrasound transducer. (b) 
Typical received electrical signal at the transducer element and resulting image. Four cylindrical 
objects will display four characteristic waveforms; depending on the transducer bandwidth they 
may or may not be individually resolved (red solid vs. dashed). The absorber’s location can be 
inferred from the acoustic arrival time, and signal strength is determined by the product of 
the absorption coefﬁcient and light ﬂuence at the object location. The transducer bandwidth, 
geometry and illumination parameters determine the resolution of the image. (c). The optical 
wavelength (ь) determines the image content and penetration depth. Two wavelengths may 
provide contrast between e.g. blood and melanin. The signal fades with light attenuation. Hb: 
haemoglobin; HbO2: oxygenated haemoglobin.
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Instrumental requirements of PA imaging are application dependent, and as a result, 
various optical sources and ultrasonic detectors are reportedly used. The requirements 
on the optical source wavelength are dictated by the optical absorption spectra of the 
structures to be identiﬁed. The frequency content of the PA signal depends mostly on 
the size and shape (layer, cylinder, sphere) of a typical absorber 24: the smaller the 
source, the higher the generated frequencies. As large objects absorb more energy, 
they also generate larger pressure amplitudes, and so the ultrasonic PA spectra of 
mixed-size absorbers tend to be dominated by low-frequency signals, in the order of 
few megahertz 24.
1.2  Atherosclerosis
Obstructive vascular disorders include coronary artery disease (CAD), peripheral 
artery disease (PAD), and cerebrovascular disease, which may cause arterial 
blockages impeding the supply of oxygen and nutrients to vital organs like the heart 
and the brain. CAD is a manifestation of atherosclerosis- a systemic inﬂammatory 
disease of the arteries- causing plaques formation in the innermost layer of the 
arterial wall. Different plaques may give rise to different symptoms. A gradual 
narrowing (stenosis) of the vessel by growth of a ﬁbrous or calciﬁc plaque will, upon 
exertion, cause chest pain (due to cardiac ischemia); a condition called stable CAD. 
Sudden onset of chest pain, or chest pain at rest, is a symptom of unstable CAD or 
acute coronary syndrome (ACS), which is associated with thrombus formation on 
plaques, mostly due to the rupture of a lipid-core lesion. The most severe form of ACS 
is MI. The same process in the carotid arteries (in the neck) is the most common 
cause of stroke. Frequently, these disastrous events are the ﬁrst, and possibly lethal, 
symptoms arising from vascular disorders, preceded by decades of accumulation of 
atherosclerotic plaque. In PAD, a similar disease process can affect and even 
endanger the lower limbs.
 Catheter-based treatment of CAD consists in the implantation of a stent: a 
metallic (or bioresorbable polymer) vessel prosthesis that is usually introduced on a 
balloon. Inﬂation of the balloon opens the occluded vessel and expands the stent, 
which now supports the reopened lesion during the healing process. This procedure 
is called percutaneous coronary intervention (PCI). It is the standard of care for ACS, 
and it is also occasionally performed for stable CAD in case of severe symptoms. 
Imaging of atherosclerotic plaques during PCI is of interest for precisely positioning 
the stent to cover all of the plaque and for identifying possible lesions that may trigger 
new symptoms in the future. Intravascular imaging technologies use a vascular catheter 
to acquire image data, and deliver much higher resolution and image contrast than 
non-invasive methods for coronary imaging. Recent registries, meta-analyses and 
randomized trials have demonstrated a reduction of the relative risk of new ACS and 
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even a reduction in cardiovascular mortality in patients that undergo PCI with intra -
vascular imaging guidance, compared to angiography guidance alone 25, 26.
 The current model for unstable or rupture-prone plaques hypothesizes a particular 
morphology and composition: an eccentric plaque with a lipid-rich necrotic core 
that is covered by a thin ﬁbrous cap, which is weakened by inﬂammatory processes. 
The pathology term for this phenomenology is “thin-cap ﬁbroatheroma” (TCFA) 27-30. 
The heterogeneous nature of this plaque type provides several potential imaging 
markers for speciﬁc identiﬁcation of these lesions by means of intravascular imaging 31.
1.2.1  Intravascular photoacoustic imaging
Plaque composition: imaging of lipids
Intravascular photoacoustic (IVPA) imaging 32 is the most intensely researched application 
of PA imaging in cardiology. Most groups have focused on visualization of plaque lipids, 
as these are generally thought to be a key component of unstable or destabilizing 
plaques, such as TCFA. Being an intravascular modality, IVPA requires a dedicated 
imaging catheter that has the ability to deliver the excitation light and receive the PA 
signal. In almost all implementations, the US transducer that performs this latter task, 
is also used for conventional intravascular ultrasound (IVUS) pulse-echo imaging; 
this allows for inherent co- registration between the two modalities. IVUS can visualize 
the artery wall structure from its luminal border, through the vessel wall, and all the 
way past the outer adventitial layer, enabling the assessment of plaque burden- 
a powerful predictor of recurring cardiovascular events. It discriminates between 
soft tissues and calciﬁed lesions but cannot reliably identify soft tissue type. IVPA 
adds speciﬁc contrast for tissue composition, adding chemical speciﬁcity to IVUS 
(Figure 1.2). Together, these two imaging modalities provide a powerful way to image 
atherosclerotic plaque.
 Multi-wavelength imaging has been the default approach in PA imaging of ather-
osclerotic plaque from the ﬁrst studies onwards 33, 34. These studies demonstrated 
useful spectroscopic tissue type contrast. The choice of excitation wavelengths was 
initially limited by availability in conventional laser systems 35, demonstrating the 
concept but yielding mostly morphological imaging with limited speciﬁcity for the 
relevant tissue components.
 Atherosclerotic lipids can be imaged with excitation light pulses in either of two 
prominent absorption bands in the short-wave infrared (SWIR) spectral region, near 
1.2 эm and 1.7 эm 36-38. Both absorption bands correspond to overtones of the C—H 
stretch vibration which is abundant in hydrocarbons. Imaging of lipids ex vivo in the 
artery wall of a rabbit model of atherosclerosis provided the ﬁrst positive identiﬁcation 
of a tissue component in atherosclerosis 39. The ﬁrst in vivo imaging experiments 
were likewise performed in a rabbit aorta 40. In the longer 1.7 эm wavelength window, 
blood scattering is sufﬁciently small that imaging lipids in the artery wall with luminal 
blood is possible 41. Water absorption limits the imaging depth to a few millimetres 37. 
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At 1.2 эm, blood optical absorption is lower but the overall optical attenuation due to 
scattering is strong, reducing the energy available for generating the PA signal 38.
 The ﬁrst IVPA images of human specimens 42 highlighted the lipid content of 
advanced atherosclerosis by differential imaging at wavelengths on and off the main 
lipid absorption peak. Follow-up analyses of the detailed absorption spectra revealed 
variability in the absorption spectrum of plaque lipids, and identiﬁed differences in 
the absorption spectra between the sterol-rich content of atherosclerosis and the 
fatty-acids in adipose tissue surrounding the vessel 43. The spectral contrast is 
sufﬁciently robust to provide contrast between peri-adventitial fat and plaque lipids 
with only two wavelengths 44, 45 (Figure 1.2c), capitalising on slight shifts in the 
resonant frequency depending on the molecular conformation of the vibrating bond 
46. Using the same spectral band (1.6-1.8 эm), spectroscopic PA imaging differentiated 
collagenous tissue from lipids 38.  
 In a nutshell, the current advances in IVPA/US lipid-plaque imaging are very 
close to bringing this method to (pre-)clinical applications. Imaging in-vivo was 
demonstrated by multiple groups in various animal models (Figure 1.3a) 40, 48, 49 with 
different catheter designs 47, 50 through blood 51. Speciﬁcity to human atherosclerotic 
plaque was shown with ex-vivo specimens 43, suggesting that the achievements 
shown in-vivo on animal models could potentially be achieved on humans. 
Emphasizing on the latter, the miniaturised catheters were also shown to be ﬂexible 
enough to be navigated through swine coronaries 48 which is the closest coronary 
anatomy to human. Only two steps remain prior to the design of studies validating the 
use and advantages of the imaging method for disease monitoring and intervention 
guidance. These are intracoronary IVPA/US in-vivo imaging of atherosclerosis, and 
Figure 1.2 (a) IVPA image of human coronary artery ex-vivo and its corresponding Oil red O 
(ORO) histology evaluation (b). The PA signal in yellow-orange-red scale in (a) clearly identiﬁes 
the lipid rich plaque within the vessel wall thickening. Reprinted from 47; Copyright © 2014 
Optical Society of America. (c) Two wavelengths, 1718 nm and 1734 nm, are sufﬁcient to 
discriminate plaque lipids from peri-adventitial lipids. The blue line delineates the media/
adventitia border. Reprinted from 45; Copyright © 2015 Optical Society of America.
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demonstration of real time in-vivo spectral IVPA/US imaging for deﬁned plaque 
feature identiﬁcation. 
Plaque composition imaging: other imaging targets
Inﬂammation is a prominent mechanism driving atherosclerosis. Interventions targeting 
systemic suppression of inﬂammatory response have been shown to reduce cardio-
vascular events and CV mortality 52. Inﬂammation, in conjunction with lipid content, 
may provide important information about the event risk of an atherosclerotic plaque 
and consequently, could play a role in guiding device- or drug-based interventions. 
These features of atherosclerosis have been visualized with the aid of exogenous 
contrast agents, as recently reviewed in 53.
 Inﬂammation is an innate response to injury or stress and is mediated by a 
complex of signalling molecules and cells. The most prominent of these inﬂammatory 
cells are macrophages, which play important roles in plaque biology, interacting with 
lipid transport and sequestration, efferocytosis, and weakening of connective tissue 
by secretion of matrix-metalloproteinases (MMP) 54. Macrophages themselves do 
not exhibit a clear speciﬁc optical absorption feature. Both gold nanoparticles 55 and 
the FDA approved indocyanin green (ICG) dye 56, taken up by macrophage cells 
through endocytosis or phagocytosis were shown to enable PA imaging of 
macrophages in ex-vivo animal arteries. In-vivo imaging has yet to be demonstrated, 
which may be complicated by the choice of wavelengths, 700 nm, 750 nm and 805 
nm, that are highly absorbed by haemoglobin. Tests on gold nanorods cytotoxicity 
showed that the particles do not particularly alter cellular viability in comparison to 
control cultures 57-59. Other PA contrast agents were engineered to identify the 
presence/absence of metalloproteinases as a marker for plaque vulnerability. Both 
targeted gold nanorods 59 and MMP-sensitive activatable ﬂuorescent probe 60 were 
shown to image MMP in atherosclerotic plaques ex-vivo. 
 Since metals are efﬁcient optical absorbers, IVPA can also image stents as a 
means of evaluating stent apposition during PCI. In 61, a miniature ﬂexible catheter 
capable of high-resolution PA imaging was built. The results show a better point 
spread function (PSF) than obtained with IVUS, with a transverse resolution of 19.6 эm 
(Figure 1.3b). 
Experimental considerations and device design
IVPA can potentially target several of the plaque features of interest: lipids, macro - 
phages and intraplaque haemorrhage 62. The complementarity with IVUS adds the 
capability of evaluation of plaque morphology and even stiffness 63. A combined 
IVUS/IVPA imaging system is clearly desirable over either modality alone. In general, 
intravascular images are acquired by stacking arterial cross-section images obtained 
at different locations while pulling back the catheter from distal to proximal in the 
artery. Virtually all experimental intravascular catheter prototypes presented to date 
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are side-looking (i.e. the optical and acoustic beams are directed sideways from the 
catheter in the artery lumen) and image the arterial wall, using a single-element 
conﬁguration that is rotated around its long axis 64. A plastic sheath conﬁnes the 
rotating imaging core to provide guidewire compatibility and prevent tissue damage. 
In the following paragraphs, we discuss some of the key elements of an IVPA/US 
imaging system.
 The rotary scan sequence of common IVPA implementations requires at least 
one laser pulse for each A-scan. Faster lasers would allow for averaging and thus 
improved SNR. Thus far the fastest imaging frame rate achieved was 30 fps using a 
10 kHz pulse rate laser source at 1064 nm 65 ex-vivo. Parallel detection and electronic 
beam scanning on multiple transducers can in principle speed that up to hundreds 
of frames per second 66. However, the highest frame rate demonstrated in vivo was 
of 20 fps 48 based on a rotary scan implementation.
Figure 1.3 (a) In-vivo imaging of a rabbit aorta using a quasi-collinear/beam offset catheter 
design; reprinted from 49 , with permission; © CC BY 4.0. (b) Optical resolution intravascular 
photoacoustic imaging of a stent ex-vivo. The catheter design focuses the light through the use 
of a grin lens; reprinted from 61, with permission © 2014 Bai et al. FSC: ﬂexible stainless steel 
coil; PT1: polyimide tube 1 with an inner diameter of 0.7 mm; PT2: polyimide tube 2 with an inner 
diameter of 0.74 mm; STH: stainless steel tube housing; UST: ultrasonic transducer; SMF, 
single-mode ﬁbre; TC: transducer cable; GL: gradient-index lens; M: micro-prism; B: metal 
base.
20
The choice of all materials in the beam path, the sheath material in particular, is 
governed by the optical and acoustic compatibility at the operating wavelengths and 
frequencies. An ideal catheter sheath minimizes optical absorption, acoustic attenuation, 
acoustic reverberation and maximizes ﬂexibility. The fact that lipid imaging relies on 
C—H absorption, a molecular bond that occurs prominently in many polymers, severely 
complicates this quest. Thus far, polyurethane and speciﬁc polyethylenes were found 
to have acceptable ultrasonic and optical transmission at wavelengths around 1.7 эm 49, 
but do leave room for improvement. Use of more wavelengths for access to more 
plaque features is likely to exacerbate this issue.
 Lipids occur in tissue in different forms, such as intra-cellular and extra-cellular 
droplets, dispersed in cell and organelle membranes, and as cholesterol crystals. 
PA imaging relies on the acoustic wave emitted from an absorbing object upon 
thermo elastic expansion after exposure to a short laser pulse. The well-known 
dependence of frequency content and amplitude on the size and shape of the PA 
source applies, which explains why the PA signals from the lipid-rich plaques have 
the highest energy in the lower frequency band (< 8 MHz) 67. Thus far, in all the IVPA/
US catheter prototypes the US element was optimized for the resolution requirements 
set by IVUS imaging, using centre frequencies of 30 MHz and higher. Transducers of 
lower centre frequency (< 20 MHz) may beneﬁt the SNR of IVPA images. These need 
to ﬁt within the size required for coronary catheters () 1.1 mm outer diameter). 
Approaches such as all-optical transduction 68 and dual-element conﬁgurations 69 
may be successful in the future in achieving the required bandwidth for combined 
IVUS/PA imaging.
 Safety of currently proposed imaging systems is necessary before any potential 
use on humans. An irradiation limit exists at which laser-tissue interaction becomes 
harmful. Maximum permissible exposure values are well established for some organs 
such as the skin or the eye, but are less known for other tissue types. Design for 
safety should take into account the illumination wavelength, the laser pulse repetition 
frequency (PRF), power and pulse duration, as well as the system’s pullback and 
rotation speed. Studies on smooth muscle, macrophage and endothelial cell cultures 
ex-vivo demonstrated that the typical exposure levels used in IVPA imaging were 
not harmful to the cells (tested wavelengths: 1064 nm, 1197 nm, 1720 nm) 70. Likewise, 
in vivo IVPA imaging in the iliac artery of an Ossabaw swine showed no tissue damage 
through post-experimental histology evaluation of imaged and control vessels 71. It is 
also important to demonstrate catheter deliverability, mechanical and electrical safety.
1.2.2  Non-invasive imaging of atherosclerosis
Evaluating the progress of atherosclerosis could be non-invasively performed on 
carotid or other peripheral arteries. Several features of plaques are similar between 
the coronary and carotid arteries: thrombi, macrophage inﬁltration, TCFA cap thickness, 
lipid content, and so we can expect to see the same features in the images. The imaging 
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system is fundamentally different, though: the peripheral arteries are accessible to 
linear-array-based US imaging. PA imaging can be performed using the same 
transducer, such that parallel detection on many or all elements results in a full PA 
image from one laser pulse (subject to SNR requirements which may encourage 
averaging of multiple pulses), where catheter-based imaging required at least one 
pulse for each A-line. 
 For carotid imaging, a commercially available US array is positioned on the neck 
of the patient to receive the PA signals from the carotid artery as well as to perform 
routine US (B-mode and Doppler) imaging. Light can be delivered externally, next to 
the transducer array on the side of the neck, which results in a longer light path 
(equivalent to stronger optical and acoustic attenuation paths to reach the imaging 
target) but allows the use of larger pulse energies (Figure 1.4) 72. Alternatively, the 
illumination source can be positioned in the pharynx and/or oesophagus (Figure 1.5) 73, 
leading to a more efﬁcient delivery but a smaller illuminated volume. 
 In-vivo PA imaging of the carotid artery and jugular vein was demonstrated on 
healthy volunteers 74-76. These show the feasibility of generating sufﬁcient signal from 
the target vessels, at an imaging depth of 12-15 mm through the skin layers with 
external illumination, showing features such as the carotid bifurcation. Use of an 
ultrasonic transducer centred at about 5 MHz in combination with an excitation light 
Figure 1.4 Carotid PA/US imaging conﬁguration setup and resulting images with illumination 
source and acoustic transducer co-located on the neck. (a) PA image at 800 nm the main 
structures observed are delineated and annotated. (b) Corresponding B-mode US image.  (c) 
Spectrally unmixed image to map oxygenated haemoglobin. (d) Spectrally unmixed image to 
map deoxygenated haemoglobin. SCM:  sternocleidomastoid muscles; SM: strap muscle; ICA: 
internal carotid artery. ECA: external carotid artery; IJV: internal jugular vein; CCA: common 
carotid artery. Image reprinted from 74, with permission, Copyright © 2018 The Authors, CC 
BY-NC-ND.
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of ~800 nm and of ﬂuence compatible with optical exposure limits, enabled the 
imaging of multiple structures such as the jugular vein and the strap muscles (Figure 1.4). 
The chosen wavelength of 800 nm may, however, not be ideal for detecting athero-
sclerotic plaque, especially near the large blood pool in major vessels. Such issues 
may potentially be resolved by spectral unmixing. PA images at seven wavelengths 
between 700 and 850 nm distinguished between arterial and venous blood (Figure 1.4) 74, 
but could potentially also contain contrast for plaque haemorrhage. Indeed, PA signals of 
ex-vivo carotid plaque specimens at 808 nm correlated with intraplaque haemorrhage 
on histology 62. In addition, four wavelengths between 808 and 980 nm distinguished 
between cholesterol crystals, porcine blood and thrombus in an ex-vivo phantom using 
blind source spectral unmixing methods 77. Imaging results reported on intraplaque 
haemorrhage would however prove more valuable for clinical translation if demonstrated 
on vulnerable plaque specimen with luminal blood.
 Other studies imaged atherosclerotic carotid arteries at relevant lipid differentiat-
ing wavelengths. PA imaging of a human carotid plaque specimen was mimicked 
using a phantom that replicated the anatomy of the neck, and explored illumination 
through the pharynx 73. They showed feasibility of imaging plaque lipids at the 
illumination wavelengths around 1200 nm, using safe optical ﬂuence levels (~ 12 mJ/cm2 
< maximum permissible exposure for the skin of ~ 55mJ/cm2). At 1200 nm, external 
illumination through the skin would not be realistically achievable, due to the long 
optical path length and high absorption and scattering of skin. However, illumination 
Figure 1.5  Carotid PA/US imaging conﬁguration setup and resulting images with the illumination 
source located in the pharynx and the acoustic transducer on the neck. (a) US B-mode image 
of a neck phantom. (b) PA image at 1130 nm overlaid on US. (c) PA image at 1200 nm overlaid 
on US. (d) PA image at 1250 nm overlaid on US. Plaque lipids signals are located based 
on spectral unmixing from the surrounding collagen signals. Image reprinted from 73, with 
permission, ©  Copyright 2018 Society of Photo-Optical Instrumentation Engineers (SPIE), CC BY 3.0
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through the pharynx at 1200 nm should be in practice achievable (optical path of ~ 
30-40 mm), though full carotid, wall-to-wall illumination and in-vivo imaging, needs to 
be conﬁrmed.
1.2.3  Perspective on therapeutic interventions and risk assessment
From a cardiovascular intervention point of view, the presented research, shows that 
IVPA/IVUS is a strong candidate to determine optimal stent placement, stent sizing, 
and for pre-emptive treatment of high-risk sites during a PCI. Angiography can often 
identify the culprit lesion, but the addition of IVPA/US may help to deﬁne the entire 
implicated segment, and to identify other (asymptomatic) vulnerable plaques. This 
comprehensive assessment of the disease severity and extent within the artery may 
inform a better (pre-emptive) treatment plan. IVPA imaging can image plaque 
composition, while the structural information from IVUS relates them to the overall 
vessel wall architecture. The multimodal structural and chemical information provided 
by IVPA/US has the greatest potential for assessing plaque vulnerability to rupture. 
In clinics, other imaging technologies exist for diagnostic assessment of coronary 
atherosclerosis, such as IVUS, optical coherence tomography (OCT) and near-infrared 
spectroscopy (NIRS) 31. However, none of these has adequate sensitivity for all plaque 
features that are known to correlate with vulnerability. For instance, plaque size can 
be determined by IVUS and lipid content can be assessed by IVPA as discussed in 
the previous section. Measurement of cap thickness, which requires an imaging 
resolution of < 50 эm, has not been demonstrated but is not beyond the realm of 
possibility 61, 78.
 The eventual proof of clinical efﬁcacy of an IVPA/US imaging would be a 
demonstration of fewer ACS cases in patients undergoing IVPA-guided PCI compared 
to those receiving standard of care treatment. Such trials are now emerging with 
IVUS, more than 20 years after the clinical introduction of the technology 26, 79. Until 
then, intermediate steps would include a quantitative characterization of culprit 
lesions compared to non-culprit sites, and a natural history study documenting 
plaque changes over time. These trials with imaging endpoints will serve to deﬁne the 
IVPA-based treatment criteria that can be evaluated in an outcomes-based trial. 
 Non-invasive imaging may serve a dual role: since carotid atherosclerosis is the 
most common cause for stroke, detailed imaging of plaque content may improve risk 
assessment for patients. In today’s practice, imaging technologies such as echo, 
X-ray CT and MRI are used for this purpose, but these are limited in their ability to 
predict future events and can be expensive. PA imaging may provide a highly 
chemically detailed image of plaque composition that may augment this picture. 
Another potential application may be the monitoring of systemic atherosclerotic 
disease status. Atherosclerosis in peripheral arteries have been identiﬁed as a proxy 
for coronary artery disease, and the carotid artery has been particularly popular for 
this purpose 80, 81. 
24
1.3  Arrhythmias: atrial fibrillation
The ﬁeld of interventional electrophysiology has only started to mature over the past 
30 years, pushed by the advances made in intracardiac recording technology 82. 
Interventional electrophysiology has opened the cardiac electrophysiology ﬁeld to 
new curative approaches as opposed to traditional solutions concerned only with the 
management of the disease and pharmacology. Medication for atrial ﬁbrillation 
consists of anti-coagulants to prevent blood clots, and decrease risks of ischemic 
stroke. Other prescribed drugs are anti-arrhythmic treatments to control the heart 
rhythm. Research aiming to elucidate heart rhythm disturbance mechanisms has led to 
identiﬁcation, classiﬁcation and better understanding of different types of arrhythmias, 
each requiring its own speciﬁc therapeutic approach. For instance, bradyarrhythmias 
(lower than optimal heart rate) are often treated with pacemaker implants. Tachycardias 
(fast or irregular heart rates) often require ablation: induced tissue scarring to stop 
aberrant conductive pathways. While treatment of tachycardias initially required an 
open-chest surgery, it nowadays can be performed percutaneously with minimal risk 
in a procedure named catheter-based ablation. Such procedures rely heavily on 
imaging technology and intracardiac electrophysiological mapping for guidance and 
treatment delivery, and this is where PA imaging can make an impact.
 Atrial ﬁbrillation is one such tachycardia. The pathology of atrial ﬁbrillation is 
associated with other heart diseases such as atherosclerotic heart disease, valvular 
heart disease and diabetes mellitus. These comorbidities contribute to an increased 
mortality rate 83. Factors predisposing the disease onset include excessive alcohol 
consumption, smoking, obesity, diastolic dysfunction and ageing. Symptoms affect 
patient’s quality of life and may include chest pain, shortness of breath, palpitations, 
fatigue or heart failure. Atrial ﬁbrillation is also associated with an increased risk of 
stroke and thromboembolism, which could be fatal. In fact, 1.5% of strokes for people 
between 50-59 years old, and 24% of those aged between 80-89 are associated with 
atrial ﬁbrillation 83. The prevalence of atrial ﬁbrillation is predicted to increase, due to 
an ageing population and the mutually reinforcing CVD health factors discussed 
above 84.
1.3.1  Catheter-based ablation as a treatment for atrial fibrillation
Atrial ﬁbrillation can nowadays be treated with catheter-based ablation, mostly 
obviating the complicated open surgical intervention. It is by far one of the most 
complicated arrhythmias to treat, with procedures often lasting longer than 4 hours. 
Since atrial ﬁbrillation is the most common sustained arrhythmia, affecting 0.5% of 
the global population in 2010 84, with the highest complication rates, research into PA 
guidance of catheter-based ablations mostly target procedures for atrial ﬁbrillation.
Pharmaceutical management of the disease is nowadays being shown to be inferior 
to a curative ablation approach 85. Ablation uses heat or extreme cold to destroy 
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tissue substrates responsible for cardiac rhythm disturbance. In a minimally invasive 
procedure, an ablation catheter as well as other electrophysiological catheters (e.g. 
for recording surface potentials), are inserted through the femoral vein to the atria to 
deliver treatment locally under ﬂuoroscopy and echocardiography guidance. In 
catheter-based ablation for atrial ﬁbrillation, the targeted ablation tissue is usually at 
the ostia of the pulmonary veins in the left atrium. Catheter-based ablation procedures 
for atrial ﬁbrillation often last longer than 4 hours. 
 In catheter-based ablation procedures, technology is crucial. Long procedures 
under ﬂuoroscopy guidance lead to excess exposure of radiation for the patient. 
Insertion of the catheter sheath from the right to the left atrium is performed under 
intracardiac echography (ICE) imaging. Guidance of the procedure relies on electro- 
anatomical maps (EAM), which identify the irregular conductive pathways and 
determine the regions to be treated. Such EAMs are made by tracking the position of 
the electrophysiology catheter as it is dragged along the atrial wall to record local 
electrograms. Real-time feedback on treatment evaluation relies on electrophysio-
logical catheters (for instance, a lasso catheter) to determine cessation of conductivity 
as well as on sensors at the ablation catheter tip for feedback on energy delivery. 
These sensors comprise, among others, temperature, impedance and contact-force 
sensors which can indirectly predict the efﬁcacy of conversion of the energy delivered 
into the tissue, with the aim to induce scarring.
 Feedback on energy delivered is important. In about 4.5 % of the procedures, 
complications arise due to the ablation of untargeted areas: excessive energy delivery 
(over-ablation) reaching the oesophagus or the phrenic nerve causing serious injury 
to the patient 86. Lesion size is also important because it is believed that the low 
interventional success rate of 60-70% is due to incomplete ablation (under-ablation), 
87, 88. Gaps between lesions, healing of tissue oedema, shallow lesions and difﬁculties 
in ectopic foci identiﬁcation will lead to tissue reconduction. Thus, the cornerstones 
of catheter-based ablation intervention success are assumed to be (1) full and correct 
identiﬁcation of ectopic foci (2) transmural ablation lesion formation and (3) continuous 
lesion formation for electrical isolation.
1.3.2  Photoacoustic imaging for ablation lesion characterization
The major complications happening during the catheter-based ablation procedures 
are related to control of energy delivery, and many innovative solutions aim to provide 
a means to better control the ablation, in order to make the catheter-based intervention 
faster and safer. The types of feedback provided by today’s technologies (e.g. 
temperature, contact impedance power delivered, and duration of energy delivery 
settings), can only help the cardiologists to estimate the size of the lesions they have 
created. To this day, no commercially available technology provides full visualization 
and characterization of ablation lesions’ long-term electrical functionality, and its 
lateral and transmural extent. It is however of extreme importance for the electrophys-
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iologist to follow the progress of the tissue changes induced by the ablation process. 
Direct monitoring of energy delivery and visualization of its effect on tissue changes 
could improve the outcome of the procedure 89.
Photoacoustic tissue contrast
Initial studies of visualizing RF ablation lesions with PA imaging showed very promising 
results 90-92. Governed by Eq. (1), the detected pressure as a result of transient 
absorption depends mainly on the tissue optical properties. To visualize lesions, it is 
thus necessary to determine optical wavelengths that exhibit robust absorption 
contrast between the lesion chromophores and the surrounding tissue. The signal 
contrast may visualize treated areas among healthy tissue. The ﬁrst report of spectral 
contrast between ablated swine myocardium and healthy ventricular myocardium 
was shown in a PA spectroscopic study 91. From then on, other groups have further 
conﬁrmed capability of lesion visualization of cardiac tissue ex-vivo in 3D. Imaging 
contrast was shown for ventricular tissue 92 (Figure 1.6), with imaging depths reaching 
up to 6 mm 90. Though imaging contrast was shown on swine models, the results are 
expected to translate to human tissue because of the optical similarity between the 
two, as was shown in 93. Nonetheless, a systematic study on signal strength and 
contrast for different tissues and cardiac anatomic sites is still needed. Endocardium, 
myocardium and epicardium thickness, smoothness and orientation vary with 
location, affecting tissue scattering and optical propagation paths. 
 It is important to bear in mind that all PA studies of RF ablation lesions to date were on 
non-vascularized porcine tissue. Haemoglobin being the most dominant chromophore 
in the near infrared range could affect the lesion imaging capability, in terms of image 
contrast, image depth 94 and thus lesion delineation and correct identiﬁcation. To avoid 
this potential drawback, different imaging methods were proposed. For instance, spectral 
correlation methods were used to differentiate background signal from lesions focussing 
on the peak signature of haemoglobin at 760 nm 92. Though promising, further studies 
are needed to prove robustness of these methods to separating blood-generated 
PA signal from the lesion PA signals, as well as to quantify the effect of optical propagation 
and optical deposition in perfused tissue.
 Clinically-approved techniques other than RF ablation include balloon-based 
methods, such as cryo-ablation which applies extreme cold to locally freeze the 
tissue 95, or laser ablation and coagulation 96. Studies have shown the equivalence 
in histology of the lesions formed through different techniques 97. One may therefore 
expect that the lesion-speciﬁc chromophores be the same, regardless of the method 
of ablation. It is important, however, to consider that the strength and polarity of the 
PA signal are temperature dependent, because of its dependence on the thermal 
expansion coefﬁcient. This dependence may affect the generalization of results 
obtained with RF ablation to other energy modalities. With proper characterization, 
the temperature dependence of the signal could also be used for in-depth temperature 
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proﬁling 98. Currently, cardiologists rely on a surface measurement which is of limited 
use with ﬂushed catheters, or when underlying vessels cool the tissue. This is an 
interesting feature to explore as the tissue temperature is a key factor for the quality 
of the lesion that is produced.
Instrumentation development
Different imaging conﬁgurations were evaluated in published studies to date. PA 
monitoring of cardiac ablation needs to operate in or on the blood-ﬁlled cavities of the 
heart. The optical source and acoustic transducers have been realized as one 
integrated device 90, but separated optical and acoustic conﬁgurations have also 
been demonstrated 92. Dual modality, US-PA images were formed using transducers 
of various centre frequencies, extending from low frequencies (< 3MHz) to high 
frequencies (21 MHz), but not covering the intracardiac echography (ICE) central 
frequency of ~6 MHz. Imaging was feasible for different imaging conﬁgurations with 
the transducer positioned at different locations with respect to the tissue and 
illumination source, showcasing that PA has the potential to image the ablation 
process for different cardiac locations spanning from the trans-septal wall to the 
pulmonary veins. Current proposed imaging solutions consist of (1) intracardiac 
illumination with trans-thoracic reception of PA signals and (2) a combined catheter 
enabling intracardiac echo, RF ablation and PA imaging; both implementations have 
yet to be realistically demonstrated. 
Figure 1.6  Photoacoustic imaging of ablation lesion on porcine ventricular tissue. Photographs 
of the imaged lesion (left panel) and their corresponding PA image (red scale) overlaid on 
ultrasound (grayscale).  Figure reprinted from 92, Copyright (2014), with permission from Elsevier.
5 mm
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PA imaging and RF ablation with a dedicated PA-enabled ablation catheter delivers 
light directly at the ablation site (Figure 1.7) 98. This conﬁguration offers the advantage 
of delivering light directly at the ablated site, minimizing the impact of blood. It is also 
a solution that minimizes disruption to currently established procedural ﬂow. Another 
design 99 consisted of an ablation catheter that enables both PA and US imaging, but 
it was not evaluated for tissue ablation imaging yet. From a manufacturability point of 
view, PA-enabled catheters at a size that is compatible with today’s interventions 
appear to be feasible.
1.3.3  Looking forward to electrical mapping
Electrical mapping is the cornerstone of interventional electrophysiology. Not only is 
it the base for syndrome diagnosis and treatment planning but it also has the potential 
of being a tool to predict future ﬁbrillary substrates. A popular adage claims that 
“atrial ﬁbrillation begets atrial ﬁbrillation”, referring to the fact that AF, when persistent 
for a long period of time (> 24h), has the capability of regenerating itself after 
termination. This is due to the electrophysiological remodelling induced by the 
persistence of the AF. In such cases, cells may display shorter refractory periods than 
normal and may induce AF again. This mechanism means it is more difﬁcult to restore 
Figure 1.7. Photoacoustic-enabled ablation catheter. The optical ﬁbres are coated with copper 
to deliver both RF current and laser light. Monitoring of lesion formation/ temperature proﬁle 
was also achieved with the presented prototype using laser tuned to 780 nm. Image reprinted 
from 98, © 2018 Optical Society of America.
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the sinus rhythm in prolonged AF and identiﬁcation of such substrate might be of 
interest to the cardiologists for preventive measures. A potential advantage of imaging 
of electric potentials over current electrode-based potential measurements is the 
extension to volumetric mapping. Unravelling endocardial to epicardial signalling is 
indeed an important feature for current electrophysiology research 100.
 In absence of native electrical contrast, PA imaging methods are not able to 
image cardiac electrophysiological potentials without contrast agents. However, with 
the use of PA sensitive contrast agents, it may be possible to visualize tissue electric 
potential variations. Indeed, PA signals were found to be correlated to calcium 
dynamics of cardiomyocytes in culture  when using a dye named Arsenazo III 101. 
Electrical polarization of the muscle cell being strongly related to cellular calcium 
ﬂow, positions this dye-based imaging method as a contender for cardiac electro-
physiological potential monitoring. In vivo application of this contrast agent will 
however be limited by its absorption in the visible range, which is difﬁcult to reconcile 
with imaging through blood or in perfused tissue. PA voltage sensitive dyes were 
mostly investigated on brain tissue. Engineering of a near-infrared PA voltage- 
sensitive dye improved the depth at which brain tissue electrical potentials could 
be measured 102.  In addition to that, electrical potentials at the surface of the mouse 
brain were successfully disentangled from tissue hemodynamic signals using spectro - 
 scopic methods 103. This latter feature is potentially also useful in cardiac tissue to 
distinguish between perfusion and contractility signalling, while the former is likely 
to improve imaging of cardiac signalling at depth. Today, the research on PA voltage 
mapping of cardiac tissue is sparse, but with the right voltage sensitive dye, electrical 
mapping is not beyond the limits of PA technology. Current challenges lie in the 
engineering of the dye’s absorption wavelength and dynamics to optimize for PA 
spatio-temporal electric potential resolution at various depths. Needless to say that 
cytotoxicity and ﬂushing mechanisms must also be taken into account. 
1.4  Vascular imaging
Most of the PA imaging literature capitalizes on blood as a dominant chromophore 
and target contrast. Blood is the main biological absorber of light in the visible and 
near-infrared wavelength range and stands out from the other background biological 
absorbers with spectroscopic contrast between oxygenated and deoxygenated 
haemoglobin. An innovation in cardiovascular and intensive care medicine that 
capitalizes on this contrast develops a PA monitoring tool of the oxygen saturation of 
the venous blood in the pulmonary artery by transoesophageal illumination and 
acoustic reception104, 105. Extension of the functionality of such a device to guidance 
of atrial ablations is conceivable.
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Microvasculature is a popular imaging target in animal models 106-108 and humans 
109 through focused excitation or reception of signals. Nonetheless, high resolution 
imaging of vasculature works only superﬁcially, is time consuming, and requires 
bulky scanners. The high resolution of such systems can be put to use for PA ﬂow 
cytometry 110, demonstrated in vivo on small animal models to detect and differentiate 
between circulating red blood cell aggregates, white blood cell aggregates, and 
platelets 111, 112. Moreover, the technique was used to monitor the formation of blood 
clots during surgical procedures 111, 113, 114. Other applications are new in vitro 
diagnostics for various blood conditions, including the ability to sort cells with the 
recent feasibility demonstration of PA circulating cell focusing 115.
 The main application of these techniques lies in the monitoring of intensive care 
unit patients. The measured parameters directly relate to blood coagulability and 
hemodynamic stability, which is frequently compromised in patients with acute 
cardiovascular disorders, and so these data may in fact inform interventions in that 
population in the future. Other reviews have extensively discussed PA ﬂowmetry and 
its applications 110, 116, 117.
1.5  Myocardial infarct
A myocardial infarction (MI) is the name given to the irreversible damage to the 
myocardium by prolonged ischemia. The damage can span from loss of contractility 
to necrosis as a result of a coronary artery blockage. Myocardial tissue necrosis may 
lead in the long term to heart failure. At the onset of symptoms, the ﬁrst tests to 
conﬁrm a myocardial infarct are a diagnostic ECG to localize the area of infarct and a 
blood test to determine presence of biochemical markers for cardiomyocyte death. 
Medication is given to dilate the blood vessels and minimize thrombus formation. 
Emergency or staged PCI, usually with stent placement, are the next steps of treatment. 
 Several new mitigating or curative interventions are currently in development, 
including endovascular hypothermia application in conjunction with PCI (~ 33˚C, 
cold saline before reperfusion), which may reduce the infarct size 118. Several stem 
cell therapy approaches have also been proposed but remain highly speculative.
There are no PA imaging studies to date that show concrete translational potential in the 
localization and treatment guidance of myocardial infarcts in humans. Full murine heart 
perfusion or oxygenation 18, 119-121, which are surrogate estimates of MI features, 
corresponded well with measurements provided by left ventricular ejection fraction 
and MRI/SPECT images. However, the demonstrated non-invasive illumination, 
feasible through the thin murine chest wall, would not translate well to the human 
anatomy and size. A potential solution may include catheter-based optical delivery as 
was demonstrated in intra-atrial imaging. Tissue perfusion is also accessible with 
31
In
tro
d
u
ctio
n
myocardial contrast echography (MCE), which has been performed in patients. The 
PA alternative has the advantages of using endogenous contrast and conveys blood 
oxygenation.
 PA imaging of intramyocardial stem cell injection treatment for cardiac repair 
following an MI 122 was explored by tracking ﬂuorescently labelled stem cells in an 
animal model with multispectral optoacoustic tomography (MSOT). Stem cell therapy 
for MI repair being currently debatable, positions PA imaging of stem cell treatment 
as a promising tool for researching, understanding and improving future treatments. 
 Of particular interest to cardiac interventions is the capability of non-invasively 
monitoring patients with elevated cardiovascular risk 123. The degree of myocardial 
necrosis can initially be detected through blood tests determining levels of biomarkers 
such as troponins or creatine phosphokinase 124. Some of these byproducts are 
eliminated from the blood through the lungs in the exhaled air. In general, gas 
rebreathing techniques can measure and detect the presence of a multitude of 
biomarkers which may be related to speciﬁc diseases and/or indicate certain 
physiological imbalance 125, 126. Presence of acetone, pentene, nitric oxide, carbon 
monoxide, isoprene, pentane and ethane (byproducts of oxidative stress and 
subsequent lipid peroxidation), in the breath were shown to be related to heart failure 
127-130. Non-invasive PA breath gas analysis techniques are thus a viable option to 
evaluate heart failure development in MI (Figure 1.8). For instance, ethylene, also 
shown to be related to oxidative stress, can be detected in the breath with PA gas 
rebreathing measurements. In fact, measures of expired ethylene using gas 
rebreathing measurement methods during coronary artery bypass grafting 
procedures and valvular surgery related well to organ reperfusion injury and to 
regional myocardial ischemia 131. PA breath gas analysis can also measure cardiac 
output non-invasively, in real-time at rest and/or during exercise, to diagnose the 
severity of heart failure 132-134.  Monitoring cardiac output by the presence of speciﬁc 
biomarkers such as ethylene, ammonia or other products of lipid peroxidation were 
proven useful during surgery and at the bedside. Patented PA spectrometry-based 
gas rebreathing technology has been successfully commercialized by a company 
named Innovision in Denmark. More speciﬁcally targeted PA gas analyser, such as 
ethylene sensors, can be bought from Sensor Sense in the Netherlands. Compared 
to traditional breath analysers based on mass spectrometry PA based spectrometers 
are more portable and less complex.
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1.6   Directions for future instrumentation development
Development of a PA imaging system is a multimodal optimization problem deﬁned 
by the application: light needs to reach and penetrate the targeted absorbing biological 
structure, while the US transducer needs to accommodate for the large bandwidth 
and low pressures of the PA signals, and all components need to be integrated into 
a clinically translatable imaging system. Translation of PA imaging to any clinical 
application, including cardiovascular ones, depends critically on maturity of the technology. 
Being intrinsically multimodal, integration to robust, stable and safe devices that are 
suitable for regulatory approval is challenging. Optical delivery, acoustic functionality, 
data acquisition and the laser source need to be integrated into one system with 
validated performance and functionality.
 To date, most research activity in the ﬁeld has focused on intravascular imaging 
for the characterization of atherosclerosis and for intracardiac imaging of ablation 
lesions. These areas depend critically on invasive imaging tools, which means that 
the engineering challenge includes the economics of disposable devices. Nevertheless, 
the proof-of-concept studies, such as those discussed in this chapter, show that there is 
unique tissue contrast to be attained with PA imaging which may fulﬁl pressing clinical 
needs in the guidance of cardiovascular interventions, and that stable operation is 
possible.
Figure 1.8  Gas rebreathing measurement principle. Concentrations of two inert gases, blood 
soluble and insoluble are measured to calculate cardiac output while taking into account lung 
volume among other correcting factors. Source: http://www.innovision.dk/Products/Innocor/, 
with permission. O2: oxygen, N2O: Nitrous oxide SF6: Hexaﬂuoride.
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Besides the challenges of multimodal systems and device engineering, a critical 
component of any PA imaging system is the light source. Historically, the ﬁeld has 
developed on the ample availability of Q-switched solid-state lasers, which provide 
short pulses and high energies for a limited set of wavelengths, which usually are not 
the optimal ones for biomedical imaging. The popularity of solid-state lasers for PA 
imaging has furthered the development of sophisticated tuneable optical parametric 
oscillator systems (OPOs) pumped by Q-switched lasers. These deliver high-energy 
nanosecond pulses at any wavelength (in the visible, NIR and SWIR ranges) the 
biological system under study happens to require for optimal image contrast. Such 
lasers are versatile and powerful, but also expensive, noisy, fragile and with ﬂuctuating 
optical pulse energy. They are scientiﬁc instruments, and not primarily suitable as 
components in a clinical imaging system that needs to be robust, portable, user- 
friendly, and economical. In addition, the pulse repetition frequency of many OPO 
systems tends to be on the low side for many applications (< 100 Hz). The ﬁrst target 
for researchers interested in clinical translation of PA technology to a clinical setting 
is to identify an alternative to the tuneable laser that will deliver sufﬁcient pulsed 
power at the right wavelengths.
 A few inroads have been made towards solving this problem. One approach has 
been to shift a standard wavelength using an efﬁcient stimulated Raman scattering 
medium to create a light source at the relevant frequency. The combination of the 
fundamental Nd:YAG wavelength and Ba(NO3)2 has been used for IVPA imaging at 
1197 nm 135, 136. Many Raman active materials are available, and they may be coupled 
to a variety of base oscillators to access a range of biologically relevant wavelengths. 
Alternatively, diode lasers, pulsed or continuous wave 137, may be part of the future 
solutions 137, 138. There appears to be potentially usable contrast in imaging of ather-
osclerosis using these devices at standard wavelengths 139, 140, and other wavelengths 
may become available in the future if there is sufﬁcient demand. Light emitting diodes 
(LEDs) are also being explored for PA imaging, and may be a contender for some 
broad-illumination applications 141, 142. Compared to most PA lasers, LEDs are safer 
and allow for faster imaging frame rates, because they offer low-energy (nJ to эJ) 
pulses at high (several kHz) repetition rates. 
 For diode lasers as well as LEDs, generation of sufﬁciently energetic pulses of 
pulse duration that satisﬁes stress conﬁnement is nontrivial. Efﬁcient ﬁber coupling of 
these sources can be daunting. These considerations limit the utility of diodes for 
many of the applications discussed in this review. With suitably optimized optical 
delivery, these sources may ﬁnd their way into handheld devices for applications 
such as described in Figure 1.4. A review on the state of the art of photoacoustic 
imaging with laser diodes and LEDs can be found in 143.
 Another prominent engineering challenge that arises in many PA applications is 
the relative weakness of PA signals and the lack of control over their frequency 
content. As laser power can only be increased to the safety limit, and tends to be an 
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expensive commodity, the solution must be found in sensitive detection. The ultrasound 
scanners and transducers that are used for PA signal detection have usually been 
optimized for pulse-echo imaging. Alternative transducer types such as capacitive 
and piezoelectric micromachined ultrasound transducers (CMUT, PMUT) and inter-
ferometric sensors are currently being investigated to accommodate both the 
broadband nature of the PA signals generated and for the device integration/fabrication 
challenges 99, 144, 145. The power spectral density of PA signals tends to decrease 
with increasing frequency. Dedicated transducers with integrated ampliﬁcation 146 or 
dedicated, high-impedance data acquisition hardware 147 aim to optimize the detection 
path for sensitivity. These technical hurdles must be scaled to ascertain informative, 
robust and affordable imaging in a clinical setting.
1.7  Thesis objective and outline
Cardiovascular interventions pose many imaging needs, which can potentially be 
tackled with PA imaging. This unique capability to visualize tissue contrast means 
that PA imaging has a role in cardiovascular medicine research, and new applications 
are still emerging; especially with the on-going developments of more portable, safer, 
and faster laser sources. PA imaging is thus a promising, ionizing-radiation-free, 
contrast- agent-free solution for interventional imaging in cardiovascular interventions 
 Since the ﬁrst applications in imaging blood vessels ex vivo, PA imaging has 
revealed a number of unique features in cardiovascular medicine that may be put 
to use in the guidance and monitoring of therapy. In atherosclerosis research, PA 
imaging can play a major role in determining the plaque features predicting 
vulnerability. This is based on the capability of relating macroscopic spectroscopic 
PA signals to microscopic features 148 in an experimental setup and capability of 
using these spectral features for in-vivo identiﬁcation of plaque composition. A certain 
number of steps are still needed, though, before taking IVPA/IVUS to the clinics, 
requiring more technical innovation in the catheter and imaging system, in vivo 
validation of the images, and corroboration on the safety of the laser exposure. 
 Guidance of intracardiac ablation is another application where PA imaging can 
provide image contrast that is not available by any other means. Imaging of ablation 
lesions was reported using different methods, promising to unveil the progress of 
lesion formation in real-time to an otherwise blind cardiologist relying on model-based 
theory and experience. Evaluation of lesion gaps, discontinuity and in-depth electrical 
mapping could help the electrophysiology research ﬁeld in understanding the 
patterns of atrial ﬁbrillation and determining new methods to improve procedural 
success rates. In order for PA imaging to contribute to RF ablation lesion imaging 
for atrial ﬁbrillation, a few points remain to be researched and conﬁrmed such as 
(1) Validation of PA lesion contrast on atrial tissue and for different atrial sites 
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(2) Robustness of PA imaging methods to localize, delineate and evaluate lesion 
transmurality and continuity (3) Discrimination between lesion types such as differen-
tiation between PA signals from edema, and thrombi (4) Evaluation of imaging 
through blood (5) Feasibility of a realistic translatable photoacoustic imaging solution 
and lastly (6) Characterization of PA information on depth-resolved temperature 
gradients.
In this thesis, we showcase the potential of PA imaging in the future of cardio vascular 
research by pushing further the current achievements in PA imaging for the two 
aforementioned particular diseases: atherosclerosis and atrial ﬁbrillation. 
Chapter 2 characterizes the photoacoustic signal from RF ablation lesions. 
The imaging wavelength maximizing contrast to noise ratio is determined. A dual 
wavelength photoacoustic method, which allows high speciﬁcity and sensitivity 
discrimination of lesion extent and presence was developed. 
 
Chapter 3 compares two designs of photoacoustic-enabled radiofrequency ablation 
catheters. Tissue illumination geometry effect on imaging CNR and imaging area was 
determined. The capability of simultaneously ablating and illuminating tissue for PA 
imaging was established.
Chapter 4 demonstrates imaging of RF ablation lesion progression with clinically 
translatable instruments. An intracardiac echography catheter was used to collect 
the PA signals generated while forming ultrasound images in real-time. Dual-wave-
length imaging was proved to be robust against cardiac motion, blood and catheter 
tip artefacts.
Chapter 5 presents an IVPA/IVUS catheter design which reduces coupling damage 
at the rotary joint interface and improves light delivery to the tissue. The catheter was 
characterized for imaging capability in water and D2O media on ex-vivo human 
coronary samples. Catheter sheaths were evaluated for optimum imaging.
Chapter 6 evaluates the designed IVPA/IVUS catheter in an atherosclerotic pig 
model in-vivo. Using the previously in-house developed IVPA/IVUS system, we show 
capability of imaging lipid-rich plaques in-vivo. Imaging depth and effect of luminal 
blood is evaluated. The images are compared to NIRS/IVUS and OCT images.
Chapter 7 explores a technique based on PA spectral imaging to super-localize PA 
sources of different optical absorption confounded within one same image resolution 
cell. By taking the difference between the PA sources radiofrequency (RF) signal’s 
phase and performing a number of calculations across an array of transducers 
36
(acoustic detectors) the separation distance between the sources can be recovered 
with high accuracy.
Chapter 8 summarizes the work presented in this thesis and discusses the future 
steps for pre-clinical developments. 
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Abstract
Catheter-based radiofrequency ablation for atrial ﬁbrillation has long-term success in 
60-70% of cases. A better assessment of lesion quality, depth, and continuity could 
improve the procedure’s outcome. We investigate here photoacoustic contrast 
between ablated and healthy atrial-wall tissue in vitro in wavelengths spanning from 
410 nm to 1000 nm. We studied single- and multi-wavelength imaging of ablation 
lesions and we demonstrate that a two-wavelength technique yields precise detection 
and delineation of lesions, achieving a diagnostic accuracy of 97%. We compare this 
with a best single-wavelength (640 nm) analysis that correctly identiﬁes 82% of 
lesions. We discuss the origin of relevant spectroscopic features and perspectives for 
translation to clinical imaging.
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2.1 Introduction
2.1.1  Atrial fibrillation
Atrial ﬁbrillation (AF) is a cardiac arrhythmia which arises as a result of electrical 
activation patterns originating from the atrial wall, rather than the sino-atrial node. 
The atrium contracts more frequently and asynchronous from the ventricles, leading 
to reduced overall pump efﬁciency and vortex ﬂow. Approximately 5% of people over 
55 in Western countries suffer from AF, while prevalence increases with age 1, 2. 
The pathology is associated with a variety of cardiovascular symptoms, such as a 
higher probability of thromboembolism and stroke, and heart failure, unfolding into 
increased mortality. Current treatment strategies include pharmaceutical treatment, 
surgical interventions, and minimally-invasive catheter-based ablation.
 In catheter-based radiofrequency (RF) ablation, errant conduction loops are 
interrupted by inducing tissue necrosis through application of thermal energy. The scar 
tissue that subsequently forms is non-conductive and effects restoration of a regular 
contraction pattern. Patients who do not respond to pharmaceutical therapy (~60% 3), 
or who are at high risk for surgery, are candidates for catheter-based ablation. It is 
also advised as a more economical alternative for therapy in younger patients, who 
would otherwise require lifelong medication 4. However, current catheter- based ablation 
procedures have a success rate of about 60-70% 5. The intervention frequently fails 
as a result of tissue electrical reconduction, arising in the days, weeks or months after 
ablation. Causes for reconduction are insufﬁcient ablation, ablation gaps and tissue 
remodelling. On the other hand, complications due to over-ablation include venous 
stenosis, thrombus formation, and tamponade; which explains the tendency for inter-
ventionists to err on the side of caution and ablate conservatively. Feedback on lesion 
progression is currently indirect: lesion extent is assessed via impedance changes, 
as well as temperature and contact force values, all measured at the catheter tip. 
Finally, the end point of ablation is determined by the cessation of electrical activity at 
the ectopic foci after pacing. Better monitoring and control of the ablation process, 
quantifying both extent and functionality of the lesion is one way to reduce the duration 
and improve the outcome of the procedure 6.
2.1.2  RF ablation lesion imaging in the literature
In the quest of improving the success rate of catheter-based ablation procedures, 
much research has been directed towards assessment of the lesions created by 
ablation. Multiple imaging modalities have been explored; the most successful thus 
far being CMR (cardiac magnetic resonance) gadolinium enhanced imaging. 
However, CMR, compared to other imaging modalities, is difﬁcult to apply during an 
intervention, as it requires an MRI-equipped cardiac electrophysiology catheteriza-
tion room, and MRI-compatible instruments 7. It has mediocre image resolution 
(resolution cell 5 1-2 mm 5 atrial wall depth), leading to a poor assessment of lesion 
area, volume and transmurality 8, and is relatively expensive.
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Optical methods which were explored for lesion delineation include Optical 
Coherence Tomography (OCT) 9, Near Infrared Spectroscopy (NIRS) 10 and auto- 
Fluorescence Hyperspectral Imaging (aHSI) 11. These methods are based on scattered, 
reﬂected and emitted light from the tissue. However, despite demonstration of contrast 
between lesion and non-ablated tissue in all three modalities, they lack reliable evaluation 
of lesion extent in depth.
 Other imaging modalities which were explored for ablation lesion monitoring are 
conventional ultrasound 12-15 as well as ultrasound elastography 16-18. Visibility of 
lesions on grayscale ultrasound has been disputed in literature, with contradictory 
reports of both decrease and increase in echogenicity in lesion areas. Elastography, 
on the other hand, seems more successful at lesion identiﬁcation and looks quite 
promising. However, monitoring lesion progression with shear wave elastography is 
still a challenge due to the estimation of atrial wall curvature for wave propagation 
progression and the difﬁculty in aligning the ultrasound beam to the lesion site across 
the ablation catheter 18.
2.1.3  Photoacoustic imaging for lesion progression monitoring
Previous studies have shown optical, mechanical as well as acoustic contrast between 
lesions and the remaining non-ablated tissue; yet the challenge of the development 
of an accurate lesion delineation method that is easily translatable to the clinical 
setting remains. Photoacoustic (PA) imaging incorporates all aforementioned types 
of contrast. The PA source pressure p0(z) = Э(z)·эa(z,ь)·F(z,ь) is the product of the 
local optical ﬂuence F, the local optical absorption coefﬁcient эa, and the Grüneisen 
coefﬁcient Э. The absorption and ﬂuence depend on wavelength and tissue optical 
properties. The Grüneisen coefﬁcient is the conversion factor between optical energy 
to thermo-elastic strain, and potentially provides information on tissue stiffness and 
temperature. PA imaging is unique in its access to such a wide array of tissue 
properties which may play a role in lesion characterization.
 Intracardiac echo (ICE) is frequently used to guide septal puncture in ablation 
procedures for atrial ﬁbrillation. The ultrasound catheter, with a typical centre 
frequency of about 7 MHz, could also be used for detection of PA signals if light could 
be delivered through a modiﬁed ablation catheter for instance. The potential for 
clinical translation and enhanced contrast encouraged us to look further into 
photoacoustic imaging as a means of monitoring lesion formation.
 Two groups have previously performed PA imaging of RF ablation lesions on 
porcine cardiac tissue ex-vivo 19, 20. Pang et al. 19 have identiﬁed a maximum lesion 
to non-ablated tissue contrast at 780 nm using a 3 MHz transducer. Dana et al.20 
revealed a spectral signature providing contrast at wavelengths near 760 nm (which 
was attributed to the haemoglobin spectral signature disappearing) using a 21 MHz 
transducer. Both studies evaluated lesion formation in ventricular tissue, which is not 
directly generalizable to atrial ablation. 
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In this study we analysed the PA signal from healthy and ablated porcine left atrial 
tissue including endocardial and epicardial layers. We acquired PA signals with a 
linear array transducer of centre frequency matching that of ICE catheters to verify 
bandwidth compatibility. We performed PA spectroscopic imaging prior to, and after 
ablation. We identify the spectral changes between fresh and ablated tissue in order 
to visualize the induced changes in tissue composition, as well as identify wavelengths 
for optimal contrast, imaging depth and signal to noise ratio (SNR). We demonstrate 
robust contrast for identiﬁcation of ablation lesions and quantify the diagnostic 
accuracy by computing the receiver-operator curve for lesion detection, using either 
a single wavelength or an optimal combination of two wavelengths.
2.2  Materials and methods
2.2.1  Sample materials and tissue handling 
We evaluated PA image contrast after RF ablation of fresh excised porcine left atria 
(0-24 h post mortem), obtained from a local butcher and from the Dept. of Experimental 
Cardiology in our institute. We collected 23 spectra (23 lesions) from 14 different 
tissue samples originating from 12 different hearts. The average depth/thickness of 
the tissue examined was of 2.7 mm with a maximum of 8 mm and a minimum of 400 
эm, as measured from US images.
 Tissues were mounted in a water tank, suspended by wires. For ablation we used 
an EPT 1000 XP APM system (Boston Scientiﬁc, Marlborough, Massachusetts, 
United States) with a Blazer II HTD, Asym #4 (model: 5031 THN4) catheter. We 
delivered ablation energy to localized site(s) of the endocardium in the imaging plane, 
using appropriate settings (Power * 20W, Temperature * 60˚C, time * 20s). We kept 
ablating the same lesion site (n * 1) until a visible lesion was produced on the 
endocardium side. After PA imaging, we sectioned the tissue through the lesion for 
visual inspection. We determined the imaged plane by inserting needles that are 
visible on the ultrasound image. Throughout the measurement, the tissue was kept in 
a HEPES buffer mixed with saline solution of pH 7.4 at room temperature.
2.2.2  Setup Description
We performed photoacoustic spectroscopy with a pulsed laser source (10 Hz ) tuned 
from 410 nm to 708 nm, and 712 nm to 1000 nm (Vibrant B-355II, Opotek, Santa 
Clara, CA, USA) in steps of 2 nm. The setup consisted of a linear array transducer 
(192 channels, L12-3v, fc = 7.8 MHz, Verasonics, Kirkland, Washington) connected to 
a Verasonics Vantage 256 research system. The acquisition was programmed to 
overlay images created from pulse echo plane wave ultrasound (US) at 3 different 
angles (-18 ,˚ 0 ,˚ +18˚), and from photoacoustic signals averaged over 6 laser pulses. 
During the photoacoustic acquisition, the time-gain compensation (TGC) was set to 
52
its maximum value (not changing with depth), to optimize examination of the signal 
attenuation with depth. The tissue was mounted in a transmission-mode PA setup 
(Figure 2.1), with the endocardium facing a broad illumination source. We performed 
spectroscopic imaging, before and after ablating the tissue, keeping the relative 
position of the tissue and the transducer as stable as possible, in order to compare 
the signal before and after ablation from the same portion of tissue. After acquiring 
tissue spectroscopy data, we measured the OPO tuning curve for calibration of the 
PA signal. The ﬂuence varied between 0.3 and 1 mJ/cm2 depending on the wavelength.
2.2.3  Extraction and validation of photoacoustic spectra
From the beamformed photoacoustic images, we averaged the intensity (I) in a 
user-deﬁned image region of interest (ROI, IROI), as a function of excitation wavelength. 
We identiﬁed regions in co-registered images generated prior to and after ablation. 
The lesion position was identiﬁed as the location of the ablation catheter and the 
lesion extent was deﬁned from the visual inspection of the tissue cross section after 
the experiment. In post-ablation images, we selected two regions, a lesion site (L, 
post) and a non-ablated site (N/N’, post). Deﬁnition of ROIs on the illuminated 
endocardial side minimizes the impact of spectral colouring when evaluating the 
tissue spectral photoacoustic features. ROI size ranged from 3×3 pixels (= 0.3×0.6 
mm axial × lateral) to 10×10 pixels (= 1×2 mm) depending on visual lesion size.
 We averaged all spectra extracted from three identiﬁed region classes: lesion 
(L, post), lesion site prior to ablation (L, pre), and control after ablation (N, post), 
Figure 2.1  Transmission PA imaging setup for spectroscopic analysis of RF ablation lesions. 
The tissue is suspended and stretched with the aid of wires. A ﬁbre bundle illuminates the 
atrium sample from the endocardial side. A 192 element 7.8 MHz centre frequency transducer 
records the generated PA signal. A black plastic sheet (optical absorber) provides a reference 
signal to assess optical attenuation. We analyse spectroscopic differences in PA response in 
lesion (L) and control (N,N’) sites.
L N N’
Optical absorber 
                             (removable)
Porcine left atrium tissue
L: lesion site
N,N’: control sites
Transducer L12-3v
Acoustic window
Illumination bundle
HEPES/Saline solution
Tunable laser
410-1000 nm
Verasonics 
Vantage 256
Trigger Q
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itch
Flashlam
p Trigger
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shown in Figure 2.2. We equalized the means across the spectrum to account for 
day-to-day variations prior to averaging all the traces and computing the standard 
deviations. We also normalized to the OPO tuning curve veriﬁed after each experiment. 
We validated our methodology by corroborating the water absorption spectrum at the 
water-air interface to those reported in the literature 21, 22.
 We assessed spectral optical attenuation by recording the signal form a highly 
absorbing black plastic phantom behind the tissue as shown in Figure 2.1. Reliable 
volumetric imaging of ablation lesions is only possible in those spectral regions that 
allow sufﬁcient penetration of excitation light. Wavelengths which reliably generate a 
signal from the black target behind the tissue are suitable for transmural imaging, 
which was true for ь > 600 nm, reﬂecting the familiar decrease of optical attenuation 
with increasing wavelength.
2.2.4  Quantitative evaluation of imaging parameters
Contrast in single wavelength images
We calculated the signal ratio (SRL) as the ratio IL/IN (subscripts refer to the regions 
as indicated in Figure 2.1) on post-ablation images, which characterizes lesion 
delineation (contrast with neighbouring tissue). We observed that at most wavelengths 
in our investigated spectral range, the PA signal increased by ablation (independent 
of temperature), in agreement with literature, so normally SRL > 1. In our data set, we 
have included multiple different tissue and lesion models (i.e. superﬁcial lesions, 
tissue slabs with 1 to 3 lesions, trabeculae structure). The mean of the collected SR 
from all lesion samples thus reﬂects the general signal contrast due to the ablation 
process, and the standard deviation indicates the expected variability in this contrast 
due to different tissue types and ablation strategies. The SRN for non-lesion sites is a 
control variable to estimate the variability in signal within one tissue sample among 
different non-ablated sites. The SRN was computed as the signal ratio between two 
different control areas IN/IN’ on post-ablation images; the mean provides information 
about the signal variation across the tissue due to the tissue intra variability and the 
standard deviation is caused by the variation in signal due to different left atrium 
tissue sites.
Wavelength selection criteria for dual wavelength imaging
We explored a dual wavelength imaging method, which takes the ratio of two 
subsequent frames acquired at different wavelengths, aiming at differentiating lesion 
sites from untreated tissue. The ﬁnal dual wavelength image was obtained by 
subtracting the mean noise value from the overall image to equalize the background 
among the data set acquired. The rationale behind a two colour imaging method is 
to develop an easily interpretable image that directly identiﬁes and delineates ablation 
lesions. A two-colour ratio image would be insensitive to both temperature effects, 
and, if the two wavelengths are sufﬁciently closely spaced, to variation in ﬂuence due 
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to tissue attenuation, approximating p0(z,ь1) / p0(z,ь2) = эa(z,ь1) / эa(z,ь2). A dual wave - 
length imaging method would eliminate the need for modelling the impact of tissue 
optics or temperature (which both change during ablation) on the photoacoustic signal.
 In order to determine the wavelength pair that provides the highest, most reliable 
lesion contrast, we ﬁrst deﬁned the two-wavelength signal ratio for control (ØN) and 
lesion (ØL) areas:
ØN =
IN(ь1)
IN(ь2)
(1)
ØL =
IL(ь1)
IL(ь2)
(2)
We restricted the wavelengths to 630 nm < ь < 1000 nm to ensure a homogeneous 
illumination in a slab of 3 mm by excluding highly attenuated wavelengths, and 
avoiding the spectral range around the OPO tuning degeneracy gap, near 709 nm 
(702-724 nm, because of low output ﬂuence < 0.3 mJ/cm2 and thus limited SNR). 
Variability in medium optical properties can be prevented by limiting the spectral 
separation between the two wavelengths. 
 We then determined the best pair of wavelengths for a ratio image by evaluating:
{ь1ь2} = arg
max < ØL >, such that < ØL >> 2 Çѓ ( ØL )Юь<150nm ØN ØN ØN (3)
< Ѧ > denotes the mean over all measurements. Images constructed from the PA signal 
at an optimal combination of two wavelengths highlight lesions against a background 
of unaffected tissue. Eq. (3) maximizes the contrast between these two tissue classes, 
while limiting the variability due to the disparity of tissue and ablation strategy. 
Evaluation of dual and single wavelength images for lesion formation
We compared the performance of a dual wavelength to a single wavelength imaging 
method for detecting whether a lesion has been created. Diagnostic accuracy can be 
evaluated by receiver-operator characteristic (ROC) analysis. As the imaged quantities 
are different for both imaging approaches, we need to deﬁne different criteria for 
lesion identiﬁcation. We calculated the number of true positives (TP; correctly identiﬁed 
lesions) in a dual wavelength image, as the amount of lesion sets for which the ratio 
exceeds a certain threshold Øthr :
ØL,post > Øthr (4)
False positives (FP) are areas in which this threshold is reached prior to ablation:
ØL,pre > Øthr (5)
In single wavelength images, we can only compare PA signal amplitude in lesion 
areas post and pre-ablation. We deﬁned the true positives as:
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ZL =
IL,post > ZthrIL,pre
(6)
and the false positives as control areas exceeding this threshold:
ZN =
IN,post > ZthrIN,pre
(7)
We divided the number of TP and FP observations by the number of lesion samples 
we have collected to obtain TP/FP rates. The total number of controls was equal to the 
number of lesions collected. Both Z and Ø are amplitude ratios and so are comparable 
variables. Ideally, the two wavelengths chosen for the dual wavelength images should 
yield a featureless image prior to ablation, and clearly discernible areas corresponding 
to lesion sites in post-ablation images. An equivalent representation in a single 
wavelength imaging scheme would occur if we divide the post-ablation frame with 
the pre-ablation one.
Evaluation of dual and single wavelength images for lesion delineation
Delineation of lesions is important to assess lesion continuity in ablation procedures. 
This can be evaluated as the contrast between lesion areas and neighbouring tissue 
after ablation. We evaluated delineation capability of single and dual wavelength 
imaging by ROC analysis. For two-wavelength imaging, we deﬁned the true positives 
as in (Equ. 4), while false positives are control areas satisfying the threshold criterion:
ØN,post > Øthr (8)
In single-wavelength images, the true positives (lesions are clearly delineated from 
the rest of the tissue) are deﬁned as the lesions for which the SRL exceeds the 
threshold ratio Zthr, while false positives are control areas SRN meeting that norm.
2.3  Results
2.3.1  Photoacoustic signal variation with illumination wavelength
In Figure 2.2, we plot the average of PA signals normalized to the mean variation over 
the imaging wavelengths at different tissue sites. The orange and green curves in 
Figure 2.2 present spectra of non-ablated sites on tissue before and after ablation 
respectively. These curves show that ablation modiﬁes the spectral absorption features 
at the ablated site only: the control site after ablation has the same appearance as 
the lesion before. In the spectra we identify spectral features representing the charac-
teristics of myoglobin with distinctive peaks at 555 nm and 760 nm. The ﬂattened 
peak around 550 nm indicates that the observed spectrum is resulting from a mix of 
oxymyoglobin and myoglobin. 
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In our spectroscopic characterization of ablation lesions (Figure 2.2a,b) we observe 
that there are no distinct absorption peaks in the spectral range we investigated, with 
the exception of that at 420 nm, which appears the same as in the non-ablated tissue. 
The PA response at wavelengths around 500 and 600 nm is higher than that of fresh 
tissue. In the near infrared range, as in 20, we ﬁnd that the lesion is characterized by an 
attenuation of the 760 nm peak associated with the optical absorption of haemoglobin 
and myoglobin. 
2.3.2  Imaging parameters 
SR and SNR
The most characteristic parameter available for identiﬁcation and delineation of lesions 
within a single-wavelength PA image is the SRL. In Figure 2.3, the mean SRL exceeds 
the control (SRN in red) for the range of 600 nm onward. The variability of the SRL in 
our data set is large, likely resulting from intrinsic variability in tissue response at different 
locations. This impacts the reliability of lesion delineation. Nevertheless, from Figure 2.3 
we can identify the wavelengths for maximum lesion to non-lesion contrast in single 
wavelength images to be 640, 680, 800 and 730 nm in decreasing contrast. From the 
transmission measurements using the black absorbing target behind the tissue, 
we conclude that the imaging range for full tissue illumination ranges from 600 to 
1000 nm. 
Figure 2.2  Average (э) of spectra extracted from 23 tissue sites. (a) Comparison of non-lesion 
sites before and after ablation. (b) Lesion sites before and after ablation.
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2.3.3  Imaging lesions
Single wavelength imaging
The analysis in section 2.3.2 suggests that the most suitable single wavelength for RF 
ablation lesion imaging, detection and delineation, is 640 nm. Figure 2.4a and Figure 
2.5a show PA images of two different tissue samples (Figure 2.4d, Figure 2.5d), pre- 
and post-ablation at selected wavelengths including 640 nm. In Figure 2.4, two lesions 
were made, while in Figure 2.5, a single lesion is present. The photoacoustic images 
are normalized to the 95th percentile and displayed on a logarithmic scale. Inspection 
of the single-wavelength images in Figure 2.4a,c1 and Figure 2.5a,c2 shows that there is 
a variable increase of PA contrast in lesion sites by 2—10 dB, as observed in the SR 
assessment. In Figure 2.4a, focal enhancements can be appreciated in ablated sites, 
while in Figure 2.5a, there appears to be a homogeneous signal increase after ablation.
 A movie of the ablation process in the right-hand lesion site in Figure 2.4 is available 
as Visualization 1 (Figure 2.4c1) . The frame rate is ~ 0.4/s. We observe a slight increase 
in tissue thickness during ablation on ultrasound imaging. In the video, the lesion 
progress is perceptible as a gradual increase in PA signal but the lesion extent is 
poorly visible. Single wavelengths PA images acquired after the tissue cooled down 
show that the signal increase observed in Visualization 1 is not necessarily permanent. 
In Figure 2.5a, the lesion is indiscernible from the surrounding tissue. Lesion visibility 
was inconsistent over the data sets we have collected, reﬂecting the high standard 
deviations observed in our analysis in 2.3.2. 
Figure 2.3 Variation of the SR across wavelengths for lesion and control sites. ѓ represents the 
standard deviation; μ represents the mean.
μ SR non-lesion
μ SR lesion
μ +/- σ
μ +/- σ
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Dual wavelength imaging
The slope of the signal variation with wavelengths in the near infrared range is different 
in the lesion areas than that in the non-ablated areas (Figure 2.2). We investigate the 
utility of this difference for identiﬁcation and delineation of lesions by taking the ratio 
of signals at two wavelengths to distinguish lesion from untreated tissue. We evaluate 
the ratio of two-wavelength contrast ratios ØL / ØN as described in 2.2.4, which we 
display in Figure 2.6. We look for maxima in this matrix, excluding the range where the 
standard deviation is greater than half the mean (white border), which would lead to 
increased sensitivity to the innate variability identiﬁed previously. The optimal 
wavelength pair emerging from this analysis is 790 +⁄- 10 nm and 930 +⁄- 10 nm. 
 We evaluate the imaging performance of a dual wavelength ratio imaging method 
using this optimal pair. We divide the ﬂuence-corrected PA image at 790 nm by that 
acquired at 930 nm in both pre- and post-ablation acquisitions. We create images 
from this ratio, subtracting the background which arises from the (variable) noise in 
the PA image. Images of the example tissues we examined before are shown in 
Figure 2.4b and 2.5b. We observe that on pre-ablation images we see a uniform 
signal indicating the absence of lesions, and on post-ablation images we see bright 
signal at the lesion spots. In Figure 2.5, the lesion was not visible on any of the single 
wavelength post-ablation images, but becomes quite clear with the dual wavelength 
ratio imaging method. Figure 2.4b shows a case where the lesions’ presence, lateral 
Figure 2.4 (a) Pre- and post-ablation PA images of a tissue sample at 640, 790 and 930 nm. (b) 
Dual wavelength images pre- and post-ablation. (c) Single wavelength (c1, Visualization 1) and 
dual wavelength (c2) images overlaid on ultrasound. (d) Photo of the tissue sample. Arrows 
point at the ablation sites.
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extent and transmurality is clearly visible with the proposed imaging method, compared 
to uncertain identiﬁcation and impossible delineation with a single wavelength. 
Figure 2.5 (a) Pre- and post-ablation PA images of a tissue sample at 640, 790 and 930 nm. (b) 
Dual wavelength images pre- and post-ablation. (c) Single wavelength (c1) and dual wavelength 
(c2) images overlaid on ultrasound. (d) Photo of the tissue sample. The arrow points at the 
ablation site.
Figure 2.6  ØL / ØN over all eligible wavelengths.
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Quantitative performance evaluation
We quantitatively evaluate the performance of the proposed two-wavelength imaging 
technique by computing receiver-operator characteristic (ROC) curves. We apply different 
criteria for lesion identiﬁcation and delineation, deﬁned in 2.2.4. We compare two- 
wavelength imaging with two single-wavelength analyses, the optimal wavelength of 
640 nm we identiﬁed based on the SR analysis, and 780 nm, which was previously 
identiﬁed as providing optimal contrast. The analysis is shown in Figure 2.7a and 2.7b.
 The dual-wavelength analysis achieves an overall diagnostic accuracy of 0.97 for 
identiﬁcation of lesions (comparing pre-/post-ablation) and also 0.97 for delineation 
(comparing lesions to neighboring control sites). The sensitivity and speciﬁcity at the 
operating point are 0.88 and 1.0, respectively, at a threshold of 0.39. The performance 
of any single wavelength imaging technique is inferior, with the optimal area under the 
curve (AUC) equal to 0.82 for lesion identiﬁcation and 0.87 for delineation. We also 
ﬁnd that 640 nm is consistently more effective than 780 nm for imaging RF ablation 
lesions.
The ROC analysis shows that the dual wavelength is more robust at detecting lesions. 
It also conﬁrms that the dual wavelength imaging method proposed can highlight the 
lesion extent from the surrounding tissue better than a single wavelength imaging 
method. 
Figure 2.7 Comparison between the Receiver Operating Characteristics (ROC) curves for 
lesion detection (A) and lesion delineation (B) of dual wavelength imaging, and single wavelength 
imaging at 640 and 780 nm. (AUC: area under the curve, Sens.: sensitivity, Spec.: speciﬁcity).
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2.4  Discussion
2.4.1  Contribution of this work
In this work, we present a photoacoustic spectroscopic characterization of ablation 
lesions in left atrial tissue. We introduce a dual wavelength (790/930 nm) imaging 
method which forms an image based on two consecutive frames acquired at two 
optical wavelengths. Advantages over single wavelength imaging approaches presented 
before 19, 20 are insensitivity to ﬂuence and temperature variations, resulting in more 
robust lesion detection and delineation (important for assessing transmurality). 
Quantitatively, we ﬁnd that the best-performing single wavelength is 640 nm, in contrast 
to 780 nm that was suggested previously, based on qualitative assessment in single 
lesions 19.
 We also found the reproducibility of lesion visibility with a single wavelength 
monitoring to be inferior to our proposed dual wavelength imaging method. Indeed, 
the proposed method reduces the number of false negatives making it a more 
suitable imaging method for both lesion formation monitoring and depth extent 
evaluation as well as for post-ablation mapping. The proposed method reduces the 
variability in signal strength due to the differences in tissue sites and geometry 
(trabeculae vs. smooth). Further studies will be needed to evaluate the balance 
between these beneﬁts and the increased cost of dual wavelength imaging.
 The signal change from 790 nm to 930 nm for lesions follows a negative slope, 
while that of untreated tissue is rather constant. The ratio of the signal at these two 
wavelengths is > 1 for lesions and 5 1 elsewhere. Blood has oxy/haemoglobin as its 
main chromophores, which are spectrally very similar to oxy/myoglobin. The absorption 
ratio at the chosen wavelengths is  1, making dual wavelength imaging more robust 
than single wavelength image in a blood environment, as it is based on highlighting 
signal from chromophores with a negative slope in that same range.
 We conﬁrm the spectral signature observed by Dana et al. 20, as well as the 
increase in signal from ablated tissue observed by Pang et al. 19. However, we ﬁnd 
that the correlation based imaging proposed in 20 highlights also the artefacts caused 
by image reconstruction and that the correlation to non-ablated tissue remains high 
making it difﬁcult at instances to identify lesions from the rest of the tissue. 
2.4.2  Interpretation of spectra
The main chromophores in healthy myocardium tissue are myoglobin, cytochrome c 
and hemoglobin in their reduced, oxygenated and oxidized states, as well as water, 
lipid and collagen. Myoglobin dominates the optical absorption response of cardiac 
tissue in the examined range but the contributions of lipid, water and collagen 
become more signiﬁcant in the near infrared. Our spectroscopy results of non-ablated 
tissue do consistently reﬂect this mix of chromophores. We identiﬁed oxygenation 
effects in the shape of myoglobin features: the more the tissue is exposed to air, 
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the more oxymyoglobin is formed. Therefore, the oxymyoglobin spectral signature in 
the visible range provides information on the freshness of the specimens received 
from the butcher. In fact, the ﬂatness of the peak observed in our data set is representative 
of approximately 20% oxymyoglobin and 80% myoglobin on average. Sometimes 
there is also variability within the content of a sample (variation in tissue color Figure 
2.4d). Indeed, in Figure 2.3, we note that the variability in SRN is mainly representative 
of the variability of oxymyoglobin and myoglobin content of the tissue. The sharp 
variability observed at 690 and 660 nm could be associated with metmyoglobin 
formation. 
 RF ablation is a process where the tissue is heated over the transmission of 
radiofrequency current (~ 500kHz) through a resistive pathway to the indifferent 
electrode. The result of this process is the formation of coagulation necrosis 
associated with the denaturation of proteins 23. Previous work on RF ablation lesion 
imaging based on optical methods, such as 24, reported lesions to be more optically 
scattering and to correspond better spectroscopically with the formation of 
metmyoglobin. Metmyoglobin is an oxidized form of myoglobin (where the heme iron 
within the porphyrin ring is oxidized to Fe3+) 25. The rate of auto-oxidation of myoglobin 
is accelerated at higher temperatures under speciﬁc pH conditions. However, this 
state is reversible and is not an indication of proper lesion formation 26. In the larger 
spectral range we investigated, we found that the optical absorption changes effected 
by ablation are not consistent with metmyoglobin formation. The denaturation 
process occurring during RF ablation is one in which proteins decompose and lose 
their spatial conformation. In the case of myoglobin, two of the resultants of such a 
process are denatured globin (optically transparent) and heme groups that form new 
compounds called hemichromes 27. The spectrum we observe in lesions corresponds 
to that reported of hemichromes 28.
 We performed our experiments on porcine cardiac tissue, which is a commonly 
used model for human cardiac tissue. We expect our proposed method to work on 
human tissue; indeed as reported by 10 the optical changes in porcine and human 
tissue due to ablation are similar with the human tissue being slightly more scattering. 
AF is often associated with an underlying disease called atrial ﬁbrosis 29. In this 
disease tissue is mechanically and structurally remodelled to contain more collagen; 
the targeted tissue is thus perhaps slightly different in structure and composition in 
comparison with the healthy pigs we have used. Nevertheless, the spectral absorption 
of collagen in the range of 790 to 930 nm would also yield a negative ratio value as 
opposed to the positive ratio value found for lesions. The denaturation of collagen 
results in gelatine 30 which would result in a positive ratio value 31, similar to the 
lesions we observed. 
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2.4.3  Future work and considerations for application
Future studies will explore the relation between ratio values and degree of ablation. 
Other studies such as 24, 32 noticed that the change in signal within the ranges of 600 
to 700 nm, and 800 to 960 nm could possibly be an indicator of the degree of ablation. 
Moreover, we will also analyze lesion features on ultrasound for a more robust lesion 
assessment relying on a dual imaging modality scheme with the proposed PA dual 
wavelength imaging. 
 Finally, we have demonstrated the ability to visualize RF ablation lesions on ex 
vivo porcine tissue. We do anticipate similar results on cryo and microwave ablation 
lesions as they were reported to be histologically similar to RF ablation lesion 33. Our 
setup likely has higher image resolution and greater sensitivity than can be expected 
from intracardiac echography probes, and represents a motionless and bloodless 
environment. Nevertheless, we foresee that our method should work in a clinical 
environment. Indeed, lesion formation is a slow process (~ 30, 60 s), and current 
laser repetition rates and pulse-to-pulse wavelength tuning should be enough to 
monitor ablation. Irrigated catheters effectively displace the blood at the ablation site. 
In order to translate this work to a more practical catheter-based illumination setup, 
we will focus on dedicated catheters for PA-guided ablation. 
2.5  Conclusion
We have characterized the photoacoustic signal from fresh and ablated porcine left 
atria tissue specimens over the range of 410 to 1000 nm. The changes we observe 
can be interpreted in terms of known irreversible processes occurring in thermal 
protein denaturation. We have demonstrated that imaging lesion formation using the 
ratio of two wavelengths achieves a diagnostic accuracy of 97% and displays a 
sensitivity of 88% and speciﬁcity of 100% at detecting and delineating lesions from 
the surrounding tissue, for an optimal wavelength pair of 790 and 930 nm. This 
method outperforms single-color imaging at any wavelength in the investigated 
range: ablated tissue generates a higher PA signal than untreated tissue but the 
variability in the enhancement is too large to provide reliable image contrast. Du-
al-wavelength ratio-based imaging removes the need of modelling the PA signal 
variation with tissue attenuation and temperature, which are relatively independent of 
temperature. The technique we explore in this study can be translated to intracardiac 
imaging with the application of modiﬁed ablation catheters for light delivery and ICE 
probes for signal detection.
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Abstract
Atrial ﬁbrillation is a cardiac arrhythmia stemming from abnormal electrical conduction/ 
impulse formation in the atria. To restore cardiac rhythm an RF ablation (RFA) procedure, 
interrupting aberrant electrical patterns, is commonly performed. One way of improving 
the procedure (current success rate ~ 60%) is to enable visual feedback on lesion 
progression, thereby reducing complications linked to over- ablation and mitigating 
recurrent conductivity due to under-ablation. To visualize the ablation process, we 
propose photoacoustic (PA) imaging using an ablation catheter for light delivery and 
an ICE (Intracardiac Echo) catheter for signal reception In this work, we demonstrate 
two PA-enabled ablation catheters which provide sufﬁcient optical intensity to image 
fresh and ablated porcine tissue ex vivo.  
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3.1  Introduction
Atrial ﬁbrillation is a cardiac arrhythmia stemming from abnormal electrical conduction/ 
impulse formation in the atria. To restore cardiac rhythm an RF ablation procedure, 
interrupting aberrant electrical patterns, is commonly performed. During the procedure 
the ablation catheter is inserted into the left atrium through a transeptal puncture 
guided by an intracardiac echo (ICE) probe. Electroanatomical maps (EAM), which 
are volumetric rendering of the atrial cavity structure and potentials, are generally 
used to guide and record treatment at identiﬁed electrically abnormal areas. Information 
on delivered treatment (i.e. induced lesions) is deduced from a combination of parameters 
provided by different sensors at the ablation catheter tip 1. Indeed, RF ablation (RFA) 
catheters carry nowadays more and more functionality. They provide temperature, 
impedance, contact force estimates and can also integrate electromagnetic sensor 
for localization and angular apposition determination. RF energy is generally delivered 
in a unipolar mode through an irrigated tip catheter, which features a ﬂush channel to 
cool the tissue surface while ablating. The development of different catheter types 
and sensory feedback at the ablation catheter tip was driven by the need to improve 
RF energy transfer to tissue, mainly for adequate and predictable lesion formation, 
but also to avoid complications related to excess of energy delivery 2, 3. Different 
catheters may generate different lesion proﬁles, and the ablation system can be used 
in two modes, namely power controlled or temperature controlled. Cardiologists 
need to interpret multiple sensor feedbacks to determine the end point of ablation for 
different cardiac loci and to prevent potential threats to patient safety (formation of 
steam pops, delivering energy to underlying nerves structures or organs etc.). 
However, the presence of fat or vessels can change the proﬁle of the delivered energy 
and temperatures reached in the tissue, complicating the interpretation of the various 
sensor readouts. This yields incomplete lesion proﬁles, or worse excess of energy 
delivery leading to unwanted complications such as tamponade. One way to reduce 
potential procedural risks and to ensure good lesion formation proﬁles is to develop 
an imaging tool for direct lesion visualization and ablation evaluation. 
 Optically, to the naked eye, ablation lesions are quite discernible from the rest of 
the tissue, both from the surface of the endocardium and through the depth of the 
myocardium. Absorption of a nanosecond laser pulse by tissue generates (photo)
acoustic waves detectable by ultrasound transducers. Based on this principle, 
photo acoustic imaging maps the absorption of light by tissue. It was previously 
shown that lesions and untreated tissue have different photoacoustic absorption 
spectra, and that these spectral differences are sufﬁcient to image lesions and 
distinguish them from the rest of the tissue 4-6. In addition to that, previous work 
characterized signals generated from PA-enabled ablation catheters 7, 8. Unlike in 7 
we propose separating the illumination source from the receive transducer. Also, 
unlike 8, we propose modifying an RFA catheter to deliver light, and receiving the 
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generated photoacoustic signals (PA) with an ICE to visualize the lesion formation 
process and identify lesion loci and extent. In this work, we investigate and evaluate 
two RF ablation catheter designs enabling photoacoustic imaging of ablation lesions. 
We evaluate light delivery capability, signal generation extent as well as lesion 
identiﬁcation capability within this restricted illumination geometry. Finally, we discuss 
the impact of the metallic electrode on the photoacoustic imaging capability. 
3.2  Methods and materials
3.2.1  RF ablation catheter design and evaluation
We modiﬁed commercially available RFA catheters (Blazer, EPT9620K2 Boston 
Scientiﬁc Marlborough, MA, USA) and replaced the irrigation channel either with one 
single optical ﬁber of 400 эm, 0.39 NA (FT400EMT, Thorlabs, Newton, NJ, USA) at 
the center of the catheter tip (Design A) or three 200 эm optical ﬁbers of 0.5 NA 
(FP 200ERT, Thorlabs, Newton, NJ, USA) surrounding the catheter tip (Design B). 
A new electrode made of stainless steel was glued instead of the original one. 
This way, we retained the steering capability of the catheter while allowing the delivery 
of light for PA signal generation. The positions of the ﬁbres are such that the illumination 
direction is parallel to the direction of the catheter shaft, as shown in Figure 3.1a,b. 
The ablation catheters were compatible with the EPT 1000 XP APM ablation system 
(Boston Scientiﬁc, Marlborough, MA, USA). 
To evaluate light delivery, we coupled the modiﬁed RF ablation catheters to a tungsten 
halogen lamp (LS-1, Ocean optics, Largo, FL, USA) and measured the beam proﬁle 
(BP209, Thorlabs, Newton, NJ, USA) at about 2 mm distance from the catheter tip. 
For characterization of tissue imaging capability, we analyzed PA images obtained 
with both catheters and evaluated imaging depth and signal extent. Finally, to further 
evaluate the effect of the illumination spot size on the signal generated we acquired 
images at different catheter-tissue distances pre and post ablation. 
Figure 3.1 (a) Catheter design including one single optical ﬁber through its center: design A. 
(b) Catheter design including three optical ﬁbers surrounding the ablation electrode : design B.
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3.2.2  Imaging setup
We imaged fresh porcine left atrium specimens in a transmission mode photoacoustic 
setup (Fig. 3.4d). We positioned the prototype catheter at the endocardium side 
and the transducer at the epicardium side. We used a linear array transducer (192 
channels, L12-3v, Verasonics, Redmond, Washington) connected to a Verasonics 
Vantage 256 research ultrasound system to collect the photoacoustic signals. 
The laser source (Vibrant B-355II, Opotek, Santa Clara, CA, USA) was tuned between 
790 nm and 930 nm. We acquired two sets of images, before ablation and after 
ablation. The tissue was submerged in a HEPES buffer. Ablation settings were 
P  28W, t  45s.  We positioned a black plastic absorber, from plastisol, after the 
tissue to assess transmission of light through the tissue. Detecting PA signal from 
the black plastic absorber means that enough light is transmitted from the catheter 
to penetrate the tissue slab and reach the surface of the phantom. One imaging 
frame was composed of pulse echo plane wave ultrasound (US) at 3 different angles 
(-18 ,˚ 0, +18˚). The photoacoustic signals were averaged over 6 laser pulses per 
wavelength (ь). The ﬁnal images were normalized to the 95th percentile signal.
3.3  Results
3.3.1  Evaluation of catheter designs
From a design and fabrication point of view, the single ﬁber catheter, design A, is simpler 
(Fig. 3.1). It is easier to couple to a laser source with less risks of damage at the 
catheter input. The laser light needs only to be shaped to match the opening angle 
of the one single ﬁber, while for the multiple ﬁbers bundled with glue, this won’t be 
achievable. In addition to that, the multiple ﬁber catheter damage threshold is lower 
Figure 3.2 (a) Beam proﬁle ~2 mm from the tip of catheter design A shown in the photograph 
inset. (b) Beam proﬁle ~2 mm from the tip of catheter design B shown in the photograph inset. 
The axis units are in эm.
(a) (b)Design A Design B
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than its single ﬁber counterpart, limited by the glue damage threshold. Therefore, 
the coupling efﬁciency achieved with the catheter incorporating three ﬁbers, design 
B, is only 60% of that of the single ﬁber design. However, catheter design B has 
the advantage of illuminating a larger tissue area, but at the cost of a lower ﬂuence. 
In Figure 3.2, we observe that the illumination spot for catheter design A is about 1.5 
x 1.5 mm diameter (Gaussian)  at a distance of 2 mm, while that of catheter design B 
is about 4.5 x 4.2 mm at a similar distance as measured by the device software. 
The illumination proﬁle from catheter design A is quite symmetrical and Gaussian, 
but that from catheter design B presents asymmetrical peak ﬂuence spots. The catheters 
were tested for ablation and illumination and both capabilities were achieved. Lesion 
proﬁles achieved with both catheters were slightly different, but due to the multi- 
factorial nature (contact, force, angle, tissue width etc.) of the lesion formation process 
we cannot conclude whether the difference observed was directly related to the 
 dissimilarities between electrodes or not.
3.3.2  Imaging capability
Each design compromised one of two aspects, namely illuminated area and ﬂuence 
distribution, as can be seen on Figure 3.2. Thus to evaluate the inﬂuence of the two 
parameters we compared images obtained with the two catheters on fresh and 
ablated porcine left atria with the catheter held far away from the tissue surface.
Figure 3.3 shows that, prior to ablation, regardless of the catheter design, both walls 
(endocardium and epicardium) generated signal.  After ablation we observed signal 
from the lesion area only. The PA signal after ablation was in general higher than prior 
Figure 3.3 Comparison of different catheter illumination geometries on the PA image. Overlay 
of US image in gray scale over PA image in yellow-red scale (dynamic range US 40 dB), (a) 
using catheter design A for illumination and (b) using catheter design B for illumination.
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to ablation. The ﬂuence from catheter design A was ~ 120 mW/cm2 at 10 Hz and that 
of design B was ~ 6 mW/cm2 at 10 Hz. PA signals generated using catheter design 
A were higher in amplitude than those using catheter design B, as expected. However, 
despite the larger illumination spot of catheter design B, the signal extent achieved 
laterally with both designs is the same: ~5 mm before ablation, and ~ 3 mm after 
ablation. The black plastic absorber positioned after the tissue generated PA signals 
in all imaging cases. This means that both catheter designs transmitted enough light 
to penetrate the whole tissue slab. 
3.3.3  Distance to catheter effect
The illumination spot size is expected to change with respect to the distance of the 
catheter from the tissue. Since we are imaging in an aqueous solution, we don’t 
expect a large increase in light attenuation at the studied wavelengths, but we do 
expect decrease of ﬂuence with increasing separation distance. We advanced the 
catheter farther and closer to the tissue to evaluate the effect of the catheter on 
imaging. When monitoring the formation of ablation lesions the catheter needs to lie 
against the tissue surface. The fact that the catheter tip is metallic (to conduct RF 
current) makes generation of PA signals at the catheter tip unavoidable. 
Figure 3.4 PA image variations due to varying the catheter-tissue distance prior to ablation. 
Overlay of US image (40dB dynamic range) in gray scale over PA image at 790 nm in yellow-red 
scale. (a) The catheter (Design A) is positioned 2 mm away from the tissue. (b) The catheter is 
slightly pushing against the tissue as can be noticed from the displaced tissue in gray scale. (c) 
The catheter is farther away from the tissue. (d) Photograph of the setup detailing the respective 
positioning of the catheter, tissue and transducer.
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In Figure 3.4a the catheter shows a strong signal, generating signiﬁcant echoic clutter 
around it. Figure 3.4 demonstrates how the image deteriorates (clutter, grating lobes) 
with the catheter in plane. As can be seen from the scale of the images in Figure 3.4, 
the metallic catheter tip saturates the image as it gets closer to the tissue. The dynamic 
range needs to be extended because the strongest PA emitting source in view is now 
the catheter rather than the tissue (Figure 3.4a,c). The intensity value of the PA signal 
generated by tissue increases as the catheter gets closer to the tissue, however the 
increase of tissue signal is not comparable to that of the signal from the catheter. 
When the catheter touched the tissue, the signal from the catheter tip was inseparable 
from the tissue signal at the endocardium. 
 We expected the imaging area to change with the distance of the catheter from 
the tissue, especially because we integrated optical ﬁbers of high numerical aperture 
(NA). However this was not the case. The portion of tissue generating a signal is 
about 3 mm laterally and 5 mm in depth regardless of the catheter position. In Figure 3.4b, 
the signal from the tissue endocardial side is present, even when the catheter is in 
contact with the tissue.
 When imaging ablated tissue (Figure 3.5), we observed that the detected signals 
were weaker (Figure 3.5a) at depth than prior ablation, but that the imaged region 
extended in a wider range laterally: ~4.5 mm. When we advanced the catheter closer, 
the signal from the catheter tip became more dominant, as in the pre ablation case. 
Figure 3.5 Overlay of US image (40dB dynamic range) in gray scale over PA image at 790 nm 
in yellow-red scale of fresh porcine tissue after ablation for different catheter-tissue distances. 
(a) The catheter (Design A) is positioned ~ 6 mm away from the tissue. (b) The catheter is 
slightly pushing against the tissue as can be noticed from the displaced tissue in gray scale. (c) 
The catheter is farther and laterally displaced illuminating a different portion of the tissue. (d) 
Photograph of the lesion made.
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The PA signal from ablated tissue is stronger than from untreated tissue; this is 
noticeable when comparing the signal of tissue to that from the catheter tip. While 
Figure 3.4 and 3.5 were obtained with catheter design A, similar results were obtained 
when using catheter design B.
3.3.4  Identifying lesions
In Figures 3.4b and 3.5b, the tissue signal is hardly separable from the catheter tip. 
This is a major issue, especially since the proposed solution suggests to monitor the 
formation of lesion while ablating with the same probe. 
 Previously, we have shown that lesion progression and extent can be identiﬁed 
in contrast to untreated tissue by taking the PA image ratios at 790 nm over that at 
930 nm 6 (Chapter 2). We showed that these dual wavelength images were more 
robust at lesion identiﬁcation than single wavelength images. If we take such ratio 
images (Figure 3.6) we can see that the cluttering, artefact caused by the catheter 
touching the surface of the tissue is eliminated. Prior to ablation (Figure 3.6c,d), 
this ratio, based on the spectral differences found between ablated and untreated 
tissue, is lower than 1. Since the catheter response is spectrally ﬂat, its signal is also 
eliminated from the images by thresholding to a ratio value of unity. This yields images 
without any PA signal prior to ablation. The ratio value for ablated tissue is higher than 1. 
In Figure 3.6a,b, the signal from the lesion becomes quite clear whether the catheter 
is in contact with the tissue or not, and the clutter due to the signal from the catheter 
tip is eliminated.
Figure 3.6 Dual wavelength image (PA790/PA930) overlaid on 40 dB US images (a) Ablated 
tissue with the catheter touching the tissue. (b) Ablated tissue with the catheter not in contact. 
(c) Non-ablated tissue with the catheter in contact. (d) Non-ablated tissue with the catheter not 
in contact.
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3.4  Discussion
3.4.1  Generalization of results
The results obtained show capability of imaging ablated and untreated atrial tissue 
with a limited-view, catheter-based illumination source. We performed the experiments 
in a HEPES buffer solution, where optical path may be different than in blood. 
Therefore, the observations made on the tissue signal extent for different tissue- 
catheter distances may not be directly generalizable to the real case scenario. 
We observed that we could image a bigger region of the ablated tissue than the fresh 
tissue probably due to an increased optical scattering characteristic 9. Perhaps, 
tissue perfusion and blood would increase the imaged surface as well. 
 In the future, a PA-enabled catheter could also provide depth temperature 
proﬁles during monitoring, as PA generation efﬁciency is temperature dependent 10. 
This valuable information is unavailable to the physician at present.
3.4.2  Effect of Fluence disparity
In this study, we observed that a larger illumination area does not necessarily imply a 
larger imaged area. Indeed, the photoacoustic pressure is proportional to the 
delivered ﬂuence as described by Equation 1.
p0(z,ь) = Э(z)·эa(z,ь)·F(z,ь) (1)
where F is the optical ﬂuence, эa the local optical absorption coefﬁcient and Э the 
Grüneisen coefﬁcient. With catheter design B we achieved a larger illumination area, 
but not necessarily sufﬁcient ﬂuence to generate a detectable signal in the entire 
illuminated volume. Therefore, we did not clearly observe a difference in image size, 
but rather observed a difference in image absolute signal intensity, which was weaker 
with design B. In other words, it seems that the minimum detectable signal is limited 
by a speciﬁc ﬂuence threshold which is only reached near the center of the beam. We 
thus have a tradeoff between the area probed and the minimum signal detected by 
the transducer system for a certain coupled energy. 
 By taking the ratio of PA image at 790 nm to that at 930 nm, we circumvented the 
problems arising with ﬂuence asymmetry and with signals at the catheter tip. Indeed, 
as long as sufﬁcient light is sent to penetrate and generate detectable signals along 
the tissue depth then dual wavelength images will identify the presence/absence of 
lesion as well as its geometrical span. However, lesions bigger than ~ 4mm in lateral 
extent may require moving the catheter along the tissue surface for a better volumetric 
evaluation of the lesion size.
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3.5  Conclusion
The ideal PA-enabled RF ablation catheter shall deliver sufﬁcient light to generate 
signals from the largest achievable tissue volume. Both designs presented here 
achieved similar minimum detectable ﬂuence spot size contours in tissue despite 
their original difference in ﬂuence proﬁle at the catheter output. Dragging the catheter 
along the tissue surface would provide a more complete lesion extent laterally, 
overcoming the limitations of illumination with a small optical beam at the output of 
the catheter. Thus, catheter design shall target maximum ﬂuence at depth. In this 
study, we observed that a dual wavelength method circumvents any saturation 
effects due to the PA signal generated at the catheter tip as well as mitigated effects 
of illumination asymmetry, making any further effort in catheter design optimization 
needless. However, it is important that any future catheter design takes into account 
an optimal light delivery to tissue for different catheter-tissue angular appositions.
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Abstract
Intravascular photoacoustic/ultrasound imaging (IVPA/US) can image the structure 
and composition of atherosclerotic lesions identifying lipid-rich plaques ex vivo and 
in vivo. In the literature, multiple IVPA/US catheter designs were presented and 
validated both in ex-vivo models and preclinical in-vivo situations. Since the catheter 
is a critical component of the imaging system, we discuss here a catheter design 
oriented to imaging plaque in a realistic and translatable setting. We present a 
catheter optimized for light delivery, manageable ﬂush parameters and robustness 
with reduced mechanical damage risks at the laser/catheter joint interface. We also 
show capability of imaging within sheath and in water medium. The optimized 
catheter allows imaging of human atherosclerotic coronary artery ex-vivo as well as 
of porcine diseased coronaries in-vivo.
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5.1  Introduction
Coronary artery diseases (CAD) are the leading cause of death worldwide, posing a 
substantial health care and economic burden to society.1  The ﬁrst clinical manifestation 
of CAD is commonly acute coronary syndrome (ACS), which is mainly triggered by 
the rupture of vulnerable plaque and thrombosis.2, 3 To treat ACS, percutaneous 
coronary interventions (PCI) are usually performed, placing a stent at the culprit 
lesion site in coronary artery. In PCI, an intravascular imaging modality which would 
potentially identify (asymptomatic) vulnerable plaque in addition to the culprit lesion 
is highly desirable for optimal stent placement, stent sizing, and for pre-emptive 
treatment of high-risk sites. In clinics, several imaging technologies are currently 
used for diagnostic assessment of coronary atherosclerosis, such as Intravascular 
UltraSound (IVUS), IntraVascular Optical Coherence Tomography (IVOCT) and Near 
InfraRed Spectroscopy (NIRS).  However, none of the available imaging modalities 
provide conclusive identiﬁcation of vulnerable plaque.4 
 Combined intravascular photoacoustic and ultrasound (IVPA/US) imaging is a 
powerful and promising alternative to identify vulnerable plaque.5, 6 By using optical 
absorption contrast, IVPA imaging can discern the different components in a vulnerable 
plaque, and the co-registered IVUS imaging provides information on the artery wall 
structure.  Successful plaque visualization was previously demonstrated ex vivo on 
animal or human samples.7-9 Research efforts are ongoing to further develop IVPA/
US imaging for clinical imaging.  Recently, we demonstrated the ﬁrst in vivo volumetric 
plaque imaging in a pig model 6, indicating the practicality of clinical translation of 
IVPA imaging. The dual modality catheter is critical for the imaging capability of the 
IVPA system.
 Since IVPA imaging is based on transmitting light and receiving ultrasound, both 
a light delivery port and an acoustic transducer form an integral part of the IVPA 
catheter. Their relative conﬁguration deﬁnes different catheter designs. There are 
mainly two types of IVPA catheter designs: one is with an offset (longitudinal or 
lateral) between the optical output and the acoustic transducer and the other is a 
co-linear catheter. The latter design can achieve a full overlap between the optical 
and acoustic beams and can thus accomplish a high signal sensitivity.10, 11 However, 
this design is more prone to imaging artifacts due to near ﬁeld optical scattering. The 
former design is more preferable for miniaturization despite its curved PA point 
spread function .12 The smallest IVPA imaging catheter (0.9 mm) reported so far was 
fabricated based on the offset design.13 
 To achieve in vivo imaging, the IVPA imaging catheter must satisfy the following 
technical requirements: miniature, ﬂexibility, safety, and robustness. Most implemen-
tations of IVPA to date have relied on clearance of the blood, meaning that the 
catheter should support ﬂushing of the artery under study. A miniature, ﬂexible, IVPA 
catheter capable of in vivo lipid imaging in pig model was developed in our previous 
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work.6 In this paper, we discuss several design parameters and optimize the design 
of our previous catheter for practical in vivo imaging to optimize sensitivity and 
robustness. We quantiﬁed the optical and acoustical attenuation of different sheath 
materials and we show that by modifying the design of the distal optics we could 
minimize the imaging complications introduced by the sheath. The capability of 
the modiﬁed IVPA catheter is validated on ex-vivo measurements of human athero-
sclerotic coronary artery specimens through sheath and in water.
5.2  Materials and Methods
5.2.1  Modified catheter design
A typical IVPA imaging catheter mainly consists of a light delivery part, an acoustic 
transducer, a torque coil and an outer sheath. The different choices of material and 
conﬁgurations of these components lead to different imaging performances. We 
discuss here an offset design. There are two common conﬁgurations for the light 
delivery component: an angle-polished ﬁber or a forward-looking ﬁber ending at the 
surface of a reﬂecting mirror. The former conﬁguration is easy to implement within a 
miniature tip design but comes at the expense of low optical coupling efﬁciency; the 
latter conﬁguration has a better optical coupling efﬁciency but presents high risk of 
optical damage at the mirror end. 
 Our previous IVPA catheter used a 100 μm angle-polished (34˚) optical ﬁber for 
light delivery. Although it is capable of in vivo IVPA imaging, more than half of the 
laser light was lost in the path (only about 40% of input optical power was delivered 
out of the catheter). Another light delivery problem, though not related to the 
conﬁguration of the light delivery at the tip, was a high susceptibility of optical and 
mechanical damage at the surface between the catheter and the optical rotary joint. 
To solve these problems, a modiﬁed light delivery part was developed. Figure 5.1a  is 
an illustration of the new catheter tip. The diameter of the tip is of 0.8 mm without 
sheath. The length of the rigid tip is 2.2 mm. In the catheter, a 0.3 mm right angle 
prism (N-BK7 Edmund Optics) modiﬁed by silver sputtering (Agar Scientiﬁc Ltd., 
Essex, UK) in house was used to deﬂect the light beam from a 200 μm multi-mode 
ﬁber. The damage threshold of the modiﬁed prism is about 200 mJ/cm2. To reduce 
the mechanical damage at the optical input of the catheter, an optical rotary joint 
coupling a 100 μm, 0.22 NA stationary beam of light to the rotating 200 μm ﬁber 
through a 50 μm air gap was developed in house (Figure 5.1b). This way we have 
reduced the susceptibility of damage (optically and mechanically) at the catheter and 
rotary joint surfaces. With the new optical rotary joint and the modiﬁed catheter 
design, 70 to 80% of the input laser light can be delivered out of the catheter. The 
same ultrasound transducer as used previously (40 MHz central frequency with 50% 
bandwidth, Blatek, USA) was placed at a distance of 0.4 mm and was tilted at 10˚ to 
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avoid the direct reﬂection from the sheath and to increase the dual beam overlap. The 
dual beam overlap starts at about 0.8 mm from the transducer. To prevent optical 
damage and contamination at the surface of the prism, we sealed the optical part 
(ﬁber and prism) with a small quartz tube. This prevents the formation of silver oxide, 
which impairs the optical damage threshold.
5.2.2  Outer sheath
The outer sheath is an essential component of the catheter for practical IVPA imaging 
because it prevents further damage to the artery wall than is already caused by the 
PCI. Identifying the ideal outer sheath material is one of the major challenges for the 
development of IVPA. The sheath material for IVPA imaging should be transparent for 
both ultrasound and light (at the wavelength of lipid detection), as well as offering 
enough mechanical support for intravascular application. With these requirements in 
mind, we performed an evaluation test on different types of medical sheath materials. 
The test was performed in water at room temperature at the wavelength of 1718 nm, 
using a 100 μm metal wire imaging target. We compared the peak to peak amplitude 
of the PA and US signals of the metal wire with and without sheath to quantify the PA 
and US attenuation due to the sheath. Figure 5.2 shows a typical PA and US signal 
of the metal wire with and without sheath. The PA and US attenuation (AttPA/US) is 
deﬁned as the lost PA (US) energy of the target signal in dB:
AttPA/US = (E
PA/US – E PA/US )dBno sheath no sheath (1)
where EPA/US denotes the PA or US signal energy. Simply, by pulse-echo US imaging, 
the one-way acoustic attenuation,Attacoustic, can be regarded as half of the US 
attenuation deﬁned in Equation (1). While the optical attenuation, Attoptical, can be 
calculated as the difference between the PA attenuation and the one-way acoustic 
attenuation. Both the acoustic and optical attenuation should be positive.
Attacoustic = 0.5 · AttUS (2)
Figure 5.1 (a) Illustration of the catheter tip. (b) Illustration of the rotary joint. Ag: silver.
(a) (b)
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Attoptical = max(0, AttPA – Attacoustic) (3)
5.2.3  Real-time IVPA imaging system 
The real-time IVPA imaging system capable of 20 fps includes: 5 kHz pulse rate laser 
source (FQ-OPO, Elforlight Ltd., Daventry, UK), scanning devices (rotation and 
translation), control unit and data display. Further details of the imaging system were 
previously described in.14 Data were acquired in a continuous stream of frames, 
consisting of  250 A-lines per frame (PA and US) and 4000 samples per A-line at a 
sampling rate of 400 MHz.
5.2.4  Imaging of a funnel phantom
In order to evaluate experimentally the imaging depth and the intersection of the 
acoustic and optical beams along depth, we image a metallic funnel. The diameter of 
the inner circle at one of the extremities is of 1.5 mm and is increasing to 10 mm at the 
other extremity over a distance of 10 mm. Since the phantom is metallic we expect 
high amplitude echo and PA signal. The echo might saturate the receive chain. The 
measurement,  done in water in the absence of sheath, provides us with a realistic 
measure of the optical and acoustic beam overlap within a medium which optical 
attenuation is well characterized in the literature. We repeat this measurement multiple 
times to evaluate the repeatability of the characterization.  Indeed, because the 
catheter is ﬂexible, it is not possible to control the orientation of the catheter with 
respect to the phantom wall; this makes the signal received dependent on the angle 
with which the transducer is facing the funnel wall.
Figure 5.2 Typical signals received from (a) photoacoustic excitation of a 100 μm wire at 1718 nm 
and (b) pulse echo of  that same wire. In blue are the signals received in presence of a sheath 
covering the catheter, and in red are the signals received without a sheath.
(a) (b)
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5.2.5  Ex-vivo IVPA imaging on human coronary sample
A human coronary artery sample (LCX) was collected at autopsy from the Department 
of Pathology of Erasmus Medical Center (MC), after obtaining consent from the 
relatives. The research protocol was sanctioned by the Medical Ethics Committee of 
Erasmus MC (MEC-2007-081). The coronary artery was frozen within 2h after autopsy 
and stored at -80° until analysis a few months later. Prior to analysis, the artery was 
thawed and measured within a few hours. The volumetric IVPA/US measurement was 
performed at room temperature at the wavelength of 1720 nm using a maximum 
ﬂuence of 35 mJ/cm2 at the tissue surface. To evaluate the capability of the IVPA 
catheter, we performed a series of measurements on the same tissue sample under 
different conditions: without PE sheath in D2O saline, with PE sheath in D2O saline, 
without PE sheath in normal saline and with PE sheath in normal saline. This way we 
evaluated the effects of increased optical attenuation when using H2O at 1700 rather 
than D2O, as well as the effects of increased acoustical attenuation when using the 
catheter sheath, on the image interpretation and information conveyed. At least 200 
frames of data were acquired for one pullback and the pullback speed was set to 
0.5mm/s. All the IVPA/IVUS images were non-averaged. All the received data were 
ﬁltered (band pass, median ﬁlter) and converted for display as in our previous work. 
After the measurement, we cut the imaged part of the artery sample, embedded in 
Optimal Cutting Temperature compound (Tissue-Tek®, Sakura Finetek Europe B.V., 
Alphen a/d Rijn, The Netherlands), and stored it at -80°C until further processing. For 
histology, we sliced the whole frozen artery block into a series of 10 μm thick sections. 
Oil Red O (ORO) staining was applied to all these sections to detect lipids. 
5.3  Results
5.3.1  Sheath attenuation
Table 5.1 summarizes the decoupled optical and acoustic attenuation of all the sheath 
material we obtained. We ﬁnd that FEP, PTFE and ETFE have no measurable optical 
attenuation based on their PA performance. Indeed, carbon–ﬂuorine bonds (C-F) in 
the material do not absorb optical energy at the chosen wavelength. In other materials, 
carbon-hydrogen bonds (C-H) are responsible for the loss in optical power observed. 
Comparing all the listed materials, we ﬁnd the PE sheath to be the best candidate for 
IVPA catheter if we also take into account malleability for artery accessibility. The 
NIRS tube shows the best performance for IVPA imaging, but its manufacturer or 
exact formulation is proprietary. 
5.3.2  Catheter characterization
The imaging results from the funnel phantom are shown in Figure 5.3. Figure 5.3a 
shows the PA images at one selected A-line along the pullback direction. In the ﬁgure, 
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the fundamental PA signal from the phantom and its multiple reverberations are 
clearly visible. Figure 5.3b shows the mean and standard deviation of the PA Signal 
to Noise Ratio (SNR) at different imaging depths. The statistics are computed from 
two pullback image sequences of the metallic funnel phantom and using the signals 
from all A-lines. The 20-dB imaging range is from 0.7 mm to 2.2 mm with the optimal 
imaging response observed at a depth of 1 mm. Since the measurement was performed 
in water we plot the attenuation of light by water vs. travelled distance (depth) for 
comparison. The attenuation from 1 to 1.5 mm attenuation could be attributed to water, 
the dip right before 2 mm to the design. 
Table 5.1 Measured US and PA signal attenuation due to different sheath materials.
Sheath material Optical attenuation(dB) Acoustic attenuation(dB)
PE 1.5 1.2
FEP 0 12.5
ETFE 0 15.5
PTFE 0 6
Pebax 8.3 1.2
OCT sheath 3.4 3.3
NIRS sheath 0.5 0.3
PE = polyethylene, FEP = ﬂuorinated ethylene propylene, ETFE = Ethylene tetraﬂuoroethylene , PTFE = 
Polytetraﬂuoroethylene.
Figure 5.3 Evaluation of the PA signal with depth.(a) Selected A-line for different catheter 
positions along a metallic funnel length. (b) Variation in PA signal strength from a metallic funnel 
for different depths of imaging.
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5.3.3  Ex vivo human coronary sample imaging
We imaged the same artery ex vivo in different settings. The same image frame for all 
acquisition settings was selected and displayed in Figure 5.4 The presence of the 
sheath (PE sheath) affects the ultrasound image signiﬁcantly. Indeed, it impairs a 
clear identiﬁcation of the lumen. On the photoacoustic images we are capable of 
identifying the plaque even through H2O saline ﬂush and tubing. The corresponding 
histology sections are shown in Figure 5.4e. We used the calcium to match the frames 
with one another and with the histology. The PA signal picked up through water and 
tube is ~10 dB lower than that through D2O. In addition to that, comparing the signal 
strength in a peri-advential fat region at about 1.4 mm depth, we ﬁnd that the PA 
signal is 1 to 2 dB lower when the tube is inserted, consistent with the wire test result 
presented in Table 5.1. We also ﬁnd that the PA signal is about 10 dB lower in H2O 
than in D2O. The ultrasound signal is about 4 dB lower when the tube is inserted. 
These values are slightly different than the numbers reported in Table 5.1, perhaps 
due to the nature of the measurement being a fully processed pullback, with no 
beam-target angular control, versus a static measurement.
5.4  Discussion
Our work demonstrated a modiﬁed IVPA/US catheter design for the translation of 
IVPA/US to a clinical setting. A similar design was reported in13, 15, 16, but not at this 
miniaturized level and with a protective glass tube. The miniaturization was challenging 
in terms of designing an optical delivery mechanism which is durable, resistant to 
damage due to contaminants and withstanding high energy ﬂuences. 
 This modiﬁed IVPA/US catheter shows the big advantage of highly effective light 
coupling while signiﬁcantly reducing the risk of optical and mechanical damage. The 
efﬁcient light delivery is achieved by the unique combination of home-made silver 
coated micro-prism, the protective quartz tube as well as the air coupled rotary joint.
We presented here the ﬁrst evaluation report on different catheter sheath materials, a 
crucial step in making an IVPA catheter for practical imaging. Although the current PE 
sheath attenuates the PA signal, we still managed to image lipid-rich plaque human 
coronary artery samples in normal water ex vivo. The result can be signiﬁcantly 
improved by changing the sheath material to the material used in the commercial 
NIRS catheter sheath or other ﬂuorinated polymers. This work shows the capability of 
imaging lipid-rich plaques with IVPA in a more realistic setting, which allows ﬂushing 
with normal saline instead of expensive heavy saline as used in most current IVPA 
experiments. Since blood and water have similar optical attenuation and diffraction 
properties at ~ 1700 nm, it could eventually be possible to achieve IVPA imaging of 
plaque without ﬂushing17. 
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Figure 5.4 (a) Merged PA and US image on human coronary plaque acquired in D2O saline 
and without sheath. (b) Merged PA and US image on human coronary plaque acquired in D2O 
saline and through sheath. (c) Merged PA and US image on human coronary plaque acquired 
in normal saline and without sheath. (d) Merged PA and US image on human coronary plaque 
acquired in normal saline and through sheath. All images display a PA signal dynamic range of 
15 dB and an US dynamic range of 35 dB. (e) The corresponding histology on the selected 
image cross section (Oil Red O staining, lipids are in red). Scale bar represents 1 mm.
(a)
(c)
(e)
(b)
(d)
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We characterized the imaging depth of the catheter using a metallic phantom. During 
a pullback the angle between the phantom and the transducer is not necessarily 
perpendicular.  This results in varying signal strength for a speciﬁed depth of image; 
this is reﬂected by the standard deviation of the PA signal attenuation (Fig. 5.3b). This 
angular variation affects in a similar fashion the US echo signal from the funnel as it 
is also variable for a set depth. Nonetheless, the PA signal amplitude variation 
matched the variation in acoustic echo. 
 The sheath effect is more prominent in imaging artefacts than in signal attenuation. 
In the absence of a sheath we could achieve very clear ultrasound images matching 
the structure on histology, while with the sheath, reverberations overlapped with the 
lumen border, affecting image interpretation. The photoacoustic images matched 
well with histology even with H2O ﬂush and through the tubing. Further work needs to 
be done to develop algorithms detecting sheath related artefacts on both PA and US 
images. Moreover, it may be possible to forgo ﬂushing altogether, since optical 
scattering of blood at 1700 nm is small18, but we did not test that situation. 
5.5  Conclusion
The demonstrated modiﬁed ﬂexible miniature IVPA catheter showed an improved 
imaging capability of lipid-rich plaque in addition to having a low damage risk 
(robustness), and manageable ﬂushing. The proposed catheter design is thus closer 
to satisfying the requirements of an ideal IVPA imaging catheter for practical 
application. It would accelerate the translation of IVPA imaging to the clinics.
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Abstract
Aims: Intravascular photoacoustic (IVPA) imaging can visualize plaque composition 
in coronary arteries affected by atherosclerosis. Lipid-rich atherosclerotic plaques 
are the substrate of the majority of acute coronary syndromes (ACS). In the so-called 
“vulnerable plaque” paradigm, detection of such plaques would enable pre-emptive 
treatment of ACS, while also providing improved guidance of percutaneous coronary 
intervention. We present the ﬁrst IVPA images of lipids in coronary atherosclerosis, 
obtained in vivo in an hyperlipidemic animal model.
Methods and results: Atherosclerosis was induced in familial-hypercholesterolemia 
Bretoncelles Meishan (FBM) swine fed a high-fat diet for 9 months. A custom-built 
IVPA/intravascular ultrasound (IVUS) catheter and imaging system were used to 
image coronary artery segments. Intravascular optical coherence tomography 
(IVOCT) and near-infrared spectroscopy (NIRS/IVUS) were deployed in the same 
vessels. After sacriﬁce, the coronary arteries were dissected from the heart and 
prepared for histological processing. IVPA showed an intimal lipid signal in areas 
where histology also showed positive lipid staining. When histology showed no lipids, 
IVPA was negative. In IVPA lipid-positive segments, IVOCT also suggested the 
presence of lipids locally, while NIRS was negative in absence of necrosis.
Conclusions: Plaque lipids were successfully imaged in vivo with IVPA in an animal 
model of coronary atherosclerosis.
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6.1  Introduction
Ischemic heart disease, caused by impaired circulation in the coronary arteries, is the 
leading cause of death worldwide and is likely to remain in that position with globalization 
of Western diets and lifestyles to low- and middle-income countries. Lipid-rich athero-
sclerotic plaques in the coronary circulation are the culprit of the majority of acute 
coronary syndromes (ACS) and cardiac deaths 1, 2. Such lesions have also been 
associated with adverse events after percutaneous coronary interventions (PCI) 3-5. 
The clinically validated features that predispose a plaque for triggering an adverse 
event include the presence of a lipid-rich necrotic core, covered by a thin ﬁbrous cap 
(thin-cap ﬁbroatheroma; TCFA), plaque burden greater than 70%, and a minimal lumen 
area smaller than 4 mm2 4. Prospective detection of such “vulnerable” plaques may 
enable pre-emptive interventions, and requires imaging of the composition and 
morphology of the lesion. Today’s clinically available intravascular imaging technology 
cannot characterize all these features simultaneously 6. While the high resolution of 
intravascular optical coherence tomography (IVOCT) is sufﬁcient to identify the thin 
cap, it relies on subjective image interpretation for lipid detection 7. IVOCT cannot 
directly quantify plaque burden, which is accessible by intravascular ultrasound (IVUS) 
only 8. Near-infrared spectroscopy (NIRS), the only validated technology for lipid-core 
plaque detection 9, 10, lacks depth resolution so cannot measure cap thickness, 
although the combination with IVUS 11 does provide morphological imaging.
 A technology to comprehensively characterize coronary atherosclerotic plaques 
is needed, and intravascular photoacoustic (IVPA) imaging has been proposed as a 
candidate 12. Photoacoustic imaging relies on the detection of ultrasound waves that 
propagate after transient thermoelastic expansion, generated by optical absorption 
of short laser pulses 13. Through the acoustic propagation delay, optical absorbers 
can be localized in the structure that can be conveniently imaged with ultrasound. 
Different tissue types and compositions can be imaged when varying laser 
wavelength. In photoacoustic imaging of atherosclerosis, plaque lipid has been the 
most prominent target 14-16. IVPA has frequently been combined with IVUS, since the 
transducer used for photoacoustic signal detection can also make ultrasound images 
in pulse-echo mode. Multimodal IVPA/IVUS data provides a rich combination of 
structural and composition plaque imaging 15, 17. The imaging resolution of IVPA is 
comparable with IVUS: down to 50 эm × 120 эm (axial × lateral) 18.
 The intrinsically multimodal nature of IVPA implies that engineering a robust and 
sufﬁciently sensitive imaging catheter, coupled to a real-time imaging system 19, 20 is 
challenging. In vivo IVPA imaging of atherosclerotic lipids has been demonstrated in rabbit 
aorta injury models 21, 22 and peripheral vessels of hyperlipidemic swine 23, while imaging in 
the highly mobile and tortuous coronary arteries has been limited to artiﬁcial lipid targets 19. 
In this study, we demonstrate IVPA imaging of intimal lipids in an animal model of coronary 
atherosclerosis, a crucial step in the clinical translation of this new modality.
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6.2  Methods
6.2.1  Imaging system
The imaging system we used is schematically shown in Figure 6.119; the catheter 
design was presented in Chapter 5, Figure 5.1a 24. Brieﬂy, a delay generator (BNC 
575, Berkeley Nucleonics Corporation, San Rafael, CA, USA) triggered two lasers 
(FQ-OPO, Elforlight Ltd., Daventry, UK), an ultrasound pulser and a digital acquisition 
card (DAQ) (PX14400, Signatec, New York, NY, USA). Every A-line acquisition was 
composed of one pulse-echo and two photoacoustic acquisitions at a wavelength ь 
5 1725 nm. The compound A-line acquisition rate was 5 kHz, limited by the laser 
pulse repetition frequency. The catheter was rotated at 1200 rpm, resulting in 20 
frames per second of 250 A-lines per frame. The pullback speed was 1 mm/s. The 
IVPA/IVUS catheter comprised a 40 MHz ultrasound single element transducer (50% 
bandwidth, Blatek, USA) and a 200 эm diameter optical ﬁber, enclosed in a ﬂexible 
drive shaft (Asahi Intecc, outer diameter 0.8 mm). A silver coated prism deﬂected the 
light at the output of the catheter. The rotating core was ﬁtted into the sheath of a 
commercially available NIRS/IVUS catheter (TVC Insight Coronary Imaging Catheter, 
Infraredx, Burlington, MA, USA), which had radiopaque markers. The lasers were 
coupled to the rotating optical ﬁbre of the IVPA/IVUS catheter through a home-built 
rotary joint (Chapter 5, Fig5.1b). The laser pulse energy at the output of the catheter 
ranged between 40 and 50 эJ. Acquired data were ampliﬁed (43 dB; AU1263, Miteq, 
Long Island, NY, USA) and band-pass ﬁltered (13-60 MHz 5th order Butterworth; built 
in-house) before digitization (14-bit, 400 MHz), processing and visualization.
6.2.2  Animal model and imaging protocol
Invasive imaging of the coronary arteries of a familial hypercholesterolemia Bretoncelles 
Meishan (FBM) mini swine 25 was performed. The swine was fed a restricted high fat 
diet (10% lard and 0.75% cholesterol, The National Institute of Agronomic Research, 
Figure 6.1 System diagram; purple: control and timing, orange: optical signal, black: analogue 
pulse signal, green: analogue received echo. DAQ: data acquisition; amp: ampliﬁer.
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France) for 9 months to promote atherosclerotic plaque development. The animal study, 
approved by the local animal ethics committee (DEC EMC3125 (109-12-25)) was 
performed according to the National Institutes of Health guide for the Care and Use 
of Laboratory animals 26. The animal (castrated male, 74 kg) was sedated using a mix 
of Xylazine (2.25mg/kg, 20 mg/ml) and Zoletil 100 (tiletamine/zolazepam; 6 mg/kg, 
100 mg/ml) injected intramuscularly. Anaesthesia was maintained by isoﬂurane inhalation 
(1–2.5% v/v). Through a sheath in the carotid artery, 250 mg of acetylsalicylic acid 
(Aspegic, Sanoﬁ-Aventis Nederlands BV, Gouda, The Netherlands) and 10,000 I.U. of 
heparin (Heparine, Leo Pharma, Amsterdam, The Netherlands) were administered 
intra- arterially, the latter being subsequently injected every hour in dose of 5,000 I.U.
 Access to the ostia of the right coronary artery (RCA) and the left anterior 
descending artery (LAD) was achieved by inserting a guiding catheter (Mach 1, 8F, 
Boston Scientiﬁc, Marlborough, MA, USA) through the carotid sheath.  This process as 
well as imaging catheter positions (start and end of pullback) in the coronary arteries 
was guided by angiography. We imaged the coronary vasculature with three imaging 
modalities: IVPA/IVUS as described above, commercial IVOCT (Ilumien Optis with 
Dragonﬂy Optis catheter, St, Jude Medical, St. Paul, MN, USA) and NIRS/IVUS (TVC 
Insight Coronary Imaging Catheter, Infraredx, Burlington, MA, USA). The IVOCT 
pullback (36 mm/s) required the artery to be ﬂushed from blood with contrast (Visipaque 
320, GE Healthcare, Buckinghamshire, UK) under a constant ﬂush rate of 4 ml/s 
(Medrad Injection System, Bayer HealthCare LLC, Whippany, NJ, USA). Similarly, 
the IVPA/IVUS pullback (1 mm/s) was performed under manual ﬂushing of the artery 
from blood with a saline solution based on heavy water (deuterium oxide, D2O), an 
optically clear liquid at the imaging wavelength. After imaging, animals were sacriﬁced 
by an overdose of pentobarbital (Euthasate AST farma, Oudewater, the Netherlands).
6.2.3  Data processing
Digital processing of the data acquired was performed on MATLAB (R2017b, The 
Mathworks, Natick, MA, USA). Ultrasound signals were band-pass ﬁltered between 
16 and 60 MHz, while photoacoustic signals were band-pass ﬁltered between 14 and 
21 MHz (4th order Butterworth). To accommodate for transmit artefacts, tubing 
artefacts and high frequency glitches, data were individually corrected for jitter and 
high-pass ﬁltered across the A-lines to remove repeating signals. The samples 
representing the space within the catheter inner tube were blacked out. The two IVPA 
acquisitions in each A-scan were summed to improve signal-to-noise ratio (SNR). 
A 3D median ﬁlter of kernel 3×3×3 voxels was applied to suppress interference noise. 
Final images were used to assess lipid deposition in the vessel, and compared to 
histology and independent imaging.
 Using angiographic guidance, it was conﬁrmed that the NIRS/IVUS and IVOCT 
(pullback length of approximately 75 mm) fully covered the IVPA/IVUS pullbacks 
(length of 20-25 mm). The NIRS/IVUS and IVOCT pullbacks were matched by two 
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independent experts based on angiographic records and anatomic landmarks. IVPA/
IVUS was matched to NIRS/IVUS based on angiographic position, side branches, 
and identiﬁable features on IVUS images of both modalities.
6.2.4  Histology 
After imaging and animal sacriﬁce, the coronary arteries, including the ostium, were 
dissected from the epicardium, embedded for cryosectioning, and frozen on dry ice. 
Arteries were stored at -80˚C until further preparation for histology. For four locations 
(both vessel proximal and distal) we cut three sections separated by 4 mm; we estimate 
longitudinal vessel shrinking following dissection prior to freezing at 30%. These were 
stained with Oil-red-O (ORO), which stains lipids in pink/red, and counterstained by 
Hematoxylin.
6.3  Results 
6.3.1  IVPA imaging results matched with OCT and NIRS/IVUS
The LAD and RCA of an FBM mini-pig were successfully imaged with IVPA/IVUS, 
NIRS/IVUS and IVOCT. In the LAD, stationary locations were imaged in both the distal 
and proximal segments of the artery. NIRS/IVUS did not detect lipid-rich plaque in 
either artery but revealed intimal thickening in the LAD and a near absence of 
abnormalities in the RCA. Inspection of the IVOCT conﬁrmed these observations. 
Comparison of the IVUS images between the NIRS/IVUS and IVPA/IVUS data allowed 
matching of individual frames based on anatomical landmarks with high conﬁdence; 
IVOCT could be matched using the same features.
6.3.2  IVPA/IVUS imaging 
Inspection of the IVPA data in the LAD revealed a circumferential positive signal in the 
intimal layer (Figure 6.2a). A longitudinal section clearly shows that the signal has a 
repetitive pattern that follows the cardiac cycle, as is familiar from the well-known 
“sawtooth” artefact in IVUS pullbacks (Figure 6.2b). This supports the hypothesis that 
the signal originates from tissue and not from an artefactual source. The presence of 
circumferential dispersed lipids in the thickened intima is clearly visible in a histological 
section from the imaged vessel segment (Figure 6.2c), which also shows that there is 
no necrotic core. The intima in the IVOCT image at this site is heterogeneous, but not 
strongly attenuating as in advanced plaque 7, indeed suggestive of extracellular lipids. 
The NIRS-image is negative (Figure 6.2d), which is expected in the absence of necrosis.
 More proximally in the LAD (Figure 6.3) the IVPA signal density in the intima 
diminishes. In Figure 6.3B, IVPA/IVUS indicates focal presence of intimal lipids (white 
arrowheads) and peri-adventitial lipids (blue arrowheads). IVOCT (Figure 6.3a) shows 
local areas with reduced signal, as observed in areas with extracellular lipid droplets 
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or proteoglycans. Histology (Figure 6.3d,e) also indicates that intimal lipid in this 
vessel segment is heterogeneously dispersed. The IVUS images acquired with IVPA 
show increased signal from the lumen, indicative of poor ﬂush. The strongly absorbing 
H2O water from blood mixed with D2O ﬂush media leads to an IVPA ﬂush artefact as 
in IVOCT. Blood also attenuates the optical excitation. A strong guidewire-associated 
artefact is visible in the IVPA data in some of these images.
 Compared to the LAD, less extensive disease was found in the RCA (Figure 6.4), 
according to the conventional imaging technologies IVOCT (Figure 6.4a), IVUS, and 
NIRS (Figure 6.4c). No intimal lipids were observed with IVPA (Figure 6.4b), with the 
exception of on small spot (white arrowhead). Detailed examination of this segment 
in Figure 6.4f demonstrates that the intimal signal does persist longitudinally and 
originates from tissue. Intimal lipids in the RCA could not be positively conﬁrmed by 
histology (very faint coloring for lipids) or IVOCT (Figure 6.4a,d). A positive IVPA signal 
Figure 6.2 IVPA acquisition in the distal LAD of an FBM swine. (a) Overlay of IVPA images (red-
yellow-white scale, dynamic range 20dB) on IVUS images (grayscale, dynamic range 30dB, 
scalebar represents 1 mm). Circumferential intimal lipids generate IVPA signal (white arrowheads). 
(b) Signal variation over seven heartbeats at the angular location indicated by the green line in A. 
(c) Corresponding histology indicates presence of lipids. (d) Corresponding NIRS/IVUS frame 
was negative for lipid-core plaque. (e) Matched IVOCT conﬁrms presence of lipids. (f) Angiogram 
snapshot localizing the radio-opaque catheter. The green arrow in (a), (c) and (d) is the side 
branch ostium used for registration; * in (a), (d) and (e) is the guidewire artefact. IVPA: Intravascular 
photoacoustic imaging, LAD: left anterior descending artery, FBM: familial hypercholesterolemia 
Bretoncelles-Meishan, IVUS: intravascular ultrasound, NIRS: near-infrared spectroscopy, IVOCT: 
intravascular optical coherence tomography.
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close to the catheter does not coincide with tissue structure according to IVUS and is 
attributed to blood/ﬂush media mixing Figure 6.4e). In the IVPA data in Figure 6.4b,e, 
peri-adventitial lipids are prominently visible (blue arrowheads). 
Figure 6.3 IVPA/IVUS acquisition in the proximal swine LAD. Selected frames and their 
matches in different modalities; (a) IVOCT; (b) IVPA/IVUS, including a longitudinal section; (c) 
NIRS/IVUS. Corresponding histological sections (d) in the distal and (e) proximal segments of 
the acquisition conﬁrm that the vessel has focal intimal lipids as indicated by the images in (b) 
(white arrowheads), surrounded by perivascular fat (blue arrowheads). Scalebars are 1 mm; 
dynamic range as in Fig. 6.2. IVPA: Intravascular photoacoustic imaging, IVUS: intravascular 
ultrasound, LAD: left anterior descending artery, NIRS: near-infrared spectroscopy, IVOCT: 
intravascular optical coherence tomography.
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Figure 6.4 Matched IVOCT, IVUS/IVPA and NIRS/IVUS frames of pullback in the swine RCA. (a) 
IVOCT frames matched to locations in (b) and (c). (b) Merged IVPA/IVUS; the detected IVPA 
signal originates from peri-adventitial lipids (blue arrowheads). One site with intimal lipids is 
visible (white arrowhead). (c) NIRS/IVUS is negative for the whole RCA. (d) Histology conﬁrms 
absence of major plaque lipids; white arrowheads indicate tiny positive spots for lipids. 
Longitudinal section through the IVPA/IVUS pullback in the swine RCA at the plane represented 
by the blue dotted line (e) and the green dotted line (f) shown in the cross-sectional images in 
(b). Arrows in (e) indicate peri-adventitial fat, and an artefact attributed to blood mixed with ﬂush 
media. Scalebars are 1 mm; dynamic range as in Fig. 6.2. IVOCT: intravascular optical coherence 
tomography, IVUS: intravascular ultrasound, IVPA: intravascular photoacoustic imaging, NIRS: 
near-infrared spectroscopy, RCA: right coronary artery.
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6.4  Discussion and Conclusion
6.4.1  In vivo coronary IVPA imaging
Lipids exhibit a few characteristic absorption bands 16, 27, 28 that photoacoustic 
imaging can target for identiﬁcation and localization in tissue. In this study, we have 
shown that catheter-based IVPA can do this in vivo, in the highly mobile and difﬁcult 
to access coronary circulation of an atherosclerotic swine model. Independent 
imaging with IVOCT, and histologic analysis, conﬁrm the plaque lipid detection by 
IVPA. Compared to our previous in vivo work, improvements to the catheter geometry 
and data processing have enhanced the depth range of the IVPA signal. This makes 
it possible to see tissue lipids at various depths as evident from the images presented 
here. The imaging catheter and operation of the system are highly similar to clinically 
available IVUS; the difference being the need for ﬂushing of the blood, at least at the 
wavelengths chosen in this experiment. Imaging of lipid-rich plaque during PCI may 
improve understanding of the risk for developing future ACS, and as such inform 
treatment strategy. Further development of the technology (e.g. catheter sheath, 
noise-suppressing electronics and dual-frequency transducer) and evaluation in 
clinical trials are needed to establish the utility of IVPA and imaging criteria that may 
improve outcomes.
6.4.2  Comparison to other modalities
Imaging of lipid-rich plaque has been a goal for intravascular imaging since the 
concept of the vulnerable plaque was established 29. NIRS, a technology that we 
used in this study, aims to detect lipid-core plaque by doing optical reﬂection 
spectroscopy of the vessel wall through blood. A classiﬁcation algorithm, trained on 
a large database of spectra in autopsy vessels, detects lipid-core plaque following a 
strict set of pathological criteria 9. The NIRS colour scale represents the probability of 
ﬁnding lipid-core plaque in a circumferential arc. Since it is principally a sensing and 
not an imaging technology, it does not have depth resolution and cannot locate the 
lipid accumulation relative to the lumen boundary or other anatomical features. IVPA 
also uses the absorption spectrum to identify lipid, but in its current form uses fewer 
wavelengths and directly represents the signal amplitude, which is proportional to the 
absorption coefﬁcient and the optical intensity 13. In comparison with NIRS, IVPA 
assessment of lipids is not constrained by limited sampling of natural variability in an 
algorithm training set; however, IVPA may also detect perivascular adipose lipids and 
thus is potentially less speciﬁc. In the images presented in this study, peri-adventitial 
lipids signal could not be discriminated from plaque lipids by IVPA, whereas NIRS 
detects necrotic lipid-core plaque speciﬁcally 9. Previous work has demonstrated that 
it is possible to make this distinction with dual 30 or multi 31 wavelength imaging. In 
this study, we did not pursue lipid differentiation due to the relatively high noise level 
in the IVPA data. Enhanced sensitivity of the catheter to photoacoustics signals below 
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the IVUS band 32, and other improvements in immunity to environmental noise 
sources in the system, may enable this distinction in future studies. Increased 
sensitivity will also eliminate the need for ﬂushing with expensive D2O, which also 
leads to artefacts similar to IVOCT imaging. IVPA lipid imaging through blood has 
been demonstrated 33: 15-20 dB of imaging dynamic range through blood appears 
to be feasible for imaging up to a depth of about 3 mm, as observed in Figure 6.4e.
An alternative approach to discriminate between atherosclerotic and adipose lipids 
relies on segmentation of IVPA data using the IVUS images. In such an approach, 
identiﬁcation of a lipid spot as intimal or perivascular will depend on the resolution 
and contrast of the IVUS images. In its present form, the resolution of IVUS and IVPA 
is insufﬁcient to measure cap thickness, which can currently only be done by OCT. It 
is possible to assess the plaque lipid “in contact with the lumen”, a criterion that is 
also applied in IVUS-VH analyses for identiﬁcation of TCFA 4, 5. In IVUS-VH and 
related techniques, analysis of ultrasound echo radio-frequency data identiﬁes 
“necrotic core” tissue type; but the correspondence to actual tissue composition has 
proved challenging in the past 34, 35. In contrast, IVPA robustly capitalizes on the 
well-documented absorption spectra of lipid molecules 36 to establish chemical 
tissue composition.
6.4.3  Limitations
This is a preclinical study, performed in a large-animal model of coronary atheroscle-
rosis. Animal models cannot represent all aspects of human disease. We found 
extensive lipid-rich plaque in this animal, but no clear signs of necrotic core according 
to histology or NIRS, although necrotic core plaque was observed in this animal 
model previously 25. Studies with IVPA on human autopsy coronary arteries have 
demonstrated consistent and strong signal from necrotic core plaque 15. Future 
animal trials will have to demonstrate this capability with improved SNR. Data were 
acquired in one animal only; as a result, we do not have sufﬁcient data to quantify the 
diagnostic accuracy of IVPA. These aspects of the study limit the scope of the 
conclusions that can be drawn from the results.
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6.5  Conclusions
We have demonstrated in vivo IVPA imaging of coronary lipid-rich atherosclerotic 
plaque in a preclinical setting. Two arteries were examined. In one artery, extensive 
plaque was found in which IVPA showed a positive signal for intimal lipids. The other 
artery exhibited mild intimal thickening with sparse or no lipid. Both ﬁndings were 
conﬁrmed by IVOCT imaging and histology. We realized a miniaturized, ﬂexible 
catheter that could successfully be deployed in the coronary circulation of a swine for 
pullback imaging in an acquisition sequence similar to IVUS imaging. These results 
constitute a crucial step in the translation of IVPA towards clinical trials.
 This study highlights the potential for future clinical translation of a new catheter- 
based technology for imaging lipids in atherosclerotic plaque, intravascular photo -
acoustic imaging. It identiﬁes the presence of lipid-rich plaque, but importantly, 
it also locates the depth of these lipids relative to the lumen boundary as outlined 
by intravascular ultrasound, allowing an assessment of cap thickness. In the future, 
such data may provide a prospective, lesion-speciﬁc risk assessment for adverse 
cardiac events.
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Abstract
Photoacoustic imaging couples the chemical speciﬁcity of optical absorption with 
the viewing depth of ultrasound. Systems based on linear array transducers have the 
versatility to be applied in various (pre-) clinical scenarios, but face a tradeoff between 
viewing depth and image resolution depending on transducer frequency and 
aperture. We propose here a method to disentangle, with precision, small, closely 
spaced targets with optical spectral contrast, without impairing the imaging depth. 
Photoacoustic datasets were recorded at two different optical wavelengths. We 
accurately recovered object separation distances (mean error= 2.3±6 %) from the 
phase difference between signals across the array, down to a spacing of 1/20th of the 
system’s beamformed lateral resolution. The proposed method may enable the 
translation of super-resolution microscopy to deep tissue imaging.
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Photoacoustic imaging (PAI) is an emerging modality for biomedical imaging. It is 
based on the absorption of optical energy by chromophores in the tissue, which 
induces a thermoelastic expansion that can be detected by an acoustic transducer. 
PAI capitalizes on optical contrast, which has the potential to discern biological 
structures at the molecular level 1, and on ultrasound propagation, which has less 
wavefront distortion and thus a much larger penetration depth than regular optical 
imaging. Generally, there are three ways of implementing PAI. The ﬁrst is PA 
microscopy, scanning a focused light source and/or a focused acoustic receiver 
across the object of interest. The second is PA computed tomography, enclosing the 
object with acoustic receivers and relying on a relatively large laser beam, propagating 
diffusely into scattering tissue, for illumination. The third, and most of interest to this 
study, is using broad-area illumination, and receiving with a limited transducer 
aperture 1. This geometry is commonly called limited-view photoacoustic tomography 
(PAT). It is the easiest to translate into a clinical setting, because it allows the use of 
conventional handheld ultrasound transducers, requiring only the addition of a light 
source. It also has the potential for real-time imaging of either macroscopic details or 
microscopic ones; this is referred to as ‘scalability’ of PAT. However, this scalability 
has its limits: it is currently impossible to image both macroscopic and microscopic 
structures simultaneously; indeed, there is a tradeoff between imaging depth and 
resolution. Therefore, multiple imaging systems need to be deployed to assess 
different length scales 2.
 Much effort has been put into improving the resolution of PAI. Several studies 
used custom-made ultrasound detectors with large apertures or large transverse 
sampling density to achieve a better image 3, 4. Spatial modulation of the illumination 
pattern to improve the lateral resolution enabled imaging of structures 1.5 to 6 times 
smaller than the acoustic diffraction limit 5, 6. In this work, we discuss a method based 
on a standard limited-view PAT setup, relying on imaging algorithms to enhance the 
imaging of microscopic structures at depth. It is inspired by super-resolution and 
single-molecule microscopy techniques 7, 8 and their acoustic analogue 9, enabling 
the localization of point-like sources by activating only one source per resolution cell 
at a time. We propose here to use spectral contrast between different objects to 
separate their signals 8, 10. The presented method extracts sub-resolution spatial 
information from the difference in signal phase of PA data sets acquired at different 
optical wavelengths, without using heuristic classiﬁcation criteria 11, to achieve source 
localization to a scale of a fraction of the diffraction-limited acoustic resolution.
 In limited-view PAT imaging, the received signals are a superposition of the 
waves emitted by all PA sources. In the process of image reconstruction, these 
signals are backpropagated towards the source locations, but the accuracy of this 
procedure is fundamentally limited by acoustic wave diffraction in the detection setup 
(determined by aperture size, element size, and bandwidth). As a result, structures 
cannot be resolved below the typical size of the point-spread function (PSF) of the 
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imaging system. Ideally, we want to separate all PA sources of any size and at any 
mutual distance. A family of image processing techniques, based on centroid ﬁtting 
of the impulse response in an image, achieves this by capturing the signal from one 
source at a time 7-10, 12. A common approach , in limited-view PAT, to selectively 
acquire and discriminate the signals from different classes of photoacoustic 
absorbers is making use of spectral contrast. In vasculature imaging for example, the 
variation in optical absorption with blood oxygenation enables selective targeting of 
arteries in one acquisition and veins in another, by tuning the excitation source to 
different wavelengths. Each data set then represents an image of the distribution of 
the targeted PA source. Overlapping objects in the frames indicate the presence of a 
small artery and a small vein, within one resolution cell. Reporter gene expression, 
contrast delivery in microvascular networks, and cleavable molecular beacons are 
other applications where spectral contrast is available and deep, high-resolution in 
vivo imaging is an asset 2, 13. We show here that the phase difference between PA 
acquisitions can detect multiple sources in a resolution cell, and measure the distance 
between those sources. In principle, as many wavelengths are needed as there are 
different source types; here, we present the algorithm and demonstrate its functionality 
with two different sources per cluster. 
 The principle stems from the following features of PAI. Neighboring sources with 
optical contrast, as opposed to aggregates of PA sources of similar absorption 
spectra, emit, in theory, separable PA signals 14, 15. The signal of a point-like source 
as recorded by a linear transducer array is described by a hyperbola (Figure 7.1a,b). 
If both sources are geometrically identical or smaller than the imaging system’s PSF, 
then their individual recorded photoacoustic signals are similar but shifted laterally (to 
adjacent elements), axially (in time), or according to a superposition of these, depending 
on the two objects’ relative positions 16. The phase difference between the signals 
across the array provides detailed and accurate information on the relative positioning 
of the sources, with distinct signatures of lateral and axial separation (Figure 7.1c). 
Thus, if we could image one PA object type per frame, then the phase difference 
across the transducer’s elements between those frames provides an accurate 
Figure 7.1  Concept of the differential phase photoacoustic algorithm. (a) Neighboring PA sources 
and (b) their respective signals received by an array of transducers. (c) Phase difference і
between laterally (triangle) and axially shifted sources (star) relative to zero (dashed line).
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estimate of the localization of different clusters of PA sources. Path length differences 
can be estimated by cross-correlation, but this requires upsampling and region 
selection, without ﬁnally delivering per-pixel estimates.
 Phase differences between ultrasound frames acquired at high frame rate were 
previously utilized to detect submicron displacement of artery walls 16. The differential 
phase photoacoustic (DPPA) algorithm uses an analogous approach to improve the 
accuracy of localization of PA sources imaged with a limited-view PAT setup, by using 
the phase difference between frames acquired at different wavelengths. The 
algorithm assumes point-like sources, and wavelengths are chosen to produce 
contrasting and known PA responses. 
 It applies the following steps: ﬁrst, two different wavelengths ь1 and ь2 are tuned 
to acquire two frames targeting two different chromophores A and B. Second, the 
channel data is converted to analytical signals (i.e., in In-phase Quadrature, IQ, 
format) through the Hilbert transform. Third, low signal regions are masked out to 
remove noise and spurious signals. Fourth, the phase difference іn between the two 
frames is calculated for all elements and is converted to a path length difference 
using щn = іn · 
c
2Mc
, where c is the speed of sound and fc the center frequency of 
the transducer. 
 Choosing the sampling frequency (fs) above the Nyquist rate ensures that the 
minimal detectable іn becomes independent of fs. Assuming source A is located at 
the pixel center (xi,zj), we refer to the quantity щ(i,j),n as the additional path delay from 
source B to transducer element n located at (xn, 0). Here, x is the coordinate along the 
transducer array, and z is the depth coordinate. In conventional image beamforming, 
the travel paths used in the delay-and-sum algorithm to reconstruct pixel (i,j) are:
S(i,j),n = 3 zj2 + (xn – xi)2 (1)
For the second frame, we compute a second set of travel paths D(i,j),n = S(i,j),n + щ(i,j),n 
using the information contained in the path delay. As a rule, the analyzed pixels 
display a high signal at both imaging wavelengths, indicating the presence of both 
sources at the selected location (xi,zj). Setting the position estimate of source A at ь1 
(^ xa,^ za) = (xi,zj), the second set of travel paths yields multiple possible locations (a set 
of equidistant points to transducer n at distance D(i,j),n) for source B at ь2. To reduce 
the set of possible locations, we solve for the intersections I(i,j),k, (k ĘB
1
2 n (n – 1)]), of 
the circles centered at pairs of transducers {na , nb}, with radii D(i,j),na and D(i,j),nb. 
Taking the median of the set of intersections I(i,j),k obtained from all possible pairs of 
transducer elements provides an estimate of the position (^ xb,^ zb) of the unresolved 
source B, relative to the source A at (xi,zj). However, generally, at the chosen illumination 
wavelengths, both targeted sources emit PA waves. If these sources cannot be 
resolved, the resulting signal as detected by a transducer is a superposition of both. 
With the following steps, we can further disentangle the PA sources. Signals appear 
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to be originating from one PA source located at the center of mass of those two 
sources, weighted by their PA response, μA and μB, depending on the absorption 
coefﬁcient and potentially other parameters, which are assumed to be known 11. The 
center of mass Oь1 at wavelength ь1 located at (^ xa,^ za) or Oь2 at wavelength ь2 located 
at (^ xb,^ zb) is related to the location of the targeted PA sources A (xA, zA) responding at 
ь1 and B (xB, zB) responding at ь2 as described by the following vector relation:
AOь =
μB,ь AB
μB,ь+ μA,ь
(2)
The true positions for sources A (xA, zA)and B (xB, zB) are obtained by solving Eq.2 for 
both frames at ь1 and ь2.
Three experiments were performed to test the algorithm. Because lateral resolution is 
worse than axial resolution in limited-view PAT systems, and because і(i,j),n is more 
challenging to analyze for laterally separated sources, we set up the ﬁrst experiment 
to evaluate the DPPA algorithm on a pair of laterally separated wires. We imaged two 
parallel wires, with a diameter of 40 эm, colored red and blue. The blue wire is 
movable to adjust the separation distance. Light at 440 nm, 680 nm and 540 nm was 
delivered to the phantom by a ﬁber connected to a tunable laser (Vibrant B-355II, 
Opotek, Santa Clara, CA, USA); at 440 nm the red wire PA signal is dominant, at 680  nm 
the blue wire PA signal is dominant and at 540 nm both wires emit equally (Figure 7.2a). 
A phased array transducer (ATL P4-1, 1-4 MHz bandwidth, 295μm pitch) connected 
to an ultrasound research system (Vantage 256, Verasonics, Redmond, Washington, 
USA) collected the PA signal from the two wires at the three mentioned illumination 
wavelengths. The lateral resolution in the reconstructed images was 0.8 mm (-3 dB 
lateral width, at ~2 cm depth). Simultaneously, a needle hydrophone (20MHz, Precision 
Acoustics, Dorset, UK), perpendicular to the wires, also collected the PA signals. Cross- 
correlation of the hydrophone traces at 680 nm and 440 nm provided an accurate 
estimate of the distance between the two wires. Comparisons with peak-to-peak 
distance measurements on the traces obtained at 540 nm for distances greater than 
100 эm yield a maximum position error of ± 3 эm. 
Figure 7.2  Lateral cut through the beamformed envelope of two wires at different distances (a) 
1.4 mm and (b) 71 эm separation distance at three imaging wavelengths and the Gaussian ﬁt 
to the 540 nm proﬁle.
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We analyzed the data from red and blue parallel wires using two different pairs of 
wavelengths. When using the combination of 680 nm and 440 nm, it is as though we 
are imaging each of the wires individually (since at both those wavelengths one wire 
is clearly dominant). When using the combination of 540 nm and 680 nm, we are 
actually analyzing a frame where both wires emit equally and a frame where one wire 
is dominant, as shown by Figure 7.2a. In Figure 7.2b we see that at small separation 
distances, the PA signal does not reveal the presence of two wires, but rather 
suggests the presence of only one PA source at either of the illumination wavelengths. 
In these cases, spectral unmixing algorithms cannot disentangle the two sources. 
Applying the DPPA algorithm we recover a range of separation distances spanning 
from 40 эm (wires touching) to a maximum separation distance of 1.6 mm (equal to 
the illumination spot size). For distances greater than 0.8 mm, the wires are clearly 
separable, and the DPPA algorithm is not needed. Nevertheless, we evaluated the 
precision of the proposed algorithm in those cases as well for generality. In order to 
estimate separation distances that are larger than the image resolution, meaning 
щ(i,j),n > 
c
Mc
, the phase і(i,j),n is unwrapped prior to the analysis. In Figure 7.3, we plotted 
the estimated separation distance against the distance extracted from the hydrophone 
measurement (which we take as a ground truth). We ﬁtted the data to a linear 
regression model (y=ax+b), resulting in [a = 0.98 ± 0.06, b = (1 ± 5)·10-5, R2 = 0.97] 
from the frames at 540/680 nm, and [a = 0.99 ± 0.05, b = (1 ± 5)·10-5, R2 = 0.98] 
from the 440/680 nm combination. The difference with the ground truth was not 
signiﬁcant in either case. We also found that in both analyses we are able to recover 
the separation distance with a mean percentage error of 2.3% and a standard 
deviation of 6%. Figure 7.3 also shows distances recovered using Gaussian ﬁts (red/
blue crosses) to the lateral proﬁle at the centerline of the beamformed image (dashed 
Figure 7.3  Separation distance estimates using two different pairs of wavelengths for both 
centroid ﬁtting and DPPA. The ﬁts to the DPPA are approximately equal to the unity line.
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lines in Figure 7.2a,b). The separation distance from the centroid ﬁts is deﬁned as the 
position difference of the maxima of the ﬁtted curves at both wavelengths, using the 
440/680 and 540/680 nm combinations. We observe that DPPA is superior to 
Gaussian ﬁtting, especially at estimating small distances. We note that the algorithm 
is robust for a range of object separations and contrast ratios.
 In a second experiment, we assessed the capacity of the DPPA to isolate multiple 
targets using a phantom consisting of three pairs of 40 эm red and blue wires, axially 
and laterally offset as shown on Figure 7.4a. The intrapair distances were 160 эm, 283 
эm and 539 эm by mechanical design; the actual distances may be slightly different 
in water. The beamformed images indicate the presence of a single PA source at 
each cluster (Figure 7.4b). We selected clusters containing mixed signals, i.e. image 
regions with a beamformed signal greater than a preset threshold at both illumination 
wavelengths, and isolated the RF signals. Application of the DPPA algorithm indicates 
the presence of more than one absorber. Figure 7.4c shows both the ground truth 
and the reconstructed dots. The blue circles in Figure 7.4c are the local maxima, 
representing the position of the PA sources at ь1, and the red circles are the reconstructed 
positions of the second PA source. Crosses in Figure 7.4c indicate the true object positions. 
The estimated separation distances and angles were recovered with 5% accuracy.
Figure 7.4 True vs. reconstructed position of multiple complex sources. (a) Experimental setup 
for three wire pairs. (b) Beamformed image and selected maxima. (c) Separation of the 
unresolved sources. (d) Experimental setup for dot pattern. (e) Combined 500 nm and 680 nm 
images. (f) Reconstructed dots using DPPA vs. measured position.
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Finally, we created a more complex object, mimicking a cross sectional view of 
microvascular structures, consisting of six pairs of ~260 эm diameter green and red 
dots along with a single green dot, printed on transparent ﬁlm. The excitation 
wavelengths were 500 nm (red absorbing), and 680 nm (green absorbing). The ﬁlm 
was placed in the acoustic imaging plane, parallel to the beam, and illuminated from 
the side (Figure 7.4d). This experiment is more challenging because the complex 
sources were located farther from the transducer, leading to poorer PSF. Figure 7.4f 
shows the ground truth as printed on the transparent ﬁlm as well as the dots 
reconstructed with DPPA, showing adequate identiﬁcation of multiple sources in the 
resolution cell and a relatively accurate estimate of their positions. The DPPA algorithm 
also successfully identiﬁes the unpaired green dot as not containing a complex 
source. We observe a larger separation error, and an overall image distortion because 
the beamforming does not account for  heterogeneity in the speed of sound in the 
ﬁlm/water medium. Regardless, the DPPA algorithm enables us to create a reconstruction 
of the phantom, which reﬂects the clustered sources that remain hidden in the 
beamformed image in Figure 7.4e.
 It must be noted that the lower boundary in the distance measurements we 
present here was the result of experimental limitations. So far, we assume that each 
cluster contains no more than two sources. If more sources with optical contrast are 
expected within a cluster, the relative positions may be resolved by using as many 
wavelengths as there are expected source types, a common strategy in optical 
microscopy 17. Use of more than two wavelengths can help to account for predictable 
absorption coefﬁcient changes, such as varying oxygen saturation in microvessels. 
We have not studied the effect of extended sources, where object shape affects the 
wavefront. We anticipate that a solution, employing a library of signal characteristics 
related to a range of source conﬁgurations, combined with the distance measurement 
based on median phase difference estimates, will be able to handle structured 
objects. Moreover, the accuracy of the obtained results is representative of a highly 
controlled environment with limited acoustic heterogeneity and optimal imaging 
geometry. We assumed that the excitation ﬂuence is constant throughout the 
phantom at the two wavelengths; variations in ﬂuence are small for nearby sources. 
We do observe in the ﬁrst experiment that the error increases at larger separation, 
which we attribute to ﬂuence variation in the beam across the 1.6 mm distance in the 
optically clear medium. Scattering by tissue will homogenize the light distribution and 
hence increases the accuracy of our method, competing with an SNR decrease due 
to loss of light at the target. Potential variations in ﬂuence due to spectral coloring in 
more complex scenarii could be tackled using estimation methods, such as described 
in 18, 19.  Also, in vivo applications will beneﬁt from motion correction based on ultra-
sound-measured tissue displacement 16. The slow pulse rates of commonly used 
tunable lasers make it easy to interleave ultrafast ultrasound and PA imaging. 
Extension to 3D imaging with matrix probes is straightforward; even sparse arrays will 
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provide sufﬁcient phase difference measurements to extract high-accuracy position 
estimates.
 To conclude, differential phase imaging successfully determines the sub-resolution 
distance between sources of a-priori known optical absorption contrast. The algorithm 
can detect structure in a target that appears as a single object in a PA image, 
discriminating clustered sources from simple ones. We measured the distance 
between spectrally contrasting point absorbers with a standard deviation of 6% for 
pairs of targets that were separated by 1/20th of the PSF width. We quantitatively 
demonstrated the accuracy of reconstruction on a single pair of wires, and on multiple 
targets with both lateral and axial offsets. Potential applications are imaging of micro-
vasculature, and superlocalization of contrast agents deep inside tissue. 
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8.1  PA imaging: hearing colors
Both light and sound are waves. Their interaction with matter, and their absorption by 
matter in particular, differs fundamentally, though. Ultrasound absorption has a smooth 
dependence on frequency, while optical radiation is absorbed by excitation of electronic 
or vibrational transitions, which tend to have a ﬁnely structured frequency spectrum. 
One of the interesting implications of that difference is that optical excitation of 
acoustic signals in photoacoustics enables us to acoustically probe optical absorption 
contrast: we can hear colors.
 Biomedical photoacoustic imaging is a modality which fundamentally maps 
tissue absorption. However, on single wavelength photoacoustic images, which does 
not capitalize on this aspect of color audio, it is often challenging to correctly interpret 
an image, with no a-priori knowledge. Single wavelength photoacoustic signal 
variations across an image are the result of a mix of multiple factors. Indeed, for one, 
efﬁciency of the photoacoustic effect relies on the thermoelastic properties of the 
tissue, which usually also vary with ambient temperature. Thus, signal variations in 
one image could reﬂect temperature variations. Second, signal intensity distribution, 
in a single wavelength image, could also map the illumination/heat function (ﬂuence 
distribution) within one object, which reﬂects tissue scattering and absorption 
properties. Finally, of importance to the majority of photoacoustic studies, the signal 
distribution reveals the location and/or concentration of different chromophores. 
Thus, in photoacoustic imaging, just like in any other imaging modality, we must 
carefully ask ourselves: what are we looking at? In a laboratory environment, careful 
manipulations may shed light on the nature of the signal observed: varying the 
illumination geometry, use of external sensors (e.g. thermometers), additional imaging 
modalities (e.g. ultrasound imaging) and tissue manipulation can isolate the source 
of the signal. In an in-vivo situation, the freedom in manipulating the object is more 
limited. The need for multimodal or multispectral imaging emerges, to identify 
features with certainty and understand the origin of the PA signal. These techniques 
are always built on thorough ex-vivo validations. 
 Multiple studies demonstrated how combination of information from multiple 
images can improve photoacoustic image quality. For instance, Kruizinga et al., 
showed that using information from ultrasound images can improve photoacoustic 
image interpretation 1. More popularly, multi spectral optoacoustic tomography (MSOT), 
a wide subﬁeld of photoacoustic imaging, capitalizes on signal feature variation with 
imaging wavelength to isolate targeted compounds from background 2, 3, using a 
family of analysis techniques that are collectively called spectral unmixing. MSOT can 
also be used as a means to correct for signal variations due to the ﬂuence distribution 
in tissue and isolate those due to chromophores absorption 4. One unifying research 
target among all MSOT studies is determining the smallest number of wavelengths 
needed to extract the desired features. This minimum varies with application, 
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depending on the number of chromophores to be identiﬁed, their spectral (dis)
similarity, the spectral structure of the background, and the signal-to-noise ratio of the 
image. In this thesis we explored dual-wavelength photoacoustic methods, built on 
knowledge extracted from spectroscopic studies, as a means to improve visualization 
of cardiac features for two speciﬁc cardiovascular applications, and as a means to 
localize PA sources. In the following paragraphs we discuss the capability to translate 
laboratory experiments to the ‘real’ situation. We question the ability to reliably extract 
the same information under different circumstances, evaluating the methods we 
developed and the scientiﬁc reasoning we have followed to answer the question: 
what are we looking at?
8.2  RF ablation lesion monitoring
In chapters 2, 3 and 4 we have spectroscopically studied the features of RF ablation 
lesion and developed a robust imaging solution which can be translated in vivo. 
Based on the ratio of PA images obtained at two wavelengths 790 nm and 930 nm we 
were capable of robustly imaging RF ablation lesions with a diagnostic accuracy of 0.97. 
Figure 8.1 Envisioned use of the proposed technology. ICE catheter in green; PA-enabled RF 
ablation catheter in blue. Blue arrows point at the lesion site.
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The performance of any single wavelength (410 nm to 1000 nm) imaging technique is 
inferior. The spectroscopic analysis showed that the lesion identiﬁcation accuracy 
was possible regardless of the initial oxygenation state of the tissue. We have 
demonstrated that this solution can be applied within the context of a beating heart 
with circulating blood. A PA-enabled ablation catheter was used as the illumination 
source, demonstrating a good SNR and realizing sufﬁcient lateral imaging extent for 
2D lesion sizing, as well as for detection of gaps between lesions.
 The currently envisioned solution to RF ablation treatment monitoring for atrial 
ﬁbrillation is illustrated in Figure 8.1 where our imaging method based on a PA-enabled 
catheter and ICE probe is integrated with electro-anatomical mapping systems. Two- 
wavelength PA imaging is the ﬁrst imaging modality that has demonstrated visualization of 
lesions as they are created during an ablation procedure. With continued development, 
this initial result may impact the electrophysiology ﬁeld by providing the operating 
physician with real-time feedback on the treatment effect that is delivered by the 
ablation, showing the location and extent of lesions relative to the atrial wall and 
relative to each other.
8.2.1  Applicability of the results in this thesis
PA considerations for transmural imaging
Two-wavelength ratio-based imaging improves both lesion delineation and detection. 
For this dual-wavelength imaging method to work in identifying lesions at depth, it is 
important for the light at the chosen wavelengths to undergo similar levels of 
attenuation with depth through the imaged slab of tissue. Variable attenuation with 
wavelength introduces a spectral variation of optical ﬂuence, an effect that is called 
spectral coloring. In Figure 8.2, illuminating ablated tissue through the endocardium 
exhibits spectral coloring, visible as a change in the spectral response with depth in 
the image for both lesion and untreated tissue parts in the visible range. However, in 
the near-infrared the spectral features of both regions remained unchanged. We 
veriﬁed that the differences in spectra resulted from spectral coloring, and not from 
the presence of different chromophores, by cutting through the tissue at the imaging 
plane and illuminating the whole plane homogeneously (Figure 8.2c,d). We observed 
then that the lesion and non-ablated tissue spectra are similar throughout the depth, 
meaning that the PA sources are identical across the depth. The examined depth was 
of ~3mm. This observation conﬁrms the use of the proposed dual wavelength 
method to map lesion signals at depth and assess lesion transmurality in tissue slabs 
of 3 mm or less. It ensures homogenous (equal) ratio signal values across depth for 
lesion tissue, which we have observed in our images.
 In addition to that, the optical ﬂuence distribution affects the received PA signal 
and the interpretation of the resulting image. For instance, the absence of PA signal 
may either reﬂect the absence of absorbing chromophores, or insufﬁcient local 
ﬂuence to generate detectable signal. In the spectroscopic study we have conducted, 
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we differentiated between these two states by placing a strong absorber as a 
reference on the far side (relative to the light source) of the imaged tissue slab. When 
the reference absorber emitted a PA signal, we were certain that sufﬁcient light went 
through the imaged tissue slab and created a homogenous ﬂuence throughout. 
Manipulation of the absorber position along with the use of a point source illumination 
can be used to assess the optical parameters, such as transmission, reﬂection, 
absorption and scattering, of the tissue slab as a whole. These can be used to model 
tissue optics and correct the PA images for illumination heterogeneity, and may shed 
light on the origins of the imaging contrast changes, which may result from tissue 
scattering differences or from variations in chromophore concentration and types.
Figure 8.2 Transmission mode photoacoustic setup of fresh ablated porcine tissue. (a) Evaluation 
of PA spectra of untreated tissue areas and (b) ablated tissue areas as the tissue is illuminated 
from the endocardium (transmission mode PA setup). (c) Evaluation of PA spectra of untreated 
tissue areas and (d) ablated tissue areas as the tissue is cut and illuminated en face (orthogonal 
mode PA setup). Right column: PA spectra extracted from different depths at the regions 
indicated by colored rectangles in the photoacoustic (red scale) ultrasound (gray scale) image 
overlay.
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In this thesis we chose our wavelengths to ensure full tissue depth illumination. We have 
shown in Chapter 2 that the dual wavelength methods proposed showed better 
transmurality assessment for RF ablation lesions than any other single wavelength 
method in the range of (410 to 1000 nm). It has the advantage of homogenizing the 
signal across depth and removing clutter artefacts due to the catheter tip. Under broad 
illumination we have observed that ﬂuences between 0.3 and 1 mJ/cm2 were sufﬁcient 
to penetrate through a tissue slab of up to 8 mm. However, a systematic study on the 
extent and transmurality of a large number of lesions in different tissue thicknesses is 
still needed, especially under catheter based illumination. In addition to that, for better 
imaging precision, a resolution study for the minimum gap size detection is also needed.
Comparison between human and porcine tissue
All the results we have presented in this thesis regarding ablation lesion monitoring 
were predominantly demonstrated on porcine tissue. We foresee our results to 
generalize to human atrium tissue. In order to be a tad more conﬁdent, we compared 
PA spectroscopy signals from fresh and ablated human left atrium appendage to 
those we have obtained from porcine specimen in Chapter 2 (Figure 8.3). The ablated 
tissue PA signal is the same across wavelengths, suggesting that the method is 
potentially directly applicable on human tissue. Comparison between fresh human 
tissue and material that was kept in frozen storage does show large changes to the 
spectrum. For this reason we always worked with fresh specimens.
8.2.2  Future research topics
Lesion types
In general, PA spectroscopy is a good stepping stone to any PA study focusing on 
the capability of PA to identify tissue molecular composition. Not only does it allow 
optimizing for the best imaging wavelength, but it also allows understanding 
and identifying other potential sources of signal. Thus, similarly to Dana et al. 5 and 
Pang et al. 6, we investigated spectroscopically optimal settings for RF ablation lesion 
contrast. Unlike the other two groups, the illumination range we investigated extended 
to the visible range, covering wavelengths from 410 nm to 1000 nm. The visible range 
is obviously impractical for imaging since, optical penetration depth is limited in 
tissue in that range. However, looking at the full spectrum helped us identify some of 
the chromophores in play, and the effect of their concentration variations, in healthy 
and ablated myocardium tissue.
 For instance, we identiﬁed different tissue oxygenation levels in the studied 
ex-vivo porcine specimens, and also the likely presence of hemichromes in the 
lesions formed (Chapter 2). Despite initial varying oxygenation levels in tissue, we 
could consistently identify ablation lesions with high accuracy. This leads us to think 
that the imaging method we have proposed is robust for different tissue oxygenation 
levels. In addition to that, in the study we have conducted, it was straightforward to 
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identify myoglobin variants and lipids or collagen from their optical spectra, for they 
are very well documented in the literature. Ablation lesion components on the other 
hand were less researched. The optical properties of denatured proteins, necrosis 
coagulum, hemichromes, metmyoglobin, etc., are not fully documented in the literature. 
We foresee that the full spectra we have acquired are only the beginning for further 
studies of the different tissue components and tissue ablation stages related to 
different ablation settings. In fact, one future step in ablation lesion characterization is 
to look at the differences in spectral characteristics between the different types of 
lesions. An identiﬁcation method for different lesion stages and components could 
potentially be useful in the comparison between EP catheters and other ablative 
Figure 8.3. Porcine vs Human PA spectroscopy of (a) untreated atrial tissue and (b) ablated 
(lesion) atrial tissue. The visible and near infrared ranges were split for better visualization, due 
to the high difference in signal intensity. The fresh human sample (n=1) was more oxygenated 
than the averaged porcine samples included in this study. Initial oxygenation state does not 
affect the ablated spectrum.
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devices. PA imaging would provide a window on the different lesion stages along the 
temperature gradient, as well as the differences between the lesions formed through 
alternative energy applications such as laser light or cryotherapy. 
 An additional advantage to performing a wide range photoacoustic spectroscopy 
is developing understanding with respect to the observed signal. Atrial myocardium 
is a three-tissue layer structure, and the coupling between the layers may have a role 
in the appearance of conduction disorders. These tissue layers look optically different 
to the eye. They thus should have different photoacoustic signatures. However, we 
found it difﬁcult to isolate single spectra from different tissue components with the 
setup we have developed. Band-limited detection in PA imaging tends to emphasize 
differential contrast across boundaries, rather than bulk absorption 7. Therefore, in PA 
spectroscopy of layered tissue, it is important to understand that we are not directly 
mapping the absolute absorption of the components within that layer, but rather the 
difference in absorption at the interface between two layers (cf. Figure 8.2d signal 
from the endocardium (pink) in orthogonal mode PA setup). For the purposes of our 
study, obtaining full characterization of the tissue in two states, ablated and fresh, 
was the goal. For fundamental research, this is an important point to consider.  
 Another important observation achieved by means of spectroscopy is the effect 
of freezing tissue on the experimental protocol. Very early on, we have noticed that 
freezing tissue for conserving human left atrial appendages changes the PA spectrum 
observed. We noticed a bigger effect of metmyoglobin on the frozen tissue than in 
its other forms (Figure 8.3 blue curve, peak at 600 nm). This may have an impact 
on translation of the imaging results achieved on RF ablation to the other forms of 
ablation, namely laser and cryo ablation. This topic thus needs to be investigated 
further.
Frequency domain-analysis
We did not explore and use the differences in PA signal frequency spectra between 
ablated and untreated myocardium tissue (Figure 8.4). This is a point which can 
further be exploited when integrating with a dedicated US solution.
 Figure 8.4, shows spectra differences when measuring signals in transmission 
mode with two different transducer bandwidths. One is a linear array transducer (192 
channels, L12-3v, fc = 7.8 MHz, Verasonics, Kirkland, Washington) and the other is a 
hydrophone (20 MHz bandwidth, Precision Acoustics). We deﬁnitely observe an increase 
in the energy of higher frequencies for ablated tissue in comparison to untreated 
tissue when using the hydrophone. The limited bandwidth of the array transducer 
attenuates this contrast. We veriﬁed that these changes were not the result of other 
unknown parameters by checking that the PA signals from the water interface or the 
optical ﬁber metallic tip remained the same. This needs to be further examined.
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Integration with echocardiography?
Other research groups also investigated ways of robustly imaging ablation lesions 
and proposed different methods using other imaging modalities. Ultrasound imaging 
studies 8, 9 showed promising results in monitoring RF ablation lesions. Ultrasound 
features such as crater formation, wall thickness increase, echogenicity changes  10-12, 
were correlated with different lesion characteristics such as edema or necrosis. However, 
these were inconsistent between the studies. Our PA spectroscopic measurements 
were always accompanied by ultrasound measurements, and our echo observations 
corroborate the inconsistency observed in the literature (Figure  8.5). Contrast is 
variable across specimens, across lesions, and appears to be unstable, with a clear 
impact on identiﬁcation and delineation of lesions. Initial echogenicity will vary with 
respective imaging plane and myoﬁbers orientation 13. Hyperechoic regions may 
look (according to some studies in the literature 14) as lesions even though they are 
not (Figure 8.5, Lesion 3 pre-ablation). Perhaps more information may be extracted 
through advanced analysis, but in its raw B-mode imaging state, lesion identiﬁcation 
by echo is challenging.
 Ultrasound elastography methods were also shown to be promising 15, 16. 
Lesions do exhibit higher stiffness than the surrounding tissue. However, in-vivo US 
elastography imaging across the ablation catheter in an erratically beating heart 
remains quite complex and difﬁcult. This solution is thus not very well suited for 
monitoring of lesion progression, and may require long manipulation time. We have 
observed slight variations in the SNR of the PA signals collected during RF ablation 
through the (applied) cardiac cycle (Chapter 4). We have observed the same 
phenomenon in intravascular PA imaging (Chapter 6). There seems to be a relationship 
between signal strength and tissue stretch, and potentially tissue softness. This variation 
Figure 8.4 Frequency spectra of PA signals of ablated and untreated myocardium tissue at 
different wavelengths acquired by two different acoustic transducers.
153
D
iscu
ssio
n an
d
 C
o
n
clu
sio
n
in signal was dealt with in RF ablation PA signal processing by averaging throughout 
the heartbeat. This was possible because ablation is a slow process, for which 
feedback in the seconds range is affordable. However, we shall further exploit and 
research this feature in both RFPA and IVPA for assessing tissue mechanical properties. 
Since US is integral part of both solutions, US elastography methods could also be 
modiﬁed and integrated into a new algorithm using PA signal information.
Imaging system
In this initial work we focused on proving that the proposed dual wavelength imaging 
method is feasible in real-time acquisition and works as well in a heart beating 
mimicking setup as it does in a static one. Integration of information from the acquired 
single wavelength images to the current imaging technique could open to a wealth of 
information. For instance, in the imaging method proposed, the absence of lesion is 
represented as an absence of signal. Absence of signal could also occur if the 
imaging and ablation catheters are misaligned. Feedback from single wavelength 
images should thus be integrated to compensate for catheter position/orientation 
and its contact with tissue. In addition to that, if studied, single wavelengths images 
could provide a tissue temperature proﬁle in depth, which is  valuable information in 
EP procedures and EP research. There is thus further potential for a full PA based 
solution for EP integrating in depth temperature proﬁle mapping, tissue elastography 
assessment and differentiation between different lesion types.
Figure 8.5. Contradictory appearance of lesions on ultrasound. Lesion 1 is probably hypo - 
echoic and a bit out of the imaging plane. Lesion 2 changes echogenicity as reported in the 
literature. Lesion 3 is hyperechoic before and after ablation. Lesion gaps and transmurality 
cannot be derived from US alone.
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8.2.3  Potential impact on interventional electrophysiology
Low success rates of AF therapy by means of a pulmonary vein isolation have positioned 
this speciﬁc intervention at the center of various research studies. Two hypotheses 
were presented to explain this low procedural outcome. 
 On the one hand, it is argued that the understanding of the underlying electropa-
thology is erroneous. Current ablation strategies assume that the heart rhythm is 
perturbed by high frequency electrical activity of ectopic foci disturbing the normal 
pattern of atrial conduction. Isolation of these ectopic foci discharging at fast rates 
prevents propagation to the rest of the myocardium, restoring normal cardiac rhythm. 
This ablation strategy is derived from the open-chest surgery, the ‘Cox-Maze’, where 
determined conductive areas are cut and sewn, generating non-conductive scar 
tissue to prevent electrical wave propagation from the isolated areas to the rest of the 
myocardium. Emerging research in the electrophysiology ﬁeld has revealed that 
recurrences of AF after pulmonary vein isolation are due to the presence of an 
extensive arrhythmogenic substrate. This arrhythmogenic substrate may consist of 
rotational or endo-epicardial activity 17, 18. Electrophysiologists shall thus rather 
identify areas of electropathology, and ablate at these sites, which are involved in 
persistence of AF, to free the patient from arrhythmia. 
 On the other hand, it is argued that insufﬁcient treatment delivery is the leading 
cause for atrial ﬁbrillation recurrence in patients who have undergone RF ablation 
procedures. Gaps in the lesion traces as well as superﬁcial (non-transmural) lesions 
allow for propagation of electrical waves from the ectopic foci to the rest of the 
myocardium 19. These gaps are very plausible to occur because during the procedure, 
cardiologists have no visual feedback on the lesions they are creating; instead they 
rely on indirect parameter readouts, tissue models and heuristics. Indeed, much 
literature is available on the different parameters inﬂuencing lesion types and sizes. 
Different power settings must be selected for different atrium areas; impedance 
readouts predict different lesion sizes or other complications such as thrombus 
formation. Only recently did catheter makers integrate contact force sensors, for this 
also affects the lesion size. There remains a glaring information gap on the formed 
lesion extent and depth. It is this need, this uncertainty in lesion outline that drove 
multiple research centers into investigating ways of imaging RF ablation lesions. This 
problem also drove multiple ablation catheter companies into developing alternative 
catheters, such as contact-force sensing catheters, and looking into alternative 
energy modalities for ablation, such as laser ablation.
 The truth about AF can only be unraveled by testing the hypotheses. Capability 
of delivering continuous transmural lesions, with certainty, is a means to test to the 
2nd hypothesis. Thus, the imaging system presented in this thesis capable of RF 
ablation lesion transmurality and continuity evaluation, may serve as a tool in the 
research to determine the reasons for the low success rates of catheter-based 
ablation. The results demonstrated in this thesis, when applied to the clinic may even 
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contribute to increasing the procedural success rates. We demonstrated a method 
which evaluates lesion extent, as well as monitors lesion formation in real-time. 
Monitoring capability has the potential of preventing procedural complications related 
to excess of RF energy delivery. Indeed, delivering excessive energy may lead to 
cardiac perforation, tamponade, phrenic nerve or esophageal injuries etc. all serious 
life-threatening complications.
8.3  Intravascular photoacoustic imaging
IVPA can potentially target several of the hypothesized plaque features of interest. 
IVPA was previously demonstrated to image lipids 20, 21, macrophages 22, intraplaque 
hemorrhage 23 and temperature 24. The complementarity with intra -vascular ultrasound 
imaging adds the capability of evaluation of plaque morphology, calciﬁcation and 
stiffness 25. Key components of an IVPA/US system are:
• Laser source (wavelength, pulse length and pulse repetition frequency)
• Transducer center frequency and bandwidth
• Rotary joint and slip ring
• Real-time processing algorithm/software
• Receive electronics
• Catheter (sheath, optical and acoustical beam overlap, ﬂexibility, miniaturization)
All of these components need to be engineered to the speciﬁc demands of IVPA 
imaging. Choices about the catheter sheath material, the transducer bandwidth and 
the laser source depend on the imaging targets. Catheters sheaths are necessary to 
limit damage to the artery wall as a result of imaging. For the IVPA/IVUS system, the 
catheter needs to minimize both optical absorption at the imaging wavelength(s) and 
acoustic attenuation. The laser source PRF needs to be high enough to allow real-time 
imaging, and the pulse duration short enough for a good SNR. The wavelength(s) 
need(s) to be targeted toward discriminating plaque features of interest. The 
transducer center frequency needs to be high for IVUS high resolution images, but 
also needs to accommodate the large bandwidth of the PA signals generated by the 
targeted plaque features.
 Our current IVPA system and catheter model is optimized for imaging plaque 
lipids. In chapters 5 and 6 we have demonstrated imaging of atherosclerotic coronary 
specimens ex-vivo and porcine coronary arteries in-vivo. Indeed the system is 
coupled to two tunable lasers in the wavelength range of 1720 nm (targeting lipid). 
The catheter sheath was also optimized for that wavelength range and the transducer 
bandwidth (40 MHz, 50% bandwidth) was optimized for IVUS plaque morphology 
imaging. By coupling the laser static ﬁber to the catheter’s larger rotating ﬁber through 
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an 50 эm air-gap, optical output was increased, and requirements on expensive D2O 
ﬂushing were shown to be more lenient. Tubing artefacts were reduced by using a 
silver sputtered prism to deﬂect the light orthogonally to the catheter axis, which 
won’t immediately reach the 10˚ acoustic beam axis.
 Perivascular lipids were previously hypothesized to predict development of 
 atherosclerosis. In Chapter 6, peri-adventitia lipids were successfully imaged and 
identiﬁed at different imaging depths in vivo. Thus, in its current state, the IVPA/US 
system and catheter showcased in this thesis is ready to test this particular hypothesis; 
especially that safety of laser energy used on cells viability has been established 26. 
In addition to that, we have shown that imaging of plaque lipids in-vivo with an IVPA/
IVUS system was feasible. Further work is needed to robustly reject imaging artefacts 
in the near ﬁeld imaging ﬁeld, to highlight the presence of true lipid signals. Full char-
acterization of artefacts generated as a result of blood swirls and tubing in a control 
setting may help improving the imaging modality.
 We have also compared IVPA/US to two other clinical intravascular imaging 
modalities. These were in agreement when there was no lipid-rich plaque but in 
disagreement when these were present. We conjecture that this may be the result of 
NIRS/IVUS being more sensitive to necrotic cores rather than lipids, or that the pig 
model used is not as representative of human atherosclerosis as expected. 
 We also studied capability of dual wavelength imaging, however the noise level, 
the broad lasers’ spectral linewidths and the digital processing used to enhance the 
images corrupted the threshold levels for lipid identiﬁcations. Thus for lipid-rich plaque 
imaging with IVPA, further effort in electronics and systems engineering are needed 
to reduce imaging noise levels emerging from the motors and the slip ring. In addition 
to that, perhaps a better suited transducer bandwidth, or a lower illumination wavelength 
range (930/960 nm) for spectroscopic imaging is worth investigating to increase 
the signal to noise ratio (SNR). This will require further research into catheter design. 
At this stage, IVPA of atherosclerotic plaque in tortuous arteries was shown to be 
feasible, however further developments in the hardware in receive is still needed. 
A catheter design and a fast processing routine to incorporate more information on 
plaques from multiple perspectives (e.g. mechanical, optical, thermal etc.) would 
enable total plaque characterization and better understanding of disease progression. 
8.4  Differential phase photoacoustic imaging
Resolution is an important image characteristic to bear in mind when looking at an 
image. In PA  imaging, the illumination source and the acoustic detector will determine 
the imaging resolution achieved. One of the easiest PA imaging setups to translate to 
the clinics relies on commercial, medical ultrasound detectors to which a broad 
illumination source is added. This type of setup is called limited-view photoacoustic 
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tomography and its resolution cell (lateral and axial) are determined by the acoustic 
detector.
 Light absorption occurs at the molecular level, as can be elegantly visualized by 
super- resolution optical microscopy 27. Optical-resolution PA microscopy probes tissue 
absorption at a resolution of approximately 1 эm, but this technique relies on a good 
quality optical focus which rapidly degrades at depths when light scattering disperses 
the excitation. Often, for deep tissue imaging, the acoustic resolution cell is hundreds 
of micrometers. In chapter 7, we have shown that if two spectrally different photo -
acoustic sources were localized within one acoustic resolution cell, then they could 
be detected and separated with high accuracy (down to 1/20th of the point spread 
function) by using two wavelengths photoacoustic images. The method presented in 
Chapter 7 is a powerful tool to interpret and understand PA images. 
 This method is still at its infancy though. In this thesis we have solely evaluated 
capability of disentangling sources on phantoms. It is natural to ask oneself, what is 
the minimum separation distance which could be achieved? Super-localization 
accuracy will be limited by the system’s noise, and the transducer’s bandwidth. The 
PA source size will also be a parameter, since the frequency spectrum and source 
dimension are related in PA. Nonetheless, super-localization has been shown recently 
to be one of the routes to super-resolution 27-29. This method, in the future, might go 
in the same direction, with the right application. These could span from a study on the 
different gut microbe interactions, to the study of targeted contrast agents attachment 
and detachment after drug delivery.
In sum, spectral PA methods have great potential for multiple cardiovascular applications 
spanning from super-localization and image enhancement methods to treatment 
monitoring and guidance. This thesis, though barely touching the tip of that potential, 
has in the least answered a short cohort of all the “what are we looking at?” questions. 
We have identiﬁed:
9  A transmural ablation lesion
9  A healthy myocardium
9  An ablation lesion gap
9  A PA-enabled ablation catheter tip
9  A lesion in the process of being formed
9  Peri-adventitial lipids
9  Atherosclerotic plaque-lipids
9  ….. more than two PA sources localized within a precise amount of unit distance.
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Summary
According to the world health organization reports, ischemic heart disease and stroke, 
two cardiovascular diseases were the major global causes of death, in 2016, in middle 
and higher-income countries (15.2 million deaths globally); and this has been the 
case for the past 15 years. Cardiovascular diseases (CVDs) are often intertwined, and 
multifactorial from a clinical standpoint.  It has, for instance, been shown that athero-
sclerosis may be a factor in atrial ﬁbrillation development 1, 2. Since CVDs often display 
speciﬁc biomarkers,  photoacoustics may, one day, help in unravelling the condition’s 
intricate web of causes and effects.
 Many cardiovascular conditions that used to require surgery, such as coronary 
artery disease or atrial ﬁbrillation, can now be treated using catheters. Minimally- 
invasive interventions rely heavily on imaging. What used to be in the direct line of 
sight of the cardiologist, uncovered to the eye, tangible and palpable, is now hidden 
behind layers of opaque tissue. Thus, without imaging and guidance, cardiologists 
would be totally incapacitated, completely blind. To start, navigating catheters through 
vessels located in the groin, neck or arm to reach the heart, is in itself quite challenging 
if not for ﬂuoroscopic guidance. Secondly, identifying the treatment location requires 
a panoply of dedicated diagnostic devices identifying targeted abnormalities. Finally, 
monitoring and feedback of treatment requires yet other complex multi-purpose 
smart catheters. This reliance drives a billion-dollar industry of cardiac catheters and 
imaging technology. Indeed, besides cardiologist’s experience, technology is the 
one essential element to the success of minimally-invasive surgery. 
 Photoacoustic imaging is an emerging technology with an exponentially growing 
number of published papers in biomedicine over the past decade. The photoacoustic 
principle describes the phenomenon through which acoustic waves are generated 
as a result of light absorption. Analysis of the signal generated for different illumination 
wavelengths and experimental conﬁgurations carries a wealth of information regarding 
tissue properties. This radiation-free technology can image tissue molecular composition 
at multiple scales, depending on the choice of instrumentation conﬁguration. 
 Thus, we focused in this thesis on how photoacoustics could solve issues related 
to two particular cardiac interventions, namely Radiofrequency (RF) ablation for atrial 
ﬁbrillation and percutaneous coronary intervention (PCI) for coronary atherosclerosis.
 The ﬁrst application we addressed, in the ﬁeld of interventional electrophysiology, 
targets ablation of abnormal conductive tissue substrate. In RF ablation for atrial 
ﬁbrillation the procedural success rate is varying between 60-70%; this staggering 
low number does even include patients given a redo surgery and following post- 
procedural anti-arrhythmic drug treatments. This low success rate is often attributed 
to inadequate treatment delivery. Ablation lesions are at the core of the procedure, 
whereby applying RF energy to tissue destroys its capability to conduct electrical 
potentials, blocking undesired conductive pathways. Lacking visual feedback on 
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delivered treatment, lesions often tend to lack transmurality or continuity. Occurrence 
of gaps in-between lesions (lesion discontinuity), and between lesion and epicardial 
surface (lesion submurality) allows for electrical pathways to propagate defeating the 
purpose of the procedure.
 In the ﬁrst chapters of this thesis we developped a photoacoustic solution for RF 
ablation lesion monitoring of atrial ﬁbrillation procedures with photoacoustic imaging. 
The solution comprised a modiﬁed ablation catheter for localized light delivery at the 
treated area, and an intracardiac echography probe for reception of the photoacoustic 
signals generated. In Chapter 2, we studied in depth photoacoustic characteristics 
of ablation lesions with respect to the surrounding tissue. We found that for a range 
of wavelengths greater than 600 nm (up to the maximum wavelength studied 1350 
nm), light in the range of few miliJoules per cm2 is sufﬁcient to penetrate through the 
whole atrial tissue slab to generate  photoacoustic signals. We also found that 
illumination at 640 nm generated best lesion-to-tissue- contrast for acoustic 
transducer center frequency of 7 MHz and 100% bandwidth. Finally, we determined 
an imaging method founded on the ratio of two photoacoustic images acquired at 
790 nm and 930 nm to delineate and identify lesion with a diagnostic accuracy of 
97%. Armed with this robust method of evaluating ablation lesions depth and lateral 
extents, we investigate in Chapter 3, methods of delivering light to the area treated. 
We designed and tested two photoacoustic-enabled RF ablation catheters for 
simultaneous ablation via RF current and illumination for photoacoustic imaging. We 
showed that in terms of illumination area and SNR a simple model comprising a 
single optical ﬁber at the center of the catheter is equivalent to a more complicated 
design of ﬁbers surrounding the ablation electrode. In addition to that, we showed 
how the dual wavelength imaging method developed in chapter 2, solves clutter 
problems related to the catheter tip. Finally, with all devices ready at hand, within 
suitable sizes and conﬁgurations for ease of translation, we monitored RF ablation 
lesion formation. In Chapter 4, we showed feasibility of monitoring RF ablation lesion 
formation in real time in a readily translatable setup. The dual wavelength imaging 
method allowed us to successfully monitor lesion continuity and transmurality, in an 
ex-vivo porcine heart through circulating blood. Strong photoacoustic signals 
generated by blood, as well as by the catheter tip were correctly classiﬁed as 
non-lesion signals. This experiment also taught us that perhaps the more complex 
ablation catheter design with multiple optical ﬁbers surrounding the tool shaft was 
after all a better design when taking into account experimental maneuverability and 
the resulting different catheter positions against the cardiac wall. In this ﬁrst part, we 
conclude that photoacoustic imaging is a strong contender to solving the problems 
currently faced in interventional electrophysiology interventions for atrial ﬁbrillation 
treatment.
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The second interventional cardiology application we address in this thesis is 
percutaneous coronary intervention. Narrowing of coronary arteries impedes blood 
ﬂow, and subsequently nutrition and oxygen provisions to cardiac tissue. This endangers 
the long term viability of the concerned myocardial areas. Rupture of ‘vulnerable’ 
atherosclerotic plaque can provoke myocardial infarcts. Thus, at the onset of the very 
ﬁrst symptoms, such as chest pain, a PCI is performed; in narrowed vessel areas a 
stent is deployed maintaining the artery wall open to recover blood ﬂow. Of imminent 
importance is the localization of the culprit area, which is believed to be a lipid-rich 
plaque. Photoacoustic imaging was previously shown to provide information on 
plaque lipid content. In Chapter 5 we designed and tested a miniature intravascular 
photoacoustic imaging catheter for robustness and SNR. The design was oriented 
towards imaging plaque in a realistic and translatable setting. We optimized the 
catheter for light delivery, manageable ﬂush parameters and robustness with reduced 
mechanical damage risks at the laser/catheter joint interface. We also showed 
capability of imaging atherosclerotic plaque through sheath and in water medium ex 
vivo. In Chapter 6 we used the designed catheter to image the coronary arteries of 
an atherosclerotic pig model. We could successfully identify peri-adventitial lipids as 
well as lipid rich plaques in ﬂushed D2O as well as through blood. We compared the 
images to two other clinically-approved imaging modalities, namely NIRS and OCT 
and showed good accordance with OCT but surprisingly poor correlation to NIRS, a 
modality which theoretically also images tissue lipid content. The technology is 
promising, but more work is needed from the systems engineering point of view as 
well as from the imaging point of view in terms of photoacoustic spectral methods for 
better plaque vulnerability speciﬁcity.
 Photoacoustic signals contain information that goes beyond tissue absorption. 
Processing and analysis of signals already enabled us to increase ablation lesion 
identiﬁcation rates. We showed in Chapter 7 that by manipulating signals of two 
photoacoustic acquisitions at two different wavelengths we can detect whether 
certain signal regions contain more than one photoacoustic source. We further 
showed that with a-priori knowledge of the expected photoacoustic sources 
absorption contrast ratio we can separate and co-localize them with high accuracy, 
down to the 1/20th of the imaging system’s beamformed lateral resolution. This 
processing technique holds promise in co-localization of targeted dual-modality 
contrast agents. If tweaked, this method could also be implemented to track and 
localize with high accuracy catheter tip position in an electrophysiology setup. 
 In a nutshell, this thesis describes novel photoacoustic imaging solutions to 
improve guidance and treatment of two speciﬁc minimally-invasive procedures in 
cardiology. Albeit, identiﬁcation of tissue molecular markers with photoacoustic imaging 
will guide the future of disease pathways understanding and improve treatment 
strategies.
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Samenvatting
Volgens de Wereldgezondheidsorganisatie (WHO) was in 2016 hart- en vaatziekten 
wereldwijd doodsoorzaak nummer een in landen met een middel tot hoog bruto 
nationaal product. Het gaat om 15,2 miljoen doden wereldwijd en dit is de trend van 
de afgelopen 15 jaar. Hart- en vaatziekten hangen vaak samen met andere medische 
aandoeningen en klinisch gezien zijn er vaak meerdere aspecten die een rol spelen. 
Zo is bijvoorbeeld aangetoond dat aderverkalking een rol kan spelen bij de ontwikkeling 
van boezemﬁbrilleren. Met behulp van foto akoestische beeldvormingstechnieken is 
het mogelijk biologische signaalmoleculen weer te geven. Het is mogelijk dat we met 
behulp van deze signaalmoleculen dit complexe web van aandoeningen en oorzaak- 
gevolg kunnen ontrafelen. 
 Veel cardiovasculaire aandoeningen die vroeger een operatie vereisten, kunnen 
nu minimaal invasief worden behandeld met behulp van katheters. Deze minimaal- 
invasieve behandelingen zijn erg afhankelijk van beeldvormingstechnieken om deze 
procedures te begeleiden. Wat vroeger zichtbaar was voor de cardioloog, wat tastbaar 
was, is nu verborgen binnenin het lichaam. Dus zonder al deze beeldvorming zouden 
cardiologen niet kunnen handelen, hij zou volledig blind zijn. Angiograﬁe, waarbij de 
hartslagaders in beeld worden gebracht door middel van röntgen en contrastmiddel, 
is nodig om de katheter op de juist plek te krijgen. Daarnaast moet de cardioloog de 
behandellocatie bepalen en  daarna gecontroleerd hoe de behandeling verloopt en 
of deze succesvol is afgerond. Al deze stappen hebben beeldvormingstechnieken 
nodig om de cardioloog te ondersteunen. Dit heeft ervoor gezorgd dat er een miljarden-
industrie is ontstaan rondom het ontwikkelen en produceren van nieuwe cardio-
vasculaire katheters. Naast de expertise van de cardioloog zijn deze beeldvormings-
katheters een essentieel onderdeel voor een succesvolle minimaal-invasieve interventie. 
 Foto akoestische beeldvorming is een opkomende technologie met een exponentieel 
groeiend aantal publicaties in biomedische wetenschappelijke tijdschriften in het 
afgelopen decennium. Het foto akoestische principe is gebaseerd op de omzetting 
van licht naar geluid, na absorptie van het licht. Door met verschillende golﬂengtes 
naar een weefsel te kijken, waarbij verschillende delen van het weefsel verschillende 
golﬂengtes absorberen, kan veel informatie worden vergaard over de eigenschappen 
van het weefsel. Deze stralingsvrije technologie kan de moleculaire samenstelling van 
weefsels op meerdere schalen afbeelden, afhankelijk van de keuze van de instrumentatie.
 In dit proefschrift kijken we hoe we met behulp van foto akoestiek problemen 
omtrent twee verschillende cardiovasculair interventies kunnen verhelpen. Namelijk 
bij katheterablatie door middel van radiofrequente (RF) energie bij boezemﬁbrilleren 
en bij percutane coronaire interventie (PCI) voor aderverkalking, in de volksmond ook 
wel dotteren genoemd. 
 De eerste interventie waar we naar hebben gekeken op het gebied van interventie 
elektrofysiologie en richt zich op ablatie van abnormaal geleidend weefsel in het hart. 
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De slagingskans van zo’n procedure varieert tussen de 60 en 70 %. Dit lage aantal 
bevat ook patiënten die meermaals de procedure hebben ondergaan en daarnaast 
ook medicamenteuze behandeling krijgen voor hun boezemﬁbrilleren. Deze lage 
slagingskans wordt met name veroorzaakt door ontoereikende behandeling van het 
abnormaal geleidende weefsel. Tijdens radiofrequente ablatie wordt weefsel 
behandeld met als doel abnormale elektrische verbinding te onderbreken of om een 
structuur in het hart zodanig te wijzigen dat geen ritmestoornissen meer optreden. 
Het behandelde weefsel wordt een laesie genoemd. Bij gebrek aan visuele feedback 
op de geleverde behandeling, zijn laesies vaak niet transmuraal, over de gehele dikte 
van de hartwand, of zijn niet continue. Discontinuïteit en niet-transmurale laesies 
kunnen ervoor zorgen dat er alsnog abnormale geleiding en dus ﬁbrillatie optreedt. 
 In de eerste paar hoofdstukken van dit proefschrift hebben we een methode 
ontwikkeld waarbij de laesies kunnen monitoren tijdens RF ablatie. De oplossing 
bevat een aangepaste ablatiekatheter waarbij lokaal licht wordt afgegeven op het 
behandelde gebied. Met een intracardiale tranducent die het gegenereerde foto 
akoestische geluid opvangt. In Hoofdstuk 2 bestudeerden we de foto akoestische 
kenmerken van ablatielaesies in vergelijking met het omliggende, onbehandelde 
weefsel. We vonden dat vanaf 600 nm, tot en met de maximale onderzochte golﬂengte 
van 1350nm, een licht energie van een paar milli-joules per vierkante centimeter 
voldoende is om de volledige dikte van de boezem te kunnen bekijken. Daarnaast 
vonden we ook dat het foto akoestische signaal het meeste contrast geeft bij 640nm, 
in combinatie met de door ons gekozen transducent met een fundamentele frequentie 
van 7 MHz en een bandbreedte van 100%. Tenslotte hebben een beeldvormings-
methode ontwikkeld voor het bepalen van de grootte van de laesie, deze is gebaseerd 
op de verhouding tussen de beelden bij 790nm en 930nm. We kunnen hiermee een 
laesie diagnosticeren met een nauwkeurigheid van 97%. Gewapend met deze robuuste 
methode om de diepte en de laterale omvang van ablatie-laesies te evalueren, 
onderzoeken we in Hoofdstuk 3 methoden voor het afgeven van licht aan het 
behandelde gebied. We ontwierpen en testten twee ablatiekatheters voor gelijktijdige 
ablatie via RF-stroom en verlichting voor foto akoestische beeldvorming. We toonden 
aan de ons simpele ontwerp, waarbij we een enkele optische ﬁber door het midden 
van de ablatiekatheter plaatsen, net zo goed werkt als een complexer ontwerp 
waarbij meerdere ﬁbers rondom de katheter worden geplaatst. Daarnaast laten we 
zien hoe de tweevoudige golﬂengtemethode die in hoofdstuk 2 is ontwikkeld, 
problemen met ruis met betrekking tot de kathetertip oplost. In Hoofdstuk 4 lieten we 
de haalbaarheid zien van het direct volgen  van RF-ablatie laesievorming in een naar 
de kliniek vertaalbare opstelling. De beeldvormingsmethode met dubbele golﬂengte 
stelde ons in staat de continuïteit van de laesie en transmuraliteit met succes te volgen, 
in een ex-vivo hart van een varken met circulerend bloed. Sterke foto akoestische 
signalen gegenereerd door bloed, evenals door de kathetertip werden correct 
 geclassiﬁceerd als niet-laesiesignalen. Dit experiment leerde ons ook dat misschien 
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het complexere ontwerp van de ablatiekatheter met meerdere optische vezels 
rondom de katheter toch een beter ontwerp was wanneer rekening word gehouden 
met manoeuvreerbaarheid en de resulterende verschillende katheterposities tegen 
de hartwand. In dit eerste deel concluderen we dat foto akoestische beeldvorming 
een goede kandidaat is voor het oplossen van de problemen die zich momenteel 
voordoen bij elektrofysiologische interventies voor atriale ﬁbrillatiebehandeling.
 De tweede interventionele cardiologische toepassing die we in dit proefschrift 
behandelen, is percutane coronaire interventie (PCI). In deze procedure wordt de 
vernauwing van kransslagaders, aderverkalking, verholpen. Deze vernauwing zorgt 
voor een verminderde doorbloeding en waardoor de voedings- en zuurstofvoor-
zieningen aan hartweefsel ontoereikend is. Op lange termijn brengt dit de gezondheid 
van het betrokken myocardiaal gebied in gevaar. Deze aderverkalking kan loskomen 
van de vaatwand of breken met als gevolg een hartinfarct. Wanneer hier symptomen 
van zijn, zoals pijn op de borst, wordt zo’n PCI uitgevoerd, er wordt dan een stent in 
het vernauwde bloedvat geplaatst, waarmee de slagader wordt opgehouden en 
doorbloeding wordt hersteld. Tijdens deze procedure is de locatie waar de stent 
wordt geplaatst van beland, het meest risicovolle gebied wordt behandeld. Er wordt 
vanuit gegaan dat dit het gebied is waar de plaque (aderverkalking) lipide rijk is. Met 
behulp van foto akoestische beeldvorming kan het lipide gehalte van de plaque 
worden bepaald. In Hoofdstuk 5 hebben we een intravasculaire foto akoestische 
beeldvormingskatheter ontworpen en getest voor robuustheid en signaal ruis verhouding 
(SNR). Het ontwerp is zo gemaakt dat het zo realistische mogelijk en zoveel mogelijk 
op de klinische toepassing lijkt voor beeldvorming van plaque. We hebben de 
katheter geoptimaliseerd voor klinische toepasbaarheid en robuustheid met beperkte 
mechanische schade aan de laser / katheter-interface. We toonden aan dat we met 
deze katheter in een omhulsel, nodig voor klinische doeleinden, foto akoestische 
beeldvorming kunnen doen in een ex vivo kransslagader. In Hoofdstuk 6 hebben we 
de ontworpen katheter gebruikt om de kransslagaders van een atherosclerotisch 
varkensmodel in beeld te brengen. We konden zowel peri-adventitiële lipiden als 
lipide-rijke plaques in een met D2O doorgespoelde kransslagader en in een 
doorbloedde kransslagader met succes in beeld brengen. We vergeleken de beelden 
met twee beeldvormingsmodaliteiten die in de kliniek worden gebruikt, namelijk NIRS 
en OCT. De resultaten lieten een goede overeenkomst zien met OCT, maar een 
slechte correlatie met NIRS, want die theoretisch het necrotische kern van het weefsel 
visualiseert.  De technologie is veelbelovend, maar  voor een klinische toepassing is 
nog veel werk nodig om de katheter van een prototype naar een product te brengen 
en daarnaast is er ook nog werk nodig met betrekking tot foto akoestische analyse 
methoden voor een betere speciﬁcatie van de kwetsbaarheid van plaque.
 Foto akoestische signalen bevatten meer informatie dan alleen de absorptie van 
weefsel. Verwerking en analyse van signalen hebben ons al in staat gesteld om 
robuuste ablatie-laesie-identiﬁcatie te bewerkstelligen. In Hoofdstuk 7 toonden we 
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aan dat we door het manipuleren van signalen van twee foto akoestische acquisities 
bij twee verschillende golﬂengten kunnen detecteren of bepaalde signaalgebieden 
meer dan één foto akoestische bron bevatten. We toonden verder aan dat we met 
voorkennis van de verwachte absorptie contrast van de foto akoestische bronnen, 
we de bronnen kunnen scheiden en co-lokaliseren met een hoge nauwkeurigheid. 
Nauwkeurig tot aan de 1/20ste van de laterale resolutie van het beeldvormings-
systeem. Deze verwerkingstechniek is veelbelovend in co-lokalisatie van gerichte 
contrastmiddelen met twee modaliteiten. Indien aangepast, zou deze methode ook 
kunnen worden geïmplementeerd om zeer nauwkeurig de kathetertippositie in een 
elektrofysiologische opstelling te volgen en te lokaliseren.
 In een notendop beschrijft dit proefschrift nieuwe foto akoestische beeldvormings-
oplossingen om de begeleiding en behandeling van twee speciﬁeke minimaal 
invasieve procedures in de cardiologie te verbeteren. Wellicht zal de identiﬁcatie van 
moleculaire weefselmarkers met foto akoestische beeldvorming de toekomst van 
ziektetrajecten inzicht verschaffen en behandelingsstrategieën verbeteren.
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